Exploring neurocognition across the psychosis continuum by Jabben, N.E.J.G.
  
 
Exploring neurocognition across the psychosis
continuum
Citation for published version (APA):
Jabben, N. E. J. G. (2009). Exploring neurocognition across the psychosis continuum. Maastricht:
Datawyse / Universitaire Pers Maastricht.
Document status and date:
Published: 01/01/2009
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
  
EXPLORING NEUROCOGNITION 
ACROSS 
THE PSYCHOSIS CONTINUUM 
Thesis_Jabben_v3.pdf   1 30-6-2009   8:56:12
  
 
 
 
 
 
 
 
 
 
 
 
 
© Nienke Jabben, Maastricht 2009 
 
Cover Image | painting by Inge Satters - Coolen 
Print | Datawyse, Maastricht 
Universitaire Pers Maastricht 
ISBN | 978 90 5278 848 7 
 
 
 
 
All rights are reserved. No part of this thesis may be reproduced, stored or transmitted in 
any form or by any means without written permission from the author of, when appropri-
ate, the publisher of the article.
Thesis_Jabben_v3.pdf   2 30-6-2009   8:56:13
  
EXPLORING NEUROCOGNITION 
ACROSS  
THE PSYCHOSIS CONTINUUM 
  
PROEFSCHRIFT 
 
Ter verkrijging van de graad van doctor aan de Universiteit Maastricht  
op gezag van de Rector Magnificus, Prof. mr. G.P.M.F. Mols  
volgens het besluit van het College van Decanen, 
 in het openbaar te verdedigen op  
donderdag 3 september 2009  
om 14.00 uur 
 
door 
 
Nienke Elfriede Johanna Gerarda Jabben 
Geboren op 11 september 1980 te Sittard 
UNIVERSITAIRE
PERS MAASTRICHT
P
M
Thesis_Jabben_v3.pdf   3 30-6-2009   8:56:13
Promotor 
Prof. dr. J. van Os 
 
Copromotor 
Dr. L. Krabbendam 
 
Beoordelingscommissie 
Prof. dr. E. Griez (voorzitter) 
Prof. dr. W. A. Nolen (Universitair Medisch Centrum Groningen) 
Em. Prof. dr. H. van Praag 
Prof. dr. W. Riedel 
Dr. S. Sobczak 
 
 
 
 
 
 
 
 
 
 
South Limburg Mental Health Research and Teaching Network, PhD Series 
 
 
 
 
 
 
The research presented in this thesis was conducted at the Maastricht Brain & 
Behaviour Institute and the Department of Psychiatry and Neuropsychology, 
Maastricht University. 
 
The publication of this thesis was financially supported by: GlaxoSmithKline, 
Lundbeck B.V.
Thesis_Jabben_v3.pdf   4 30-6-2009   8:56:13
  
Thesis_Jabben_v3.pdf   5 30-6-2009   8:56:13
Paranimfen 
Tineke Lataster 
Pauline Peeters 
 
Thesis_Jabben_v3.pdf   6 30-6-2009   8:56:13
 CONTENTS 
         Page 
 
Chapter 1 9 
Introduction  
  
Chapter 2 19 
Meta-analyses of cognitive functioning in euthymic bipolar patients and 
their first-degree relatives 
 
  
Chapter 3 41 
Neurocognitive functioning as intermediary phenotype and predictor of 
psychosocial functioning across the psychosis continuum: studies in schi-
zophrenia and bipolar disorder 
 
  
Chapter 4 67 
Investigating the association between neurocognition and psychosis in bi-
polar disorder: further evidence for the overlap with schizophrenia 
 
  
Chapter 5 89 
COMT single marker and haplotype associations with bipolar disorder and 
neurocognitive functioning 
 
  
Chapter 6 107 
Cognitive alterations in those at risk for psychosis: neutral markers of ge-
netic risk or indicators of social disability? 
 
  
Chapter 7 125 
Is processing speed predictive of functional outcome in psychosis?  
  
Chapter 8 141 
Epilogue  
  
Summary 157 
Samenvatting 162 
Dankwoord 167 
Curriculum Vitae 169 
List of Publications 171 
Thesis_Jabben_v3.pdf   7 30-6-2009   8:56:13
Thesis_Jabben_v3.pdf   8 30-6-2009   8:56:13
 CHAPTER 1 
INTRODUCTION 
 
Page | 9  
Thesis_Jabben_v3.pdf   9 30-6-2009   8:56:13
INTRODUCTION 
Page | 10 
 
INTRODUCTION 
 
In the fifth edition of his textbook in 1896, Kraepelin classified what was 
previously considered to be a unitary concept of psychosis into two different diag-
noses (Angst, 2002). He proposed a dichotomy between manic depressive insanity 
and dementia praecox based on the episodic and relatively benign course of the 
former compared to the latter. In today’s classification systems, such as DSM IV 
(APA, 1994) and ICD-10 (WHO, 1999), bipolar disorder and schizophrenia are 
still separated.  
 
Bipolar disorder – phenomenology and aetiology 
Bipolar disorder represents a heterogeneous group of mood disorders that is de-
fined by the presence of episodes of mania or hypomania, often alternating with 
episodes of depression. Mania and depression are the two poles of emotional ex-
tremes, depressive episodes representing periods of persistent depressed feelings 
or loss of interest, mania and hypomania representing periods of abnormally ele-
vated, expansive or irritable mood. A bipolar disorder is diagnosed when at least 
one manic or hypomanic episode has occurred during life time. Bipolar disorders 
are divided into two major subgroups, bipolar I disorder and bipolar II disorder, 
that are differentiated by the presence of a manic episode in the former whereas in 
the latter depressive episodes with at least one period of hypomania must have 
occurred. The life time risk to develop bipolar I disorder is estimated around 1.3% 
(ten Have, Vollebergh, Bijl, & Nolen, 2002) whereas life time prevalence for a 
broader bipolar spectrum (including bipolar disorder NAO, cyclothymia, and hy-
pomania induced by antidepressive medication) is estimated around 5.2% (Regeer 
et al., 2004). Bipolar disorder is a lifelong, chronic illness with an onset between 
the ages of 15 and 30 in the majority of cases. The disorder interferes considerably 
with patients’ social and occupational functioning and has a large burden and cost 
for society (Oswald et al., 2007). 
There is no single cause for bipolar disorder. Family studies have indicated a large 
heritability factor in bipolar disorder, and first-degree relatives of bipolar patients 
have an eight times increased risk to develop the disorder (Craddock & Jones, 
2001). Most likely, genes interact with environmental factors in causing the disor-
der, with degree of influence of various factors differing between individuals.  
 
Schizophrenia – phenomenology and aetiology 
Schizophrenia is one of the most severe mental disorders. Among the main symp-
toms are delusions, hallucinations, thought disorders, catatonic and chaotic behav-
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iour and negative symptoms (such as flat affect and emotion, poverty of speech 
and avolition). Negative symptoms tend to be chronic, while positive symptoms 
(such as delusions and hallucinations) are more transient and tend to react better to 
antipsychotic medication. A diagnosis of psychotic disorder is made when above 
mentioned symptoms interfere with social and occupational functioning (APA, 
1994). Neurocognitive deficits are often present in psychotic disorders although 
they are not currently part of the criteria in diagnostic classification systems. The 
estimated life time prevalence of schizophrenia is about 1 % in the population 
(Jablensky et al., 1992). Age of onset has the largest peak between the ages of 20 
and 28 for males and between 26 and 32 for females. Schizophrenia is a chronic 
disease and known to be a major cause of disability, having a profound impact on 
people’s social and professional lives. 
Schizophrenia is a very heterogeneous disease with multiple causes. In general, it is 
assumed that genes and environment interact in causing the illness. First-degree 
relatives have a tenfold risk to develop the disorder, suggesting a substantial ge-
netic contribution. The inheritance pattern, however, appears to be complex, with 
multiple genes of small effect. Genetic factors alone are not sufficient to cause 
schizophrenia. Environmental factors such as living in an urban environment 
(Kirkbride et al., 2006; van Os, 2004), childhood abuse (Janssen et al., 2004), pre- 
and perinatal complications (Buka & Fan, 1999) and stress in daily life (Myin-
Germeys, Delespaul, & van Os, 2005), play an important role in the aetiology of 
psychotic disorders as well. 
 
The end of an era: Return of the unitary concept of psychosis? 
The reader will have noticed that the characteristics of bipolar disorder and 
schizophrenia overlap to some extent in the above descriptions. Current findings 
of overlap between bipolar disorder and schizophrenia are increasingly challenging 
the validity of the Kraepelinian dichotomy. The existence of a diagnosis of 
‘schizoaffective disorder’, which is used to categorize the great number of patients 
that do not fit properly into either diagnoses, is probably the best illustration of the 
lack of a strict distinction between these disorders. It was Kraepelin himself who 
admitted already in 1920 that, ‘...it is becoming increasingly clear that we cannot 
distinguish satisfactorily between these two illnesses...’. His proposed dichotomy, 
however, still stands. 
 
Findings of overlap 
Findings of overlap come from various areas. First of all, there is a great amount of 
overlap in phenomenological characteristics. Psychotic symptoms, the hallmark of 
schizophrenia, also occur in a large number of bipolar patients, and mood 
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symptoms such as depression and mania can also be present in schizophrenia. In 
addition to this, epidemiological characteristics of the two disorders, such as age of 
onset, lifetime risk (Torrey, 1999) and risk factors (Cannon & Dean, 2004; Torrey 
& Miller, 1997) tend to show overlap. Schizophrenia and bipolar disorder are both 
highly heritable and studies suggest familial co-aggregation between both disorders 
(Cardno, Rijsdijk, Sham, Murray, & McGuffin, 2002). Recent linkage and 
association studies have identified overlapping genetic loci for schizophrenia and 
bipolar disorder (Badner & Gershon, 2002; Craddock, O'Donovan, & Owen, 
2005). In brain structure investigations, ventricular enlargement, volumetric 
reduction of prefrontal regions, and white matter pathology have been consistently 
identified in schizophrenia but appear to be also present, although to a lesser 
degree, in patients with bipolar disorder (McDonald et al., 2004). Another domain 
of overlap between bipolar disorder and schizophrenia concerns pharmacological 
treatment. Atypical antipsychotic medication used for treatment of schizophrenia 
may also be successful in treatment of bipolar disorder, and recent studies suggest 
that mood stabilizing drugs may be an effective adjuvant in schizophrenia (Casey et 
al., 2003). 
 
Alternative models 
Although the categorical distinction between bipolar disorder and schizophrenia 
may be of benefit in clinical practice, the findings of overlap between 
schizophrenia and bipolar disorder suggest that the artificial split between 
disorders does not represent the psychosis phenotype as it occurs in the 
population. From the 1980s a continuum view has gained support (Crow, 1990), 
implying a continuum from unipolar to bipolar disorder to schizoaffective psycho-
sis and up to schizophrenia. According to this view psychotic symptoms are 
considered as non-specific to disease. Instead, a dimensional view describing 
phenomenology on individual dimensions is thought to provide a more valid 
representation of psychopathology.  
Murray and colleagues (Murray et al., 2004) aimed to explain similarities and dis-
similarities between bipolar disorder and schizophrenia by suggesting that bipolar 
disorder and schizophrenia share susceptibility genes that cause a predisposition to 
psychosis in general. When, in addition to this predisposition, a neurodevelopmen-
tal impairment is present, a schizophrenia-like phenotype will emerge. The neuro-
developmental impairment predisposition will contribute to the expression of 
negative and deficit symptoms and, in association with these symptom domains, to 
the cognitive deficits characteristic of schizophrenia. In the absence of these neu-
rodevelopmental impairments, however, a more affective psychotic phenotype like 
bipolar disorder will emerge. The hypothesised distinction between good outcome 
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psychotic disorder without developmental impairment (characterised by positive 
and affective symptoms) and poor outcome psychotic disorder with developmental 
impairment (with negative and cognitive symptoms) in fact goes back to the publi-
cation by Robins and Guze (Robins & Guze, 1970) that hypothesised, albeit within 
the more narrow domain of schizophrenia alone, two broad dimensions separated 
along similar lines. 
 
Neurocognitive functioning in severe mental illness 
In the above mentioned model describing the similarities and differences between 
psychosis with and without developmental impairment, another important 
characteristic present in both schizophrenia and bipolar disorder is implicated. The 
disorders also overlap in the presence of neurocognitive impairment. This will be 
the focus of the present thesis. 
 
Neurocognitive impairment as endophenotypic marker 
The presence of neurocognitive impairment is a core feature of schizophrenia. 
Impairments are found among a broad range of cognitive domains with largest 
effect sizes of deficit reported for attention, (working) memory and executive func-
tioning (Heinrichs & Zakzanis, 1998; Keefe, Eesley, & Poe, 2005). Cognitive im-
pairments are independent of positive symptoms (Dominguez, Viechtbauer, 
Simons, van Os, & Krabbendam, 2008) and remain relatively stable throughout the 
course of the illness. Cognitive alterations in similar domains are also found, to a 
lesser degree, in first-degree relatives of schizophrenia (Sitskoorn, Aleman, Ebisch, 
Appels, & Kahn, 2004; Snitz, Macdonald, & Carter, 2006) and in persons at psy-
chometrically defined risk for the disorder (Voglmaier, Seidman, Salisbury, & 
McCarley, 1997). The findings that cognitive impairment is i) heritable, ii) associ-
ated with schizophrenia but not just the consequence of the disorder, and iii) pre-
sent in relatives of patients and in those at psychometrical risk for the disorder, 
have led to the suggestion that neurocognitive impairments may represent the 
expression of the genetic vulnerability to schizophrenia and can be seen as a psy-
chosis endophenotype (Gottesman & Gould, 2003).  
Bipolar disorder is similarly accompanied by cognitive deficits and there are many 
studies showing decreased cognitive functioning during depressive episodes and 
mania (Martinez-Aran et al., 2004). Traditionally, it was assumed that cognitive 
functioning would return to normal in periods between episodes, but evidence is 
now accumulating that stable, euthymic bipolar patients continue to exhibit cogni-
tive impairments (Robinson et al., 2006). Some researchers have suggested that 
cognitive impairment is a core symptom in bipolar disorder, similar to schizophre-
nia, and that it may likewise be a endophenotypic marker for bipolar disorder 
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(Glahn, Bearden, Niendam, & Escamilla, 2004). If this is true, cognitive alterations 
should be detectable in the first-degree relatives of bipolar patients. The number of 
studies performed on cognitive functioning in relatives of bipolar disorders, how-
ever, is limited, and results have been inconsistent.  
Direct comparisons of cognitive performance in schizophrenia and bipolar pa-
tients suggest that the pattern of cognitive deficits is rather similar but that groups 
differ in the severity of impairment (Krabbendam, Arts, van Os, & Aleman, 2005). 
Comparisons of cognitive performance in relatives of patient groups are scarce and 
could provide more information regarding the role of neurocognition as endo-
phenotype in bipolar disorder and schizophrenia. In short, investigation of similari-
ties and differences in the neurocognitive domain could further our understanding 
of the true relationship between the two disorders.  
 
Neurocognitive impairments as predictor of outcome  
Cognitive impairment in severe mental illness is not only important given the pos-
sible role as a marker of genetic vulnerability, but also as a predictor of functional 
outcome. In schizophrenia it has been suggested that outcome is more strongly 
associated with stable illness characteristics such as cognitive impairment than with 
the more variable positive symptoms of psychosis (Green, 1996; Green, Kern, & 
Heaton, 2004). However, other studies suggested that it is not so much the severity 
of acute symptoms but rather the level of persisting symptoms that impact on 
outcome (Norman et al., 1999). One limitation of many published studies on cog-
nition-outcome relationships is their cross-sectional design. To be able to investi-
gate true predictive value of neurocognition on outcome, longitudinal studies in-
vestigating the impact of neurocognition on changes in functional outcome relative 
to baseline levels are required. A review of longitudinal studies concluded that 
there was considerable support for longitudinal associations between cognition and 
outcome  (Green et al., 2004), but other studies suggested that longitudinally less 
variance in outcome is explained than cross-sectional associations suggest (Milev, 
Ho, Arndt, & Andreasen, 2005; Stirling et al., 2003). 
In bipolar disorder, the relationship between neurocognitive functioning and out-
come is less extensively investigated than in schizophrenia. This is not surprising as 
for a long time it was assumed that bipolar disorder patients would return to their 
normal level of psychosocial and cognitive functioning in-between episodes. With 
increasing knowledge of the persistence of cognitive impairment in at least a sub-
group of bipolar patients, some studies have now been conducted on the func-
tional significance of this impairment, suggesting that in bipolar disorder cognitive 
impairments likewise affect the functioning of patients in their daily lives (Green, 
2006). 
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Aims and outline of the thesis 
The overall goal of this thesis is to investigate the aetiological and predictive value 
of cognitive impairment in both bipolar disorder and schizophrenia and to discuss 
their similarities and differences in the context of a continuum view of severe men-
tal illness.  
 
Part 1: Neurocognition as endophenotype 
In the first part of this thesis, the role of neurocognitive functioning as endo-
phenotypic marker for bipolar disorder and schizophrenia will be explored. First, 
the evidence of neurocognitive functioning as endophenotypic marker in bipolar 
disorder is evaluated in a meta-analysis of studies investigating neurocognitive 
functioning in bipolar patients and in their first-degree relatives (chapter 2). The 
possible role of neurocognitive functioning as genetic vulnerability marker for both 
bipolar disorder and schizophrenia is further investigated in a direct comparison of 
neurocognitive functioning in patients with schizophrenia and bipolar disorder and 
their relatives, in order to examine shared and non-shared characteristics in the 
cognitive domain. Data for this study are drawn from two samples, the 
BIPOLCOG study, a study on cognitive functioning in 81 patients with bipolar 
disorder and their healthy first-degree relatives, and the Maastricht site of the na-
tional GROUP study, a large study investigating similar cognitive domains in 345 
patients with non-affective psychotic disorder and their healthy first-degree rela-
tives (chapter 3).  
In schizophrenia, a distinction is made between psychosis with predominantly 
negative symptoms and developmental impairment and cognitive impairment on 
the one hand and psychosis with predominantly positive symptoms and without 
developmental impairment and cognitive impairment on the other. A consistent 
finding is the lack of any significant associations between neurocognitive dysfunc-
tion and the positive symptoms of psychosis. The extension of this model to the 
continuum spanning affective and non-affective psychosis, results in testable hy-
potheses regarding the cognitive profile of relatives of patients with bipolar disor-
der. In the BIPOLCOG study we investigated whether this model can be extended 
to bipolar disorder (chapter 4). Previous studies have reported associations be-
tween cognitive endophenotypes of non-affective psychoses and the catechol-O-
methyltransferase (COMT) gene. Given the suggested overlap between schizo-
phrenia and bipolar disorder, in this thesis the endophenotypic nature of neuro-
cognitive dysfunction is further explored by examining the role of the COMT gene 
in patients with a diagnosis of bipolar disorder in the BIPOLCOG study (chapter 
5).  
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Part 2: Cognition as predictor of outcome 
In the second part of this thesis, the predictive value of cognitive impairment on 
outcome in both bipolar disorder and schizophrenia is evaluated. In patients with 
psychotic disorders and in subjects with different levels of risk for psychosis, it is 
investigated whether cognitive alterations associated with the liability to psychosis 
are more than neutral indicators of risk for psychosis by examining the predictive 
value of neurocognitive functioning on outcome. This is done in the ‘Cognitive 
Functioning in Psychosis’ (CoP) study, investigating cognitive functioning and 
outcome in 29 patients with non-affective psychotic disorders, 46 non-psychotic 
first-degree relatives and 41 subjects at psychometrically defined risk for psychosis 
(chapter 6). The relative contribution of cognition in the prediction of outcome 
over and above the predictive value of symptoms is explored in a combined group 
of patients with affective and non-affective psychosis, as is the question whether 
cognition has true long-term prognostic value in relation to changes in outcome, 
taking into account the baseline level of functioning. Data for this study are drawn 
from the baseline and year 2 assessments of the UK700 Case Management Trial, a 
2-year randomised controlled trial comparing the efficacy of different intensities of 
case management in 708 psychotic patients (chapter 7). Finally, associations be-
tween symptomatology, cognitive functioning and psychosocial functioning are 
explored in both schizophrenia and in bipolar disorder, to be able to compare the 
relative influence of neurocognition on psychosocial functioning in both disorders. 
This was done with data from the GROUP and BIPOLCOG study (chapter 3). 
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Abstract 
Background:  Previous work suggests that in particular impairments in executive 
function and verbal memory may persist in euthymic bipolar patients and serve as 
an indicator of genetic risk (endophenotype). Methods: A systematic review of the 
literature was undertaken. Effects sizes were extracted from selected papers and 
pooled using meta-analytic techniques. Results: In bipolar patients, large effect 
sizes (d>0.8) were noted for executive function (working memory), mental speed 
and verbal memory. Medium effect sizes (0.5<d<0.8) were reported for aspects of 
executive function (fluency, concept shifting, executive control), visual memory, 
and sustained attention. Small effect sizes (d<0.5) were found for visuoperception. 
In first-degree relatives, effect sizes were small (d<0.5), and only significantly dif-
ferent from healthy controls for executive function. Conclusion: Executive func-
tion is a candidate bipolar endophenotypes given medium deficits in these domains 
in bipolar patients and small, but intermediate, cognitive impairments in first-
degree relatives. 
 
Key words:  bipolar patients; cognition; meta-analysis; relatives 
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Introduction 
Christensen and colleagues (2006) investigated cognitive function in healthy twins 
discordant for bipolar disorder and found evidence for an association between 
cognitive dysfunction and genetic liability. The authors concluded that cognitive 
dysfunction may be a candidate indicator of genetic risk or endophenotype (Got-
tesman and Gould 2003) for bipolar disorder. Thus, there is evidence that cogni-
tive dysfunction persists in euthymic bipolar patients (Robinson et al. 2006; Savitz 
et al. 2005a) and also non-twin genetically sensitive studies suggest that aspects of 
cognition can possibly be regarded as endophenotype for bipolar disorder (Glahn 
et al. 2004; Hasler et al. 2006; Savitz et al. 2005b). Possible candidate neurocognitive 
endophenotypes in bipolar disorder are executive function (Glahn et al. 2004; 
Savitz et al. 2005b), attention (Burdick et al. 2006; Hasler et al. 2006), and verbal 
memory (Glahn et al. 2004; Hasler et al. 2006). A recent meta-analysis of cognitive 
deficits in euthymic bipolar patients (Robinson et al. 2006) provides further evi-
dence for executive function and verbal learning as possible endophenotypes for 
bipolar disorder.  
The aim of the present review was to estimate the meta-analytic effect size of cog-
nitive functioning in euthymic bipolar patients and their first-degree relatives, thus 
updating a previous systematic review of patients (Robinson et al. 2006), and add-
ing a new review for first degree relatives. The hypothesis was that first-degree 
relatives show cognitive deficits in the same areas as bipolar patients, albeit to a 
lesser degree.  
 
Methods 
Study selection  
Articles were identified through a literature search in PUBMED / MEDLINE, 
PSYCHINFO, and EMBASE covering the period between January 1985 and Sep-
tember 2006, using the keywords “bipolar disorder” or “manic depress*” and 
“family”/ “familial” or “first-degree relative” with “cognit*” or “neuropsych*”.  
The following criteria were used for inclusion: i) the study evaluated cognitive 
performance using standardized and reliable neuropsychological testing proce-
dures; ii) the study compared adult asymptomatic bipolar patients who were diag-
nosed using a recognised criterion-based diagnostic system and / or first-degree 
relatives with a healthy control group, matched for age, sex and education; iii) the 
study reported uncorrected mean test scores and standard deviations for both the 
patient and / or family and control group; iv) the study was published as an origi-
nal article in a peer-reviewed English language journal; and v) the study with bipo-
lar patients clearly defined euthymia or provided scores on mood rating scales 
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indicating that patients were euthymic (euthymia defined as a cut-off score of <8 
on the Hamilton Depression Rating Scale and the Young Mania Rating Scale, and 
/ or a score on mood rating scales below this cut-off point). 
The references of retrieved articles were hand-searched for further relevant articles. 
A second study on the same patient group was only included if it reported differ-
ent tests. 
 
Data Analysis 
Meta-analyses were performed using STATA (version 9.2), using a random effects 
model. For each test parameter an effect size was calculated, which was Cohen’s d, 
the difference between the means of both groups (bipolar patients and / or first-
degree relatives vs. controls) divided by the pooled standard deviation. Effect sizes 
were weighted for sample size, in order to correct for upwardly biased estimation 
of the effect in small samples. Effect sizes were expressed in such a way that posi-
tive effect sizes always indicated poorer performance by the patient or family 
group. The corresponding z-value and significance level provide an indication of 
the two-sided statistical significance of the association at 5% alpha. A homogeneity 
statistic was calculated in order to test to what degree the studies can be taken to 
share a common population effect size. A significant Chi-square-statistic indicated 
heterogeneity of the individual effect sizes. 
Meta-regression is a technique for trying to work out whether particular characte-
ristics of studies are related to the sizes of the treatment effect. Thus, in the case of 
significant heterogeneity, meta-regression, using STATA (version 9.2), was per-
formed in order to examine whether any heterogeneity found could possibly be 
explained by study differences in age structure, sex ratio, and mean educational 
level. 
 
Results 
Bipolar patients 
Twenty-eight studies were included in the meta-analysis (table 1, appendix). Four 
of these stratified their samples by a third variable (Ferrier et al. 1999; Nehra et al. 
2006; Torrent et al. 2006; van Gorp et al. 1998). For reasons of homogeneity, in the 
case of stratification, only one study group was included, with bias to the less se-
vere patients or those with a better established diagnosis. Thus, Ferrier et al. (1999) 
stratified by outcome, contrasting a good outcome versus a poor outcome group; 
for the purpose of the current meta-analysis only the good outcome group was 
included. The study by Nehra and colleagues (2006) used first and multiple episode 
patients, only established bipolar patients with multiple episodes were included in 
the current analysis. Van Gorp and colleagues (1998) included patients with and 
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without prior alcohol dependence, only the group without alcohol dependence was 
used in the analysis. Finally, Torrent and colleagues (2006) used BP-I and BP-II 
patients, only BP-I patients were included. 
 
Neuropsychological domains 
The neuropsychological tests used in these studies were divided into 11 categories 
measuring approximately the same cognitive construct (adapted from Krabbendam 
et al. 2005). A neuropsychological test was included by the a priori criterion of hav-
ing been used in at least four different studies. Immediate verbal memory was assessed 
using word list learning (California Verbal Learning Test (CVLT) (Delis 1987); Rey 
Auditory Verbal Learning Test (RAVLT) (Rey 1964); Auditory Verbal Learning 
Test (AVLT) (Brand and Jolles 1985)). For the purposes of the analysis, results of 
these comparable tests were included together. Delayed verbal memory was assessed 
using the delayed recall version of the CVLT, RAVLT, and AVLT. Delayed visual 
memory was measured using the delayed recall version of the Rey Osterrieth Com-
plex Figure (Rey 1941). Working memory was assessed using the Digit Span 
(Wechsler 1955). Verbal fluency was measured using either words from a certain 
category or beginning with a certain letter (FAS; (Benton 1978)). Concept formation 
and shifting was assessed with the Wisconsin Card Sorting Test (WCST; (Heaton 
1981)); number of perseverative errors and categories achieved were separately 
analysed. Executive control was measured using the Stroop Color-Word interference 
(Stroop 1935) and Trailmaking Test part B (Reitan 1958). Sustained attention was 
assessed using a variant of the Continuous Performance Test (Kurtz 2001). The 
test parameter used was number and/or percentage correct response. Mental Speed 
was measured using the Digit Symbol Substitution Test (DSST; (Wechsler 1955)) 
and the Trailmaking Test part A (Reitan 1958). Visuoperception was assessed using 
the copy version of the Rey Osterrieth Complex Figure (Rey 1941). Intelligence was 
measured using the full scale NART (Grober 1991) or the WAIS-R vocabulary 
score (Wechsler 1981), both good estimates of premorbid intelligence. 
 
Meta-analytic results patients 
All effect sizes were in the same direction (table 2), suggesting worse performance 
in euthymic bipolar patients compared to healthy controls.  
In all instances, with the exception of visuoconstruction (Rey copy) and intelli-
gence, bipolar patients displayed significantly poorer performance compared to 
controls. The largest effect sizes were evident for working memory (Digit Span 
backward), delayed and immediate verbal recall (CVLT), and mental speed (DSST) 
(effect sizes > 0.8). Medium effect sizes (0.5<d<0.8) were observed for fluency 
(categories), executive control (Trail B, Stroop), concept shifting (WCST persever-
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ative errors), delayed visual memory (Rey figure), sustained attention (CPT) and 
mental speed (Trail A). A small effect size (0.2<d<0.5) was noted for concept 
shifting (WCST categories), fluency (FAS) and working memory (Digit Span for-
ward). 
 
Table 2. Results of meta-analyses of cognitive test performances differences between bipolar 
patients versus normal controls 
 
1 Number of studies included in the analysis; 2 mean, weighted effect size Cohen’s d; 3 95 % confidence 
interval; 4 test of significance of effect size (p); 5 test of within category heterogeneity between studies (p) 
 
For five out of 17 analyses there was evidence for significant heterogeneity be-
tween the results of the different studies. The largest heterogeneity was found for 
working memory (Digit Span backward), executive control (Trail B) and concept 
shifting (WCST categories). Two studies were largely responsible for this hetero-
geneity, namely the study of Balanza-Martinez and colleagues (2005) and Goswami 
and colleagues (2006). Both showed larger effect sizes.  In a sensitivity analysis of 
working memory (Digit Span backward) excluding the study of Goswami and col-
leagues (2006), the observed heterogeneity largely disappeared (before exclusion:  
χ2=30.50, p=0.000; after exclusion: χ2=5.70, p=0.223). The effect size reflecting 
bipolar-control differences remained significant (d=0.73; p=0.000). The study of 
Goswami and colleagues (2006) caused most of the heterogeneity in the analysis 
on executive control (Trail B). Leaving this study out resulted in non-significant 
heterogeneity (before exclusion: χ2=33.93, p=0.000; after exclusion: χ2=10.78, 
p=0.214). The effect size reflecting bipolar-control differences remained significant 
(d=0.58; p=0.000). In the case of concept shifting (WCST categories), heterogene-
ity was largely caused by the studies of Balanza-Martinez and colleagues (2005) 
(before exclusion: χ2=19.76, p=0.019; after exclusion: χ2=11.21, p= 0.190). The 
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95% CI
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 z
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p value 
Chi-
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p value 
Digit backward 6 222 205 1.02 0.49 to 1.54 3.85 0.000 30.50 0.000 
CVLT delayed recall 10 269 282 0.85 0.60 to 1.09 6.83 0.000 16.27 0.061 
DSST 7 202 249 0.84 0.53 to 1.14 5.32 0.000 13.76 0.032 
CVLT immediate rec. 12 369 382 0.82 0.65 to 0.99 9.25 0.000 13.96 0.235 
Fluency categories 7 178 178 0.75 0.44 to 1.04 4.83 0.000 10.91 0.091 
Trail B 10 319 306 0.75 0.42 to 1.10 4.47 0.000 33.93 0.000 
Stroop time 6 116 124 0.73 0.32 to 1.13 3.49 0.000 11.00 0.051 
WCST Pers. Err. 10 268 288 0.72 0.58 to 0.95 5.90 0.000 15.24 0.085 
Stroop correct 8 258 268 0.65 0.47 to 0.83 7.17 0.000 2.37 0.937 
Rey figure 4 98 89 0.62 0.32 to 0.92 4.04 0.000 2.01 0.570 
CPT correct 4 74 85 0.58 0.09 to 1.08 2.31 0.021 6.52 0.089 
Trail A 10 319 306 0.58 0.42 to 0.75 7.02 0.000 4.88 0.845 
WCST Categories 10 268 288 0.49 0.22 to 0.76 3.59 0.000 19.76 0.019 
FAS 12 369 382 0.47 0.30 to 0.65 5.14 0.000 15.54 0.159 
Digit forward 6 222 205 0.37 0.15 to 0.59 3.33 0.001 6.19 0.288 
Rey copy 4 103 94 0.22 -0.06 to 0.51 1.52 0.129 2.89 0.409 
IQ 8 237 247 0.16 -0.11 to 0.44 1.15 0.250 15.36 0.032 
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effect size reflecting bipolar-control differences remained significant (d=0.39; 
p=0.000). The fact that the most significant heterogeneity was due to only two 
studies, suggests that certain characteristics of these studies may be responsible for 
this finding. The study by Balanza-Martinez and colleagues (2005) was relatively 
small and used a bipolar population with rather low educational level and no speci-
fication of characteristics of disease (duration, number of episodes etc.). One could 
speculate that they described a rather severely ill population. Goswami and col-
leagues (2006) used a rather young population with a relatively long duration of 
illness and early illness onset. This study too likely included a rather severely ill 
group of patients. 
Meta-regression revealed a significant effect of sex ratio on the concept formation 
and shifting case-control difference (WCST) (p= 0.001; B= -2.63; 95 % CI –4.156 
to –1.11). This finding indicates that studies with higher male / female ratios 
showed smaller effect sizes. Age had a significant effect on the case-control differ-
ence of concept formation (WCST) and working memory (Digit Span backward) 
(p= 0.000; B= -32.51; 95 % CI –43.6 to – 21.4, and p=0.029; B= -11.18; 95 % CI 
–21.2 to –1.18). Thus, studies with higher mean age showed smaller effect sizes. 
Finally, educational level had a significant effect on the working memory case-
control difference (Digit Span backward), fluency (FAS) and concept formation 
(WCST) (p=0.03; B= -0.014; 95 % CI –0.027 to –0.001; p=0.007; B= 36.93; 95 % 
CI 8.38 to 52.24; p=0.014; B= 2.53; 95 % CI 0.52 to 4.55). This points in the di-
rection of larger effect sizes in studies with higher educated participants. In conclu-
sion, part of heterogeneity may be due to differences between the various studies 
in these independent variables. 
 
Meta-analytic results first-degree relatives 
A total of fourteen studies were included (table 3, appendix). Two of these studies 
used more than one family group (McIntosh et al. 2005; Sobczak et al. 2003). In the 
study by McIntosh et al. (2005), a group of unaffected relatives from bipolar fami-
lies and a group from “mixed” families was used; only the group from bipolar 
families was included in the analyses. Sobczak et al. (2003) used a group of first-
degree relatives of BP-I patients and a group of relatives of BP-II patients; only the 
group of family-members of BP-I patients was used in the meta-analysis. 
The neuropsychological tests used in the studies were divided in the same catego-
ries as described earlier and included only if used in at least four different studies. 
This resulted in less cognitive domains analysed than in the bipolar studies. These 
domains were immediate and delayed verbal memory, working memory, concept formation and 
shifting, verbal fluency, executive control, mental speed, and intelligence.  The Visual Verbal 
Learning Test used in the study by Sobczak and colleagues (2003), measuring im-
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mediate and delayed verbal memory and resembling the CVLT and RAVLT (Lezak 
1995), was added to the analysis. 
 
Table 4. Results of meta-analyses of cognitive test performance differences between first-degree 
relatives versus normal controls 
 
1 Number of studies included in the analysis; 2 mean, weighted effect size Cohen’s d; 3 95 % confidence 
interval; 4 test of significance of effect size (p); 5 test of within category heterogeneity between studies (p) 
 
Meta-analysis of the neuropsychological domains indicated that all meta-analytic 
effect sizes were in the direction of worse performance in the first-degree relatives 
compared to the healthy controls (Table 4). Effect sizes, however, were much 
smaller than in the bipolar-control comparisons (< 0.5), and only significantly dif-
ferent for executive control (Stroop and Trail B).  
There was evidence of significant heterogeneity for three out of twelve analyses, 
namely for the domains of intelligence and working memory (Digit Span). Hetero-
geneity may be due to the small number of studies with small, heterogeneous 
groups of first-degree relatives with different family histories and genetic load. The 
study by Gourovitch and colleagues (1999), for example, using monozygotic twins, 
showed relatively large but differential effect sizes for working memory and verbal 
memory, contributing to heterogeneity. Meta-regression revealed no significant 
effects of the independent variables examined. 
 
Discussion 
Patients 
This meta-analysis of cognitive functioning in euthymic bipolar patients provides 
evidence of cognitive impairments in these patients, particularly in the realm of 
executive functioning and verbal memory. Large effect sizes were found for work-
ing memory, executive control, concept shifting, fluency, verbal recall, and mental 
speed.  
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Chi-
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p value 
Stroop 4 71 125 0.49 0.05 to 0.93 2.16 0.031 5.35 0.148 
Trail B 7 143 234 0.37 0.15 to 0.60 3.27 0.001 4.98 0.546 
FAS 4 68 102 0.27 -0.04 to 0.59 1.70 0.090 3.01 0.391 
CVLT immediate 4 73 94 0.22 -0.09 to 0.53 1.38 0.167 0.08 0.994 
CVLT delayed recall 4 75 191 0.21 -0.07 to 0.50 1.45 0.146 2.11 0.550 
IQ 5 119 191 0.19 -0.27 to 0.65 0.82 0.414 12.77 0.012 
Digit span backward 5 79 266 0.18 -0.33 to 0.69 0.69 0.490 13.29 0.010 
WCST Pers. Err. 6 140 192 0.17 -0.09 to 0.43 1.26 0.207 6.26 0.282 
DSST 4 74 225 0.14 -0.16 to 0.45 0.91 0.361 3.66 0.300 
Trail A 7 143 234 0.13 -0.09 to 0.35 1.14 0.256 5.28 0.508 
Digit span forward 4 60 152 0.04 -0.72 to 0.81 0.11 0.911 15.23 0.002 
WCST Categories 4 82 127 0.04 -0.36 to 0.43 0.18 0.861 5.35 0.148 
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The finding of both executive and memory impairments has been described in the 
quantitative meta-analysis by Robinson and colleagues (2006), despite the fact that 
we used somewhat stricter inclusion criteria for euthymia and included more recent 
studies. 
There was substantial heterogeneity between the results of the different studies, 
the largest heterogeneity being noted for working memory, concept shifting, ex-
ecutive control, and fluency. Two studies (Balanza-Martinez 2005; Goswami et al. 
2006) largely caused this heterogeneity, possibly because of inclusion of relatively 
severely ill patients with a higher number of (psychotic) episodes. Thus, greater 
number of episodes, greater length of illness and higher number of hospitalizations 
has been associated with greater level of neuropsychological dysfunction in bipolar 
patients (Robinson and Ferrier 2006). Heterogeneity may also be caused by the 
differential effects of age, sex, and education on the cognitive domains mentioned 
above, as revealed by meta-regression. 
Heterogeneity may additionally be caused by residual mood symptoms, because of 
the variation in the criteria used to define euthymia. It was not possible to include 
measures of mood as a variable for the meta-regression, however, as the studies 
included did not use, or did not report, uniformly measured items of mood. An-
other confound is medication, the use and reporting of which varied between stud-
ies. The effects of different types of medication on cognitive function in bipolar 
patients are not systematically studied, but the effects of lithium may be rather 
modest, given the small effect size (d=0.3) in the study by Goswami and colleagues 
(2002). Furthermore, cognitive deficits are still evident in medication-free patients 
(Goswami 2002; Strakowski et al. 2004). Another source of heterogeneity may be 
the type of bipolar disorder under investigation. Although most studies used bipo-
lar I patients, not all studies specified the type of patients included. Bipolar I pa-
tients may show greater, and or different, deficits in cognitive function than bipolar 
II patients (Harkavy-Friedman et al. 2006; Torrent et al. 2006). Matching on educa-
tion versus IQ may be a confound too, given the study by Glahn and colleagues 
(2006), who describe less educational attainment despite comparable IQ levels in 
bipolar patients versus normal controls. Matching on educational attainment could 
thus give rise to underestimation of the difference in cognitive function between 
bipolar patients and normal controls. Finally, differences in somatic comorbidity 
(and comedication) between bipolar patients and normal controls, could contribute 
to differences in cognitive performance (Newcomer 2006). 
 
First degree relatives 
The meta-analysis in first-degree relatives showed worse performance in all cogni-
tive domains studied, compared to controls. Effect sizes, however, were small and 
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significant only in the domain of executive functioning. This suggests that execu-
tive functioning may be a trait marker for the genetic liability for bipolar disorder. 
Heterogeneity between the results of the different studies may be due to the small 
number of studies with relatively small, heterogeneous groups of first-degree rela-
tives with different family histories and genetic load. Contrary to the patient meta-
analysis, meta-regression revealed no effects of sex, education and age on the 
meta-analytic effect size, suggesting more robust results and fewer sources for 
underlying heterogeneity.   
The possible influence of family history as a source of heterogeneity is illustrated 
by the study by Schubert and McNeil (2005), who described greater cognitive im-
pairment in offspring of mothers with schizophrenia-spectrum psychosis versus 
offspring of mothers with affective-spectrum psychosis. Furthermore, Sobczak 
and colleagues (2003) found more pronounced cognitive impairments in first-
degree relatives of bipolar I patients compared to relatives of bipolar II patients. 
Another possible source of heterogeneity is the fact that only a small number of 
studies controlled for subclinical mood symptoms in first-degree relatives and 
controls. Finally, only a small number of studies directly compared cognitive func-
tion between bipolar patients, first-degree relatives and healthy controls (Ferrier et 
al. 2004; Frangou et al. 2005b; McIntosh et al. 2005). 
Our meta-analysis on cognitive function in first-degree relatives of bipolar patients 
is, to the best of our knowledge, the first in the literature. Comparison with other 
meta-analytic reviews is therefore only possible with first-degree relatives of other 
patient groups, for example patients with schizophrenia. Such a comparison is 
topical, given the fact that bipolar and schizophrenia phenotypes likely share ge-
netic risk factors (Craddock et al. 2006). Various meta-analyses of cognitive func-
tion in first-degree relatives of patients with a diagnosis of schizophrenia (Sit-
skoorn et al. 2004; Snitz et al. 2006; Szoke et al. 2005) describe the largest effect 
sizes (d= 0.5 to 0.6) for executive functioning and verbal memory, with somewhat 
different effect sizes for different executive tests used and greater effect sizes in 
multiplex families (Heydebrand 2006). This qualitative pattern of effects sizes and 
tests are rather similar to those presented here for the relatives of patients with 
bipolar disorder. In the review by Snitz and colleagues (2006), the type of biologi-
cal relative, parent, sibling, or offspring did not impact on effect sizes of cognitive 
deficits in unaffected first-degree relatives of patients with a diagnosis of schizo-
phrenia. Asymmetric psychiatric exclusion criteria and screening controls more 
stringently than relatives did influence the effect sizes in the review by Snitz and 
colleagues (2006). Therefore, this source could also contribute to the heterogeneity 
observed in the current meta-analysis. 
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Heydebrand (2006), reviewing meta-analyses on cognitive function in relatives of 
patients with a diagnosis of schizophrenia, concludes that the most consistent 
deficit shown by relatives is impaired performance on ‘maintenance plus’ frontal-
lobe tasks, requiring increased effort and higher central executive processing. This 
cognitive phenotype therefore may be a likely candidate endophenotype for both 
schizophrenia and bipolar disorder. In this respect it may be important that mem-
ory performance is affected by executive dysfunction, as shown by shared variance 
of 50-60% (Duff et al. 2005). A quantitative review of cognitive functioning in 
patients with schizophrenia and bipolar disorder yielded largest (differences in) 
effect sizes on executive function and verbal memory; bipolar patients generally 
better performing than patients with schizophrenia (Krabbendam et al. 2005). Im-
portant in this respect is the fact that there were only quantitative, and not qualita-
tive, differences between bipolar patients and patients with a diagnosis of schizo-
phrenia, which fits in with current models of the relationship between both disor-
ders. Murray and colleagues (2004) hypothesize that certain shared susceptibility 
genes may predispose individuals to psychosis in general. A candidate gene may be 
neuregulin 1, which influences susceptibility to bipolar disorder and schizophrenia, 
especially in bipolar patients with mood-incongruent psychotic features and pa-
tients with a diagnosis of schizophrenia with mania (Green et al. 2005). Polymor-
phisms of neuregulin, influencing, amongst others, synaptic signalling by glutamate 
receptors, play possibly a role in cognition (Harrison and Law 2006; Schillo et al. 
2005; Scolnick et al. 2006). Other candidate genes in this respect are Disc 1 (Can-
non et al. 2005; Porteous et al. 2006; Ross et al. 2006) and BDNF (Bath and Lee 
2006), both related to susceptibility to schizophrenia as well as bipolar disorder on 
the one hand, and cognitive dysfunction (executive function and memory) on the 
other. Finally, COMT-polymorphisms may play a role as well, in particular the 
COMT Val158Met polymorphism and other polymorphisms on the same gene, that 
have been associated with prefrontal cognitive functioning in schizophrenia and 
bipolar patients and their first-degree relatives (Bertolino et al. 2006; Goldberg et al. 
2003; Mata et al. 2006; Minzenberg et al. 2006; Rosa et al. 2004). Interestingly, the 
COMT Val158Met polymorphism influences the improvement of cognitive func-
tioning in patients with a diagnosis of schizophrenia treated with clozapine 
(Woodward et al. 2006), and differential effects are described of these polymor-
phisms on the results of different tests of executive function (Tunbridge et al. 
2006). Furthermore, the COMT Met158Met genotype is associated with heightened 
reactivity and connectivity in corticolimbic circuits, leading to inflexible processing 
of affective stimuli contributing to emotional dysregulation (Drabant et al. 2006). 
Tunbridge and colleagues (2006), reviewing the literature on COMT polymor-
phisms, conclude that the Met allele is associated with improved executive func-
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tion compared with the Val allele, but also with impaired emotional processing. 
Bilder and colleagues (2004) hypothesize that the COMT Met allele, associated 
with low enzyme activity, results in increased levels of tonic dopamine (DA) and 
reciprocal reductions in phasic DA in subcortical regions and increased D1 trans-
mission cortically, leading to increased stability but decreased flexibility of neural 
networks. This model fits in with results from, amongst others, f-MRI-studies 
pointing in the direction of dysregulation of prefrontal area influence on subcorti-
cal neural regions, explaining cognitive dysfunction and mood symptoms (Brooks 
et al. 2006; Strakowski et al. 2005; Yurgelun-Todd 2006). 
To summarize, executive function may be a candidate endophenotypes for the 
genetic liability for bipolar disorder, as suggested by the current meta-analyses on 
bipolar patients and their first-degree relatives. 
Guidelines for future research on cognitive deficits in schizophrenia and bipolar 
patients and their relatives (adapted from (Heydebrand 2006)) are: i) sufficient 
sample size to allow the examination of specific cognitive deficits as well as for 
genetic testing; ii) use of cognitive measures that are sufficiently specific and sensi-
tive, and have ecological validity; iii) longitudinal studies; iv) recruitment of hetero-
geneous control samples; v) control for psychopathology; and vi) investigation of 
heterogeneity of cognitive function in patients and relatives, in relation to neuro-
biological findings.  
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Appendix 
 
Table 1. Studies with bipolar patients included in the meta-analysis 
Author, year N Definition of euthymia Neuropsychological test 
parameters 
d
1
 
 Patients Controls    
Altshuler, 2004 40 22 HDRS
2
<6 CVLT
11
 immediate recall 0.75 
   YMRS
3
<7 CVLT delayed recall 0.78 
   prospectively for 3 months Rey Figure delayed 0.57 
    FAS
12 
0.16 
    WCST
13
 pers. err. 0.77 
    WCST cat. 0.89 
    Stroop time 0.41 
    Trail A 0.38 
    Trail B 0.40 
    IQ 0.20 
    Rey Figure copy 0.30 
Balanza-Martinez, 2005 15 26 HDRS<8 FAS 1.28 
   HDRS: 3.4 (2.9) Fluency cat. 1.79 
   CARS
4
<8 WCST pers. err. 1.67 
   CARS: 1.3 (1.8) WCST cat. 1.48 
   2 months euthymia Stroop time 1.62 
    Trail A 0.68 
    Trail B 0.89 
    DSST
14 
1.05 
Blumberg, 2003 15 20 HDRS<8 Stroop time 0.74 
   HDRS: 7.3 (7.1)   
   CARS<8   
   CARS: 4.1 (5.0)   
Bozikas, 2005 19 30 MADRS
5
<9 CPT
15
 0.10 
   MADRS: 1.53 (2.61)   
   YMRS<9   
   YMRS: 3.16 (2.48)   
Cavanagh, 2002 20 20 HDRS<8 CVLT delayed recall 0.96 
   1.0 (2.9) FAS 0.29 
   MMS
6
<3 Stroop correct 0.61 
   MMS: 0.5 (1.5)   
Clark, 2002 30 30 HDRS<9 CVLT immediate recall 0.48 
   HDRS: 2.07 (2.26) CVLT delayed recall 0.95 
   YMRS<9 CPT 0.96 
   YMRS:1.67 (2.22)   
Clark, 2005 15 15 HDRS<9 CPT 1.00 
   HDRS: 3.2 (2.5)   
   YMRS<9   
   YMRS: 1.9 (2.5)   
Deckersbach, 2004 30 30 HDRS: 3.4 (2.6) CVLT immediate recall 1.40 
   YMRS: 1.0 (1.6) CVLT delayed recall 1.67 
Deckersbach, 2004a 25 25 HDRS: 3.3 (2.5) Rey Figure delayed 0.70 
   YMRS: 1.2 (1.5) Rey Figure copy 0.06 
Dixon, 2004 15 30 BDI
7
: 6.5 (4.3) FAS 0.17 
   YMRS: 2.7 (2.2) Fluency cat. 0.30 
    Stroop correct 0.82 
    IQ -0.32 
Ferrier, 1999 20 20 HDRS: 2.7 (2.1) RAVLT
16
 immediate recall 0.93 
   MSS
8
: 4.1 (1.9) Rey Figure delayed 0.92 
    Digit Span Backward 1.11 
    FAS 0.40 
    Trail A 0.81 
    Trail B 0.92 
    DSST 0.81 
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    Digit Span forward 0.28 
    Rey Figure copy 0.64 
Fleck, 2003 14 40 HDRS<10 CVLT immediate recall 1.01 
   HDRS: 3.7 (2.8) CVLT delayed recall 0.77 
   YMRS<10   
Frangou, 2005a 10 43 HDRS<6 WCST pers. err. 0.55 
   HDRS: 3.0 (1.2) WCST cat. 0.04 
   YMRS<6   
   YMRS: 1.1 (0.5)   
   at least 1 month   
Frangou, 2005b 44 44 HDRS<10 FAS 0.88 
   HDRS: 7 WCST pers. err. 0.38 
   MRS
9
<10 WCST cat. 0.25 
   MRS: 0 Stroop correct 0.57 
    IQ 0.31 
Goswami, 2006 37 37 euthymia >1 month RAVLT immediate recall 0.69 
   HDRS: 2.35 (1.48) Digit Span backward 2.28 
   MSRS
10
: 7.91 (4.88) Trail A 0.54 
    Trail B 1.99 
    DSST 0.19 
    Digit Span forward 0.50 
Krabbendam, 2000 21 22 HDRS: 3.4 (3.0) AVLT
17
 immediate recall 0.94 
   YMRS: 0.77 (1.5) AVLT delayed recall 0.93 
    Fluency cat. 0.54 
    Stroop time 0.67 
    DSST 1.12 
Larsson, 2005 18 18 HDRS: 3 (3) IQ 0.12 
   YMRS: 2 (3)   
   follow-up for 4 to 8 weeks   
Malhi, 2005 12 12 HDRS<7 Stroop time 1.02 
   HDRS: 4.3 (1.1)   
   YMRS<7   
   YMRS: 0.9 (0.5)   
Martinez-Aran, 2004 44 30 HDRS<9 CVLT immediate recall 0.84 
   HDRS: 3.6 (2.6) CVLT delayed recall 0.96 
   YMRS<7 Digit Span backward 0.86 
   YMRS: 1.4 (1.8) FAS 0.56 
   6 months remission Fluency cat. 0.83 
    WCST pers. err. 0.62 
    WCST cat. 0.38 
    Stroop correct 0.59 
    Trail A 0.90 
    Trail B 0.57 
    Digit Span forward 0.56 
    IQ 0.75 
McIntosh, 2005 27 50 HDRS: 5 FAS 0.71 
   YMRS: 2 DSST 1.34 
    IQ -0.07 
Nehra, 2006 30 20 HDRS<8 FAS 0.45 
   HDRS: 2.67 (0.92) Fluency cat. 0.46 
   YMRS<8 WCST pers. err. 0.37 
   YMRS: 1.47 (1.25) WCST cat. 0.07 
    Trail A 0.41 
    Trail B 0.69 
Strakowski, 2004 10 10 HDRS<8 CPT 0.21 
   HDRS: 3.1 (2.5)   
   YMRS<6   
   YMRS: 1.6 (1.8)   
Thompson, 2005 63 63 HDRS<8 RAVLT immediate recall 0.59 
   HDRS: 2.1 (1.7) Digit Span backward 0.37 
   YMRS<8 FAS 0.36 
   YMRS: 1.4 (2.0) Stroop correct 0.58 
   Prosp. verified for 1 month Trail A 0.47 
    Trail B 0.23 
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1 Effect size, positive values indicate better performance in controls; 2 Hamilton depression Rating Scale; 3 
Young Mania Rating Scale; 4 Clinician Administered Rating Scale for Mania; 5 Montgomery-Asberg De-
pressive Rating Scale; 6 Modified Manic Scale; 7 Beck Depression Inventory; 8 Manic State Scale; 9 Manic 
Rating Scale; 10 Manic State Rating Scale; 11 California Verbal Learning Test; 12 Verbal fluency test; 13 Wis-
consin Card Sorting Test; 14 Digit Symbol Substitution Test; 15 Continuous Performance Test; 16 Rey Audi-
tory Verbal Learning Test; 17 Auditory Verbal Learning Test 
    DSST 0.91 
    Digit Span forward 0.05 
Thompson, 2006 20 20 HDRS<8 Digit Span backward 0.75 
   HDRS: 1.90 (2.38) Digit Span forward 0.25 
   YMRS<8   
   YMRS: 1.40 (2.08)   
Torrent, 2006 38 35 HDRS<9 CVLT immediate recall 0.58 
   HDRS: 4.29 (2.51) CVLT delayed recall 0.80 
   YMRS<7 Digit Span backward 0.86 
   YMRS: 0.79 (1.19) FAS 0.41 
    Fluency cat. 0.76 
    WCST pers. err. 0.56 
    WCST cat. 0.23 
    Stroop correct 0.58 
    Trail A 0.80 
    Trail B 0.57 
    Digit Span forward 0.70 
Van Gorp, 1998 13 22 HDRS<7 CVLT immediate recall 0.70 
   YMRS<6 CVLT delayed recall 0.52 
    Rey Figure delayed 0.25 
    FAS -0.11 
    WCST pers. err. 0.95 
    WCST cat. 1.00 
    Stroop time 0.08 
    Trail A 0.32 
    Trail B 0.24 
    Rey figure copy -0.09 
Varga, 2006 19 31 MADRS: 2.26 (3.69) AVLT immediate recall 1.52 
   MRS: 2.32 (4.10) AVLT delayed recall 1.04 
    WCST pers. err. 0.55 
    WCST cat. 0.15 
    Stroop correct 0.80 
    Trail A 0.53 
    Trail B 1.24 
    DSST 0.54 
    IQ 0.57 
Zubieta, 2001 15 15 HDRS<6 Fluency cat. 0.77 
   HDRS: 3.4 (2.1) WCST pers. err. 1.52 
   YMRS<4 WCST cat. 0.84 
   YMRS: 0.4 (0.6) Stroop correct 1.12 
   at least 6 months euthymia   
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Table 3. Studies with first-degree family members included in the meta-analysis 
 
Author, year N Sample characteristics Neuropsychological test 
parameters 
d
1
 
 Relatives Controls    
Christensen, 2006a 7 36 MZ twins discordant for bipolar 
disorder Stroop 0.37 
    Trail A 0.20 
    Trail B 0.63 
Christensen, 2006b 14 52 DZ twins discordant for bipolar Stroop 0.45 
   disorder Trail A -0.10 
    Trail B 0.25 
Clark, 2005 27 47 10 parents; 12 siblings; 5 children CVLT
6
 immediate recall 0.20 
   HDRS
2
: 1.2 (1.9) CVLT delayed recall 0.12 
   YMRS
3
: 0.4 (1.1)   
Ferrier, 2004 17 17 first-degree relatives RAVLT
7
 immediate recall 0.18 
   HDRS: 0.82 (1.01) Digit Span backward 0.99 
   YMRS: 0.47 (1.28) FAS
8 
-0.12 
   controls Stroop 0.00 
   HDRS: 0.35 (0.86) Trail A -0.07 
   YMRS: 0.18 (0.53) Trail B 0.37 
    DSST
9 
0.24 
    Digit Span forward 0.39 
Frangou, 2005 15 43 unaffected offspring of bipolar 
probands WCST
10
 pers. err. -0.42 
    WCST cat. -0.53 
    WAIS-R IQ -0.09 
Gourovitch, 1999 7 15 MZ twins CVLT immediate recall 0.33 
    CVLT delayed recall 0.80 
    Digit Span backward 0.97 
    FAS 0.28 
    WCST pers. err. 0.52 
    Trail A -0.10 
    Trail B 0.01 
    Digit Span forward 1.16 
    WAIS-R IQ 0.40 
Keri, 2001 20 20 unaffected siblings Digit Span backward -0.18 
   BP-I probands FAS 0.12 
    WCST pers. err. 0.10 
    WCST cat. 0.11 
    Digit Span forward -0.33 
Kieseppa, 2005 19 114 twins discordant for BP-I CVLT delayed recall 0.08 
    Digit Span backward -0.18 
    DSST -0.12 
Kremen, 1998 14 44 relatives of psychotic bipolar pro-
bands WCST pers. err. 0.09 
    WCST cat. 0.45 
    Trail A -0.28 
    Trail B -0.11 
    DSST -0.05 
    WAIS-R IQ -0.58 
McIntosh, 2005 24 50 unaffected relatives with > 1 first-or 
second degree BP-proband 
FAS 0.58 
   DSST 0.50 
   HDRS: 1.5 (median)   
   YMRS: 0   
   controls   
   HDRS: 0   
   YMRS: 0   
Pirkola, 2005 16 100 unaffected co-twins Digit Span backward -0.30 
   3 MZ 13 DZ Digit Span forward -0.78 
Sobczak, 2003 22 15 first-degree relatives BP-I VVLT immediate recall 0.25 
    VVLT delayed recall 0.34 
Szoke, 2006 51 50 first-degree relatives WCST pers. err. 0.22 
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   of BP-I patients Trail A 0.41 
    Trail B 0.54 
Toulopoulou, 2006 50 69 17 parents, 23 siblings WAIS-R IQ 0.42 
   10 children   
Zalla, 2004 33 20 11 parents, 22 siblings WCST pers. err. 0.57 
   MADRS
4
 < 16 WCST cat. 0.12 
   MAS
5
 < 7 Stroop 1.03 
    Trail A 0.31 
    Trail B 0.60 
    WAIS-R IQ 0.79 
 
1 effect size, positive values indicate better performance in controls; 2 Hamilton Depression Rating Scale; 3 
Young Mania Rating Scale; 4 Montgomery-Asberg Depressive Rating Scale; 5 MAS Beck and Rafaelsen 
Mania Scale; 6 California Verbal Learning Test; 7 Rey Auditory verbal Learning Test; 8 Verbal fluency; 9 
Digit Symbol Substitution Test; 10 Wisconsin Card Sorting Test 
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Abstract 
Objective: Neurocognitive functioning may represent an indicator of genetic risk 
and poor outcome in both schizophrenia and bipolar disorder. In this study, 
shared and non-shared characteristics in the cognitive domain in both disorders 
were analysed in order to determine to what degree neurocognitive functioning 
may represent a predictor of the familial vulnerability and poor functioning that 
both disorders share. Method: Neurocognition, psychopathology and psychoso-
cial functioning were assessed in samples of patients with DSM-IV diagnosis of 
schizophrenia spectrum disorder (n=345) and bipolar disorder (n=76), first-degree 
relatives of both patient groups (n=331 and n=37, respectively) and healthy con-
trols (n=260 and n=61, respectively). Multiple regression models were used to 
investigate the effect of group status on neurocognition and to explore associations 
between cognition, symptoms and psychosocial functioning in the two groups. 
Results: Cognitive deficits were more severe and more generalized in schizophre-
nia spectrum patients compared to bipolar disorder patients; cognitive alterations 
were present in relatives of patients with schizophrenia spectrum disorders but not 
in relatives of bipolar patients. The association between neurocognitive dysfunc-
tion and psychosocial functioning was more generalized in schizophrenia spectrum 
disorders than in bipolar disorder; for both disorders, associations were only partly 
mediated by symptoms. Conclusion: The evidence for cognitive dysfunction as a 
marker of familial vulnerability is stronger for schizophrenia than for bipolar dis-
order. Although the presence of multiple cognitive deficits is shared by the two 
groups, the severity of cognitive deficits and its consequences appear to partly 
differ between schizophrenia and bipolar disorder, which is in line with a model 
that implies the specific presence of a neurodevelopmental impairment in the for-
mer but not in the latter. 
 
Key words: neurocognition, vulnerability marker, schizophrenia, bipolar disorder, 
outcome
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Introduction 
The question whether schizophrenia and bipolar disorder are truly distinct diseases 
is becoming increasingly important now that diagnostic boundaries are being re-
evaluated during the development of the DSM-V. Investigating similarities and 
differences between both illnesses may help to elucidate this issue. One area of 
interest is neurocognitive functioning, given its putative roles as an intermediary 
phenotype and functional outcome predictor in both disorders. 
 
Both schizophrenia and bipolar disorder are characterized by the presence of neu-
rocognitive impairment. In schizophrenia, cognitive impairment is considered a 
core and stable feature of the illness that is present across a broad range of neuro-
psychological domains, but most consistently reported in the domains of memory, 
executive functioning and attention (Dollfus et al., 2002; Heinrichs & Zakzanis, 
1998). Evidence that the cognitive performance of first-degree relatives is interme-
diate to the performance of schizophrenia patients and controls suggests that neu-
rocognitive impairment may represent a marker of the genetic vulnerability to the 
disease (Faraone et al., 2000; Keefe et al., 1994; Krabbendam, Marcelis, Delespaul, 
Jolles, & van Os, 2001). In bipolar disorder, it has long been assumed that cogni-
tive impairments are transient and limited to periods of affective disturbance. This 
has been contradicted by recent studies indicating that cognitive deficits, particu-
larly in the domains of verbal memory and executive functioning, may persist in 
euthymic, stable bipolar patients (Arts, Jabben, Krabbendam, & Van Os, 2008; 
Robinson et al., 2006). Some studies have reported cognitive alterations in first-
degree bipolar relatives (Antila et al., 2007; Clark, Sarna, & Goodwin, 2005; Ferrier, 
Chowdhury, Thompson, Watson, & Young, 2004), suggesting that in bipolar dis-
order neurocognitive impairment may similarly be a trait marker of genetic vulner-
ability to the disease (Glahn, Bearden, Niendam, & Escamilla, 2004).  
 
Although cognitive impairments overlap in schizophrenia and bipolar disorder and 
may be a marker of genetic vulnerability for both disorders, only a few studies have 
compared neurocognitive performance in bipolar and schizophrenia patients and 
their relatives. McIntosh and colleagues showed that whereas alterations in mem-
ory functioning were related to an increased liability to psychosis in general, ab-
normalities in intellectual functioning were related to liability to schizophrenia 
more specifically (McIntosh, Harrison, Forrester, Lawrie, & Johnstone, 2005). In a 
study that examined executive functioning in bipolar and schizophrenia families, 
there were no deficits specifically related to one of both disorders (Zalla et al., 
2004). Therefore, the first goal of this study was to extend this literature by investi-
gating the role of neurocognitive functioning as a potential genetic vulnerability 
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marker for both disorders in two large samples of subjects, and to investigate 
shared and non-shared characteristics in the cognitive domain. 
 
A second key reason for studying neurocognition in schizophrenia and bipolar 
disorder is its putative role in functional outcome. In schizophrenia, cognitive defi-
cits are consistently related to functional outcome (Green, Kern, & Heaton, 2004), 
and it has been suggested that cognition predicts social and occupational function-
ing equally well as negative symptoms do (Dickinson & Coursey, 2002; Milev, Ho, 
Arndt, & Andreasen, 2005; Norman et al., 1999), and even better than positive 
symptoms (Bryson & Bell, 2003; Green, 1996). Predictors of functional recovery in 
bipolar disorder are less investigated because of the long-held assumption that 
bipolar disorder is an episodic illness with full recovery between episodes. In line 
with growing insight that symptom recovery does not necessarily imply functional 
recovery, recent studies have suggested that cognitive functioning may contribute 
substantially to psychosocial functioning in bipolar disorder (Atre-Vaidya et al., 
1998; Dickerson et al., 2004; Martinez-Aran, Vieta, Colom et al., 2004). Therefore, 
the second aim of this study was to explore the relative contribution of symptoms 
and cognitive functioning to psychosocial functioning in schizophrenia and in 
bipolar disorder.  
 
Methods 
Subjects  
The subjects in this study were recruited in the context of two related projects. 
 
Schizophrenia spectrum study 
The study sample consisted of patients with a schizophrenia spectrum disorder 
(SZ), their first-degree relatives and controls from the general population; the sam-
ple was recruited between September 2004 and January 2008, during the course of 
the baseline measurement of the Maastricht site Genetic Risk and Outcome of 
Psychosis (GROUP) project. Inclusion criteria for the Maastricht GROUP project 
were: fluent in Dutch, aged 16 to 55 years (with the exception of patients’ parents) 
and, for patients, a diagnosis of schizophrenia spectrum psychosis according to 
DSM-IV. For a patient to participate, at least one of his or her siblings had to take 
part in the study. Siblings had to be free of any lifetime non-affective psychotic 
disorder and have at least one brother or sister with a diagnosis of schizophrenia 
spectrum psychosis participating in the study. For the control subjects, the occur-
rence of any psychotic disorder in either the subject or a first-degree family mem-
ber constituted an exclusion criterion.  
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Patients were recruited through community mental health centres and psychiatric 
hospitals in the catchment area, namely South Limburg (Netherlands) and Flanders 
(Belgium). All first-degree relatives were sampled through participating patients. 
For the purpose of the current analyses, only siblings were included in the relatives 
group. Control subjects were recruited through newspaper advertisements and 
random mailings in nearby municipalities. The Comprehensive Assessment of 
Symptoms and History (CASH) (Andreasen, 1987) sections on affective and psy-
chotic disorders were used to confirm the presence of a diagnosis of schizophrenia 
spectrum psychosis in patients, the absence of such a diagnosis in siblings, and the 
absence of a lifetime diagnosis of any psychotic disorder or any current affective 
disorder in the healthy controls. Healthy controls were additionally interviewed 
using the Family Interview for Genetic Studies (FIGS) (Maxwell, 1992) in order to 
confirm the absence of family histories of psychotic or bipolar disorders in their 
first-degree relatives. 
The initial sample consisted of 353 patients, 342 siblings and 263 control subjects. 
As data on neuropsychological performance and/or diagnosis were missing for 
some subjects, the risk set comprised 345 patients, 331 siblings and 260 controls. 
In the patient group, 266 had a diagnosis of schizophrenia, 38 had a diagnosis of 
schizo-affective disorder, 5 had a diagnosis of delusional disorder, 8 had a diagno-
sis of brief psychotic disorder and 28 had a diagnosis of psychotic disorder NOS. 
Of the 331 siblings, 43 had a diagnosis of a single episode of major depressive 
disorder (of whom 38 were in full and 5 were in partial remission), 13 had a diag-
nosis of recurrent major depressive disorder (of whom 6 were in partial and 7 were 
in full remission) and 275 received no diagnosis. Of the controls, 29 had a diagno-
sis of a single episode of major depressive disorder (in full remission), 8 had a di-
agnosis of recurrent major depressive disorder (in full remission) and 223 received 
no diagnosis. Written informed consent conforming to the local ethics committee 
guidelines was obtained from all subjects. 
 
Bipolar study 
This study sample consisted of patients with bipolar disorder (BD), healthy first-
degree relatives of patients with BD and controls from the general population. The 
sample was recruited between June 2004 and July 2007, during the baseline meas-
urement of the BIPOLCOG study (Jabben, Arts, Krabbendam, & Van Os, 2009), 
which focused on cognitive functioning in bipolar disorder.  
Inclusion criteria for the BIPOLCOG study were: fluent in Dutch, aged 18 to 60 
years and, for patients, a diagnosis of bipolar disorder according to DSM-IV (APA, 
1994). Relatives had to be free of any lifetime bipolar or psychotic disorder and 
have at least one first-degree relative with a diagnosis of bipolar disorder. For the 
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control subjects, the occurrence of any psychotic or bipolar disorder in either the 
subject or a first-degree family member constituted an exclusion criterion.  
Patients were recruited through in-patient and out-patient mental health service 
facilities in South Limburg, and through the local association of bipolar patients 
and their families. First-degree relatives were sampled through participating pa-
tients. Control subjects were recruited from the general population through a ran-
dom mailing in the local area from a listing of all eligible individuals in the general 
population. 
The computer program OPCRIT was used to derive and confirm DSM-IV diagno-
ses on the basis of current and lifetime recorded symptomatology listed in the 
Operational Criteria Checklist for Psychotic Illness (OCCPI) (Mc Guffin, Farmer, 
& Harvey, 1991). First-degree relatives and controls were clinically and diagnosti-
cally interviewed using the Comprehensive Assessment of Symptoms and History 
(CASH) (Andreasen, Flaum, & Arndt, 1992) and OPCRIT criteria to exclude indi-
viduals with a diagnosis of BD or psychotic disorder. Healthy controls were addi-
tionally interviewed using the Family Interview for Genetic Studies (FIGS) (Max-
well, 1992) in order to confirm the absence of family histories of psychotic or bi-
polar disorders in their first-degree relatives. 
The initial sample consisted of 81 patients, 39 first-degree relatives and 61 healthy 
control subjects. Due to missing data on diagnosis or neuropsychological perform-
ance, the final risk set comprised 76 patients with bipolar disorder, 37 relatives and 
61 controls. In the patient group, 57 had a diagnosis of bipolar I disorder, 17 re-
ceived a diagnosis of bipolar II disorder and 2 were diagnosed with schizo-
affective disorder bipolar type. In the group of relatives, four had a diagnosis of 
major depression disorder (in full remission). The other relatives had no history of 
psychiatric disorder. One control subject had a history of major depression disor-
der but was in full remission at the time of the study. Written informed consent 
conforming to the local ethics committee guidelines was obtained from all sub-
jects.  
 
Psychiatric assessment 
In both study samples the presence of psychiatric symptoms at the time of testing 
was assessed using the extended Brief Psychiatric Rating Scale (BPRS-E: (Lukoff, 
Nuechterlein, & Ventura, 1986)). This scale assesses a wide range of current psy-
chopathology, including symptoms of depression, mania, psychosis, anxiety and 
withdrawal in the previous two weeks. 
In the schizophrenia spectrum study, patients’ current symptoms were quantified 
using the Positive and Negative Syndrome Scale (PANSS). A five-factor model was 
used, generating scores on positive, negative, disorganization, excitement and emo-
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tional distress symptom dimensions (van der Gaag et al., 2006). In the bipolar 
study, participants’ current depressive and manic symptomatology was assessed 
using the 21-item Hamilton Rating Scale for Depression (Hamilton, 1967) and the 
Young Mania Rating Scale (Young, Biggs, Ziegler, & Meyer, 1978), respectively.  
Psychosocial functioning in both patient groups was assessed using the Global 
Assessment of Functioning (APA, 1994). In the original instructions, the GAF 
rating encompasses functioning as well as symptom ratings, but in the current 
study the version of the GAF in which functioning can be rated as a separate score 
was used. 
 
Neurocognitive assessment  
In the schizophrenia spectrum study, intellectual functioning was estimated using 
the four-subtest version (Information, Block design, Digit symbol coding, Arith-
metic) of the Dutch version of the Wechsler Adult Intelligence Scale - III (Blyler, 
Gold, Iannone, & Buchanan, 2000; Wechsler, 2000). Overall intellectual function-
ing in the bipolar study was estimated using three Groningen Intelligence Test 
(GIT-2) subtests (Mental rotation, Word analogies, Mental arithmetic) (Luteijn & 
Barelds, 2004), yielding results that are comparable to those of the Wechsler Adult 
Intelligence Scale - III.  
The following neurocognitive tests were administered in both study samples: 
The Dutch version of the Visual Verbal Learning Test (Rey, 1964) was adminis-
tered as a measure of verbal memory. In three consecutive trials, 15 monosyllabic 
non-related words had to be memorized and reproduced. The total number of 
words recalled over the three trials was used as a measure of immediate recall. 
Delayed recall was measured after a 20-minute delay.  
Sustained attention was measured with the CPT-HQ – a version of the continuous 
performance test that is also known in the literature as CPT-3-7 or CPT-AX and in 
which the participant should respond to the letter Q only if it was preceded by the 
letter H. In the CPT-HQ, 300 stimuli (i.e. letters) were presented in a randomized 
sequence, at a rate of one per second. Each letter was presented for 150 ms, after 
which an empty screen was presented for 850 ms. The participant responded to a 
target by pressing the space bar of the PC keyboard. Presentation of an H-Q target 
pair had a probability of .18 (n=28) among the 150 sequential letter-pairs. In a 
similar number of sequential letter-pairs, the letter Q was presented following a 
letter other than H (I, L, J or T). In another 28 pairs, the letter H was presented 
followed by a letter other than Q (I, L, J or T). For further information, see Smid 
and colleagues (Smid, De Witte, Homminga, & van den Bosch, 2004) the present 
CPT-HQ is the non-choice version mentioned in the Discussion). Outcome meas-
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ures were expressed as the proportion of correct detections and the reaction time 
of correct detections (Nestor, Faux, McCarley, Shenton, & Sands, 1990).  
The Flanker CPT (Cogtest plc, London) (Eriksen & Schultz, 1979; Posner, Inhoff, 
Friedrich, & Cohen, 1987) is a measure of selective visual control of attention. 
Subjects are instructed to respond by pressing the right or left mouse button de-
pending on whether the middle element in a display of five lines has an arrowhead 
pointing to the right or the left. There are three trial types: i) neutral trials, in which 
the flankers are horizontal lines without arrowheads, ii) congruent trials, in which 
all flankers have an arrowhead pointing in the same direction as the target, and iii) 
incongruent trials, in which the flankers point in the direction opposite that of the 
target. The incongruent condition involves more cognitive effort, because the 
flankers are associated with a response that needs to be suppressed. Half of the 
stimuli are presented above the fixation cross and the other half are presented 
below it in order to prevent the subjects from keeping their gaze fixed in one posi-
tion. The test consists of 144 trials of neutral, congruent and incongruent flankers, 
which are presented randomly. Outcome measures are the mean reaction time for 
correct responses (RT) and the sum of correct trials in each condition.  
 
Statistical Analyses 
Statistical analyses were performed using STATA 10.0 (Statacorp, 2007). For con-
venience of interpretation of the data, cognitive reaction time variables were re-
coded so that in the analyses a higher score on all neurocognitive variables indi-
cated a better performance. In both study samples, a dummy variable indicating 
disorder vulnerability was constructed with value 1 for controls, 2 for relatives and 
3 for patients (hereafter: ‘group’). 
 
1. Neurocognitive functioning of schizophrenia spectrum and bipolar patients and 
their first-degree relatives  
First, to investigate the presence of cognitive dysfunctions in patients and their 
relatives, multiple regression models with group entered as dummy variable were 
used to investigate the effect of group status on neurocognitive performance. The 
non-independence of observations within families was addressed by the use of the 
‘robust’ command in STATA – a procedure that calculates robust estimates of 
variance that are suitable for clustered data. Analyses were performed separately in 
the bipolar and schizophrenia study and a priori adjusted for age, sex and education 
by entering these variables into the equation. In bipolar disorder, these analyses 
were repeated excluding BD patients without strictly defined euthymia (euthymia: 
HDRS score <8 and YMRS score <8).  
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Then, in both groups associations between neurocognition and current symptoma-
tology were examined by means of Pearson correlation coefficients. In SZ patients, 
current symptomatology was measured by the five dimensions obtained in a previ-
ous factor analysis on the PANSS (van der Gaag et al., 2006). In BD patients, cur-
rent depressive and manic/hypomanic symptomatology was measured using total 
HDRS and YMRS scores, respectively.  
To examine the specificity of cognitive impairment across diagnostic category, 
standardized neurocognitive scores were generated by calculating individual z-
scores for each variable using the respective control groups as the reference. This 
allows for direct comparisons of neurocognitive functioning of groups that differ 
in demographic and illness characteristics. Again, multiple regression models ad-
justed for clustering within family were used to investigate the effect of group 
status on the standardized cognitive test scores, focusing on the relevant contrasts 
between (i) SZ and BD patients and (ii) SZ and BD relatives.  
 
2. Association between cognition and psychosocial functioning in schizophrenia 
spectrum and bipolar disorder 
In order to investigate associations between neurocognition and psychosocial func-
tioning, multiple regression analyses, a priori adjusted for age, sex and education, 
were applied. Associations were investigated in SZ and BD patients separately. A 
single neurocognitive variable was entered as predictor of GAF score; in the case 
of a significant association, symptomatology measures were additionally entered 
into the equation to investigate the impact of neurocognition on functioning in 
addition to current symptoms. In SZ patients, current symptomatology was con-
trolled for using PANSS symptom dimensions (van der Gaag et al., 2006) whereas 
in the BD sample total HDRS and YMRS scores were entered into the equation. 
 
Analyses were then re-computed excluding those patients who did not have a nar-
row diagnosis of schizophrenia in the schizophrenia spectrum study (n=79) or 
bipolar disorder in the bipolar study (n=2), and controls in the schizophrenia spec-
trum study who were using antidepressants (n=6). 
 
Results 
Neurocognitive functioning in SZ 
Demographic characteristics, symptom scores and neurocognitive test scores of 
the sample in the schizophrenia study are presented in table 1.  
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Table 1. Demographics, symptom scores and neurocognitive test results of the schizophrenia 
study sample  
 
 
aBetween-group differences for demographic characteristics; gender: χ2=89.73, p=0.00, age: F=6.34, 
p=0.00, educational level: F=22.69, p=0.00 and IQ: F=62.06, p=0.00. 
 
Multiple regression analyses showed that SZ patient status was associated with a 
significantly worse neurocognitive performance on all the administered tests com-
pared to controls (table 2).  
SZ relatives performed significantly worse than controls on tests of Word List 
Learning, accuracy and RT of the CPT-HQ and the RT measures on all three con-
ditions of the Flanker CPT. For all tests, the degree of cognitive impairment was 
related to degree of psychosis vulnerability, with SZ relatives scoring intermediate 
to patients and controls (table 2). 
 
 Controls (n=260) SZ relatives (n=331) SZ patients (n=345) 
mean SD mean SD mean SD 
Demographics
a
 
Gender M/F 87 / 173 154 / 177 245 / 100 
Age range 16 - 55 16 - 55 16 - 55 
Age (years) 32.0 11.9 29.2 9.5 29.5 9.4 
Educational level 5.3 1.8 5.0 2.1 4.3 2.0 
IQ 110.3 16.6 104.9 17.0 95.2 16.9 
       
Medication (cases)       
   antipsychotics atypical 0  1  236  
   antipsychotics typical 0  0  73  
   antidepressants 6  9  76  
       
BPRS  -  -  35.9 13.6 
PANSS  -  -    
    Positive     13.3 6.8 
    Negative     12.5 6.2 
    Disorganization     14.3 6.2 
    Excitement     10.6 3.9 
    Emotional distress     14.5 6.3 
GAF  -  -  57.4 16.2 
       
Word List Learning       
   immediate recall 28.6 5.6 27.1 5.5 23.0 6.6 
   delayed recall 9.9 2.7 9.4 2.6 7.6 3.0 
CPT-HQ       
    % correct detections 0.99 0.04 0.98 0.07 0.93 0.12 
    RT correct detections 411.5 76.5 421.7 78.6 440.8 84.8 
Flanker CPT       
   correct-neutral 46.0 2.5 45.8 2.7 43.3 5.9 
   correct-congruent 46.1 2.6 46.0 3.0 43.0 6.4 
   correct-incongruent 42.7 4.6 42.4 4.9 38.2 7.8 
   RT-neutral 511.1 63.2 521.7 68.9 553.0 94.0 
   RT-congruent 513.8 65.0 523.1 71.4 559.3 98.1 
   RT-incongruent 569.4 62.7 579.8 71.4 611.0 101.2 
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Table 2. Associations between neurocognitive performance and group status in the schizophrenia 
study (controls were used as reference category) 
 
All analyses adjusted for age, sex and education 
For all cognitive variables: higher values indicate better performance 
 
Pearson correlation coefficients indicated that correlations between positive symp-
toms and neurocognitive test scores were between -0.02 and -0.13 and significant 
only for CPT-HQ RT (r=-0.13, p=0.03) and Flanker CPT congruent condition RT 
(r=-0.12, p=0.05) performance. For negative symptoms, Pearson coefficients were 
significant for all tests (r between -0.11 and -0.27, p <0.05). Disorganization symp-
toms were also significantly correlated with most neurocognitive tests (r between -
0.13 and -0.22, p <0.05), with the exception of CPT-HQ RT (r=-0.04, p=0.48). 
Symptoms of excitement only correlated significantly with CPT-HQ accuracy (r=-
0.12, p =0.03, other coefficients between 0.01 and -0.09). Emotional distress symp-
toms correlated significantly with none of the neurocognitive variables idem (r 
between -0.00 and -0.08). For all significant associations a higher symptom score 
was associated with worse cognitive performance.  
 
Neurocognitive functioning in BD 
Demographic characteristics, symptom scores and neurocognitive test scores of 
the bipolar study sample are presented in table 3.  
Multiple regression analyses showed that BD patient status was associated with a 
significantly worse neurocognitive performance on the majority of administered 
tests (table 4). Patients did not differ significantly from controls on CPT-HQ RT 
and Flanker RT neutral and incongruent conditions only. However, neurocognitive 
performance in BD relatives was comparable to that of controls. Effect sizes were 
in the expected direction but very small, with the exception of the Word List 
Learning Test, on which relatives performed slightly better than controls. 
 
SZ  relatives SZ patients 
β p β P 
Word List Learning     
   immediate recall -0.10 0.01 -0.33 0.00 
   delayed recall -0.07 0.04 -0.28 0.00 
CPT-HQ     
    % correct detections -0.06 0.04 -0.24 0.00 
    RT correct detections -0.12 0.00 -0.25 0.00 
Flanker CPT     
   correct-neutral -0.01 0.69 -0.26 0.00 
   correct-congruent -0.01 0.62 -0.29 0.00 
   correct-incongruent -0.02 0.63 -0.29 0.00 
   RT-neutral -0.13 0.00 -0.34 0.00 
   RT-congruent -0.12 0.00 -0.35 0.00 
   RT-incongruent -0.12 0.00 -0.33 0.00 
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Table 3. Demographics, symptom scores and neurocognitive test results of the bipolar study 
sample  
 
 
aBetween-group differences for demographic characteristics; gender: χ2=2.57, p=0.28, age: F=4.09, p=0.02, 
educational level: F=3.14, p=0.05 and IQ: F=6.23, p=0.00. 
 
To investigate whether cognitive dysfunction is a true trait characteristic in bipolar 
disorder, post hoc analyses were performed excluding BD patients without strictly 
defined euthymia (euthymia: HDRS score <8 and YMRS score <8). Twelve bipo-
lar patients were excluded and investigation of cognitive dysfunctions in this new 
sample yielded similar results, the only exception being that for the number of 
correct responses on the Flanker CPT in the neutral condition, the association 
slightly reduced and was no longer significant (β=-0.18, p=0.07).  
Pearson coefficients for the correlation between HDRS depression score and neu-
rocognitive performance ranged between 0.00 and -0.26 but were significant only 
for the delayed recall condition of Word List Learning (r= -0.26, p=0.03, other 
coefficients between 0.00 and -0.23). A higher depression score was associated 
 
Controls (n=61) BD relatives (n=37) BD patients (n=76) 
mean SD mean SD mean SD 
Demographics
a 
Gender M/F 23 / 38 20 / 17 35 / 41 
Age range 25 - 56 18 - 58 27 - 60 
Age (years) 45.3 8.7 40.0 12.1 44.4 7.9 
Educational level 5.8 1.7 6.5 1.7 5.6 2.1 
IQ 103.4 13.5 107.8 15.7 97.9 14.6 
       
Medications (cases)       
   antipsychotics 0  0  23  
   anticonvulsants 0  0  43  
   lithium 0  0  37  
   antidepressants 0  2  14  
       
BPRS  25.0 1.7 26.8 3.2 33.4 6.4 
HDRS 0.23 0.9 0.41 1.0 4.03 4.3 
YMRS 0.07 0.3 0.30 0.9 1.61 2.5 
GAF  89.7 3.3 84.7 5.5 67.2 10.7 
       
% previous psychotic     50.7 %  
       
Word List Learning       
   immediate recall 25.7 4.9 26.9 6.2 23.2 5.2 
   delayed recall 8.6 2.5 9.3 2.8 7.2 2.9 
CPT-HQ       
    % correct detections 0.99 0.02 0.99 0.02 0.95 0.07 
    RT correct detections 473.1 78.0 487.4 88.0 476.3 86.6 
Flanker CPT       
   correct-neutral 44.9 4.0 45.8 2.3 43.1 6.2 
   correct-congruent 45.7 3.3 45.7 2.7 43.3 6.4 
   correct-incongruent 42.1 5.1 43.2 3.4 38.9 8.9 
   RT-neutral 647.2 65.1 636.6 65.6 669.1 86.9 
   RT-congruent 644.2 55.8 640.7 60.8 669.7 85.3 
   RT-incongruent 706.3 64.6 704.0 75.5 721.7 82.7 
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with a worse verbal memory performance. Hypomanic symptoms were not signifi-
cantly correlated with any of the neurocognitive tests (coefficients between 0.14 
and -0.20). 
 
 
Table 4. Associations between neurocognition and group status in the bipolar study (controls 
were used as reference category) 
 
All analyses adjusted for age, sex and education 
For all cognitive variables: higher values indicate better performance 
 
 
Comparing cognitive performance in SZ and BD 
The mean z-scores for neurocognitive variables in both patient and relative groups 
and the results of regression analyses are presented in table 5. Multiple regression 
analyses showed that SZ patients performed significantly worse than BD patients 
on all administered tests, with the exception of CPT-HQ accuracy. SZ relatives 
performed significantly worse than BD relatives on both conditions of Word List 
Learning and Flanker CPT RT neutral condition. Trends towards significance were 
found for RT in the other Flanker CPT conditions (see table 5).  
 
Associations between cognitive functioning and psychosocial functioning  
In SZ patients, neurocognitive test performance on all cognitive tests was signifi-
cantly associated with GAF score. Associations were consistently in the direction 
of a better cognitive performance being predictive of a higher GAF score (table 6).  
After additional adjustment for current symptomatology, associations of immedi-
ate and delayed recall conditions of Word List Learning with GAF remained sig-
nificant (immediate recall: β=0.16, p=0.00; delayed recall: β=0.20, p=0.00). Accu-
racy on the CPT-HQ was no longer significantly predictive of GAF (β=0.06, 
 
BD relatives BD  patients 
β P β p 
Word List Learning     
   immediate recall  0.03 0.70 -0.20 0.01 
   delayed recall  0.07 0.43 -0.23 0.01 
CPT-HQ     
    % correct detections -0.02 0.60 -0.37 0.00 
    RT correct detections -0.09 0.31 -0.03 0.76 
Flanker CPT     
   correct-neutral -0.04 0.53 -0.20 0.03 
   correct-congruent -0.10 0.13 -0.26 0.01 
   correct-incongruent -0.04 0.43 -0.24 0.01 
   RT-neutral -0.03 0.66 -0.16 0.07 
   RT-congruent -0.06 0.39 -0.20 0.03 
   RT-incongruent -0.05 0.48 -0.12 0.19 
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p=0.18), whereas the association with the RT was reduced but still significant 
(β=0.13, p=0.01). The previously significant associations of Flanker CPT with 
GAF disappeared (all betas between 0.03 and 0.07, and p values > 0.15).  
 
 
Table 5.  Mean Z-scores of neurocognitive performance in the research groups and schizophre-
nia-bipolar comparisons 
 
All analyses adjusted for age, sex and education 
For all cognitive variables: higher values indicate better performance 
For BD relatives versus SZ relatives, the former were used as the reference category; for BD patients versus 
SZ patients, the former were used as the reference category 
 
 
PANSS negative (betas between -0.23 and -0.29, p values <0.00), disorganization 
(betas between -0.14 and -0.21, p values <0.02) and emotional distress (betas be-
tween -0.16 and -0.18, p values <0.02) symptom scores, were significantly associ-
ated with outcome in the above-mentioned models in the direction that higher 
symptom scores predicted lower GAF scores. 
In BD patients, significant associations were found between neurocognitive per-
formance and GAF score for RT in the neutral and congruent conditions of the 
Flanker CPT (neutral: β=0.27, p=0.03, congruent: β= 0.23, p=0.05), whereas 
trends towards significance were reported for RT in the incongruent condition 
(β=0.23, p=0.06) and for CPT-HQ RT (β=0.20, p=0.09). A better cognitive per-
formance was associated with a higher GAF score.  
 
 
 
 
BD relatives 
(n=37) 
SZ relatives 
(n=329) 
BD relatives vs  
SZ relatives 
BD patients 
(n=76) 
SZ patients 
(n=345) 
BD patients vs  
SZ patients 
M SD M SD β p M SD M SD β p 
Word List Learning           
   immediate recall  0.23 1.3 -0.25 1.0 -0.23 0.00 -0.52 1.1 -0.98 1.2 -0.32 0.00 
   delayed recall  0.28 1.1 -0.19 0.9 -0.28 0.00 -0.57 1.2 -0.85 1.1 -0.18 0.01 
           
CPT-HQ           
    % correct  0.06 0.9 -0.23 1.8 -0.06 0.34 -1.59 2.9 -1.34 3.2 -0.04 0.61 
    RT correct -0.18 1.1 -0.13 1.0 -0.01 0.94 -0.04 1.1 -0.38 1.1 -0.21 0.01 
           
Flanker CPT           
   correct-neutral  0.20 0.6 -0.06 1.1  0.02 0.75 -0.46 1.6 -1.07 2.3 -0.18 0.00 
   correct-congruent -0.01 0.8 -0.04 1.2  0.08 0.14 -0.74 1.9 -1.22 2.5 -0.14 0.02 
   correct-incongruent  0.22 0.7 -0.06 1.1 -0.00 0.94 -0.61 1.7 -0.99 1.7 -0.15 0.02 
   RT-neutral  0.16 1.0 -0.17 1.1 -0.17 0.02 -0.34 1.3 -0.66 1.5 -0.33 0.00 
   RT-congruent  0.06 1.1 -0.14 1.1 -0.14 0.08 -0.46 1.5 -0.70 1.5 -0.28 0.00 
   RT-incongruent  0.04 1.2 -0.17 1.1 -0.14 0.08 -0.24 1.3 -0.66 1.6 -0.33 0.00 
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Table 6. Associations between neurocognitive performance and psychosocial functioning meas-
ured by GAF in the two patient groups 
 
All analyses adjusted for age, sex and education 
For all associations: higher values indicate better performance 
 
Associations were reduced but did not disappear after additionally entering symp-
tom measures into the equation (CPT-HQ RT: β=0.17, p=0.10; Flanker RT neu-
tral: β=0.27, p=0.03; Flanker RT congruent β=0.20, p=0.07; Flanker RT incongru-
ent β=0.22, p=0.10). Higher HDRS depression ratings were consistently associated 
with lower GAF scores (betas between -0.42 and -0.46, p values <0.01), whereas 
YMRS mania/hypomania symptoms were not significantly predictive of GAF 
score (betas between -0.05 and -0.17, p values >0.12). 
 
Repeating the analyses excluding patients who did not have a narrow diagnosis of 
schizophrenia or bipolar disorder and controls who were using antidepressants, 
yielded comparable results for the analyses on neurocognitive performance in both 
disorders (data not shown). Regarding neurocognition-outcome relationships, in 
schizophrenia patients the associations between neurocognition and GAF were 
only significant for tests of verbal memory and RT on the CPT-HQ, mirroring the 
results obtained in previous analyses after additional adjustment for symptoms. In 
the bipolar study, associations did not change.  
 
Discussion 
Summary of findings 
Schizophrenia spectrum patients showed a generalized impairment across the cog-
nitive domains that were studied. Their relatives performed intermediately and 
significantly different from controls on tasks of verbal memory, sustained attention 
and reaction time components of selective attention. Bipolar patients similarly 
GAF 
SZ patients BD patients 
β p β p 
Word List Learning     
   immediate recall  0.21 0.00  0.10 0.45 
   delayed recall  0.22 0.00  0.16 0.27 
CPT-HQ     
    % correct detections  0.19 0.01  0.13 0.23 
    RT correct detections  0.20 0.00  0.20 0.09 
Flanker CPT     
   correct-neutral  0.13 0.02  0.05 0.63 
   correct-congruent  0.12 0.02  0.05 0.71 
   correct-incongruent  0.14 0.02  0.09 0.47 
   RT-neutral  0.19 0.00  0.27 0.03 
   RT-congruent  0.23 0.00  0.23 0.05 
   RT-incongruent  0.20 0.00  0.23 0.06 
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showed impairment in all three domains, although not consistently on all the task 
parameters. The cognitive performance of their first-degree relatives was compara-
ble to that of controls. Comparison of schizophrenia spectrum and bipolar study 
samples indicated that patients were impaired in overlapping cognitive domains 
but that the impairments were more severe in patients with schizophrenia spec-
trum diagnoses. Relatives of schizophrenia spectrum patients were cognitively 
more impaired than bipolar relatives on tasks of verbal memory and reaction time 
components of selective attention 
In schizophrenia spectrum patients, performance on most neurocognitive tests was 
associated with psychosocial functioning, whereas in bipolar patients this was true 
for reaction time components of selective attention only. For both groups, associa-
tions between neurocognition and psychosocial functioning were partly mediated 
by symptoms. In the schizophrenia spectrum sample, negative, disorganization and 
emotional distress symptoms were associated with psychosocial functioning to a 
similar degree as neurocognition, whereas in the bipolar sample depressive symp-
toms were strongly associated with psychosocial functioning.  
 
Neurocognition as vulnerability marker in SZ and BD 
The finding of cognitive deficits in multiple domains in schizophrenia spectrum 
patients is consistent with many previous studies that showed moderate to large 
effect sizes of deficits in verbal memory, sustained attention and selective attention 
(Aleman, Hijman, de Haan, & Kahn, 1999; Bilder et al., 2000; Heinrichs & Zakza-
nis, 1998), and confirms the idea of cognitive impairment as a core feature of the 
disorder (Altshuler et al., 2004; Keefe, 1995). The finding that first-degree relatives 
of schizophrenia spectrum patients performed intermediate to patients and con-
trols on most cognitive tests and differed significantly from controls on tasks of 
verbal memory, sustained attention and reaction time components of selective 
attention is in accordance with previous studies (Heydebrand, 2006; Kremen & 
Hoff, 2004; Sitskoorn, Aleman, Ebisch, Appels, & Kahn, 2004), and adds further 
evidence to the suggestion that neurocognitive impairments are putative markers 
of the genetic vulnerability to schizophrenia (Gur et al., 2007; Snitz, Macdonald, & 
Carter, 2006).  
 
Bipolar disorder patients differed significantly from controls on most cognitive 
tests, as previously reported in studies showing cognitive impairment in stable 
bipolar patients in verbal memory and attentional domains (Balanza-Martinez et 
al., 2005; Clark, Iversen, & Goodwin, 2002; Martinez-Aran, Vieta, Colom et al., 
2004; Quraishi & Frangou, 2002). Although cognitive alterations in verbal memory 
and attention in relatives of bipolar patients have been found in some studies (An-
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tila et al., 2007; Ferrier et al., 2004), in the current study cognitive performance of 
bipolar relatives was comparable to that of controls. This is in contradiction to the 
conclusion of a recent literature review (Glahn et al., 2004) that neurocognitive 
impairments represent candidate intermediary phenotypes for bipolar disorder. 
However, the more recent systematic review of Balanza-Martinez showed that the 
evidence in support of neurocognitive deficits in bipolar relatives is sparse 
(Balanza-Martinez et al., 2008), and a recent quantitative meta-analysis showed that 
differences between relatives and controls were generally small and significant only 
for the domain of executive control (Arts et al., 2008).  
 
Comparison of schizophrenia spectrum and bipolar patients indicated that al-
though both groups performed worse than controls in the domains of verbal 
memory and selective attention, schizophrenia spectrum patients were significantly 
more impaired than bipolar patients. Patients were equally impaired in the accuracy 
measure of sustained attention, but differed in their reaction times on this task as 
only schizophrenia spectrum patients were slower than controls on this task com-
ponent.  
Previous studies comparing neurocognitive functioning in schizophrenia and bipo-
lar disorder have yielded variable results (Altshuler et al., 2004; Dickerson, Som-
merville, Origoni, Ringel, & Parente, 2001; Hawkins et al., 1997; Rossi et al., 2000; 
Tabares-Seisdedos et al., 2003) but the broad conclusion that cognitive impairment 
in schizophrenia and bipolar disorder are qualitatively similar but quantitatively 
more marked in schizophrenia (Krabbendam, Arts, van Os, & Aleman, 2005; 
Schretlen et al., 2007) seems justified. 
 
Relatives of schizophrenia spectrum patients in this study had a poorer cognitive 
performance than bipolar relatives, and differences reached significance for tests of 
verbal memory and reaction time components of selective attention. These find-
ings are in line with the results of the few studies that have compared the cognitive 
performance of schizophrenia and bipolar relatives, namely that in general there is 
a more severe and generalized pattern of cognitive impairment in schizophrenia 
relatives (Keri, Kelemen, Benedek, & Janka, 2001; Kremen, Faraone, Seidman, 
Pepple, & Tsuang, 1998; Pirkola et al., 2005; Zalla et al., 2004). 
This study showed that, contrary to widespread assumptions, associations between 
symptoms and cognition were equally present in both groups. Although the magni-
tude of the associations was larger in the bipolar sample, it lacked statistical preci-
sion possibly due to the smaller sample size in the latter study. Cognitive perform-
ance in the schizophrenia spectrum sample was related to both negative and disor-
ganized symptoms but not to positive symptoms, as was shown in previous studies 
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(Dominguez, Viechtbauer, Simons, van Os, & Krabbendam, 2008; Harvey, Koren, 
Reichenberg, & Bowie, 2006; O'Leary et al., 2000). In line with previous sugges-
tions (Kravariti, Dixon, Frith, Murray, & McGuire, 2005), our data indicate that 
cognition shows qualitatively differential relationships with symptom dimensions, 
whereas differences between diagnostic categories are only quantitative.  
 
Predictors of psychosocial functioning in schizophrenia and bipolar disorder 
In schizophrenia spectrum patients, a better cognitive performance was predictive 
of higher psychosocial functioning as measured by GAF, a finding that is consis-
tent with previous reviews on cognition-outcome associations in schizophrenia 
(Green, 1996; Green et al., 2004). The predictive value of a better performance in 
learning and verbal memory, and reaction times of sustained attention, was inde-
pendent of the severity of current symptoms (Milev et al., 2005; Prouteau et al., 
2005; Toulopoulouand & Murray, 2004). However, negative, disorganization and 
emotional distress symptoms were also significantly associated with psychosocial 
functioning, and effect sizes for negative symptoms were comparable to those of 
the cognitive measures. Thus, specific symptom dimensions equal cognition in 
terms of their relevance in the prediction of functional outcome in schizophrenia 
(Milev et al., 2005; Norman et al., 1999). 
In the bipolar sample, faster reaction time on a selective attention task was signifi-
cantly associated with better psychosocial functioning. Other neurocognitive vari-
ables, however, were unrelated to outcome in this study. Controlling for residual 
symptoms showed that the associations with attentional reaction time variables 
remained significant, but that depressive symptomatology was a stronger predictor 
of psychosocial functioning than neurocognition in the bipolar sample. Only a few 
studies have investigated cognition-outcome associations in bipolar disorder; some 
showed positive associations between cognitive functioning on memory and ex-
ecutive functioning tests and GAF score in bipolar patients (Martinez-Aran, Vieta, 
Colom et al., 2004; Martinez-Aran, Vieta, Reinares et al., 2004; Torrent et al., 
2006). On the basis of current and previous findings, it can be concluded that 
clinical state is a crucial variable in predicting outcome in bipolar disorder. Not 
only may clinical variables, including subsyndromal depression (Marangell, 2004), 
be more predictive of psychosocial outcome than cognition (Martinez-Aran et al., 
2002), but cognition may also be more strongly related to functional outcome dur-
ing depression or mania/hypomania than in the euthymic state (Malhi et al., 2007). 
Cognition-outcome associations seem stronger in schizophrenia than in bipolar 
disorder (Laes & Sponheim, 2006; Martinez-Aran et al., 2002), and are possibly 
restricted to more selective cognitive deficits in bipolar disorder (Jaeger & Vieta, 
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2007). In contrast, residual symptomatology appears to make a larger contribution 
to functioning in bipolar disorder than in schizophrenia.  
 
Explaining similarities and differences 
In sum, although the presence of multiple cognitive deficits is shared by the two 
groups, schizophrenia spectrum disorders are associated with more severe and 
more generalized deficits, which seems to reflect the genetic vulnerability as well as 
the impact on daily life to a greater extent than in bipolar disorder.  
The current findings support a model that explains similarities and differences 
between schizophrenia and bipolar disorder by suggesting that the disorders have 
partly shared susceptibility genes predisposing to psychosis in general but are dif-
ferentiated by the presence of a neurodevelopmental impairment in the former but 
not in the latter (Murray et al., 2004). According to this model, the neurocognitive 
dysfunctions in schizophrenia and bipolar disorder have partly different origins. It 
is hypothesized that in schizophrenia dysfunctions are a consequence of problems 
in early brain development, whereas in bipolar disorder dysfunctions are more 
likely to be a consequence of the disease process itself. The presence of premorbid 
cognitive impairments in pre-schizophrenia children but not in pre-bipolar subjects 
(Cannon et al., 2002), findings of lower premorbid IQ estimation in schizophrenia 
as compared to bipolar disorder (Gilvarry et al., 2000), and other developmental 
delays as well as pregnancy and birth complications in schizophrenia (Verdoux et 
al., 1997) but not in bipolar disorder (Scott, McNeill, Cavanagh, Cannon, & 
Murray, 2006), are in line with this suggestion. The finding that in bipolar disorder 
cognitive deficits are associated with severity and progression of the illness (Robin-
son & Ferrier, 2006), and studies showing that the presence of cognitive alterations 
is more marked in schizophrenia relatives than in bipolar relatives, add further 
credence to this idea. A recent review on the causes of neurocognitive dysfunction 
in bipolar disorder suggested that the evidence was more in favour of a neurode-
generative model rather than a neurodevelopmental one (Goodwin, Martinez-
Aran, Glahn, & Vieta, 2008). 
On the other hand, the qualitatively similar pattern of neurocognitive dysfunctions 
in both disorders may also suggest partial aetiological overlap. Previous studies 
have shown a large degree of cognitive heterogeneity within the group of bipolar 
patients. There appears to be a subgroup of bipolar patients who are cognitively 
more severely impaired, even to a similar degree as in schizophrenia patients, and 
whose relatives also show significant cognitive alterations (Balanza-Martinez et al., 
2005; Sobczak, Honig, Schmitt, & Riedel, 2003). In the context of a continuum 
model spanning affective and non-affective psychosis, it can be suggested that this 
subgroup of bipolar subjects may be more towards the non-affective, neurodevel-
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opmental side of the continuum, and that for this subset of bipolar patients cogni-
tive impairments may reflect a genetic vulnerability that is also observable in their 
first-degree relatives. 
 
It is currently being argued that cognitive impairment should be included in the 
diagnostic criteria for schizophrenia (e.g.(Keefe, 2008)). Given the importance of 
neurocognition in terms of biology, function and treatment of severe mental ill-
nesses, it can be suggested that any dimensional representation of psychopathology 
should include variation in neurocognitive functioning in addition to other symp-
tom dimensions. The present findings show that there is quantitative rather than 
qualitative variation in neurocognitive functioning across diagnostic boundaries, 
providing no specificity in diagnostic terms. However, current and previous find-
ings suggest that there are valid developmental neurocognitive contrasts between 
schizophrenia and bipolar disorder that should be used for DSM-V / ICD11 (van 
Os, 2008). Future studies should focus on methods of proper assessment of deve-
lopmental cognitive deficits. 
 
Methodological considerations 
The current results should be interpreted in the context of several methodological 
issues.  
First, the cognitive assessment was limited and the broad domain of executive 
functioning could not be completely covered by the test battery. However, the 
study focused on domains that have been robustly associated with schizophrenia 
and bipolar disorder. Second, the sample sizes in the two studies were not ba-
lanced, which may have caused effect sizes in the larger sample of schizophrenia 
patients to be more statistically precise than in the sample of bipolar patients. 
Third, it cannot be excluded that the study had a bias towards inclusion of subjects 
who were functioning relatively well, yielding samples that are not representative of 
the entire population. Fourth, most patients were medicated, which may have con-
founded the results. However, studies investigating adverse cognitive side effects 
of psychotropic medication show that if negative effects are present, effect sizes 
are small (Goldberg, 2008), and some atypical antipsychotic drugs even seem to 
improve cognitive functioning (Keefe, Silva, Perkins, & Lieberman, 1999). Finally, 
psychosocial functioning in this study was assessed by a global measure of psycho-
social function (the GAF score), which may have caused results to be different 
from studies in which more explicit outcome measures were used.  
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Abstract 
Objective: In schizophrenia a distinction is made between psychosis with devel-
opmental impairment and cognitive impairment on the one hand and psychosis 
without developmental impairment and positive symptoms on the other. In this 
study it was investigated whether this model can be extended to bipolar disorder 
by testing the hypothesis that neurocognitive functioning is inversely related to 
positive psychotic symptoms in bipolar disorder. Method: Neurocognitive func-
tioning and psychopathology were assessed in i) 76 patients with bipolar disorder, 
ii) 39 of their healthy first-degree relatives, and iii) 61 healthy controls. Cognitive 
performance of bipolar patients and that of their first-degree relatives was investi-
gated taking into account the possible moderating effect of the level of expression 
of psychosis in patients and relatives. Results: Bipolar patients showed impaired 
cognitive performance on multiple cognitive domains, whereas performance of 
their relatives was comparable to that of controls. A history of psychotic symp-
toms in patients was suggestive of less likelihood of cognitive alterations in rela-
tives, and the presence of subclinical psychotic symptoms within the group of 
relatives predicted better cognitive performance. Conclusions: The finding of 
similar psychosis-cognition associations in bipolar disorder as implied by the two 
pathways leading to non-affective psychotic disorders, suggests that this model 
might be extended to the continuum spanning affective and non-affective psycho-
sis. This is in line with the idea of a partially overlapping vulnerability to bipolar 
disorder and schizophrenia and provides an explanation for the apparent differ-
ences in cognitive alterations in those at risk for the two disorders. 
 
Key words:  bipolar disorder; schizophrenia; psychosis; neurocognition; vulner-
ability markers 
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Introduction 
In the search for causal mechanisms of affective and non-affective psychosis, a 
productive focus may be the study of underlying markers of vulnerability. Inter-
mediary phenotypes associated with genetic risk may be closer to underlying 
mechanisms than illness symptoms that are the consequence of complex and vary-
ing gene-environment interactions (Kendler, 2001). 
Genetic and epidemiological studies suggest that there is substantial overlap in 
genetic risk for bipolar and non-affective psychotic disorders (Berrettini, 2003; 
Cardno, Rijsdijk, Sham, Murray, & McGuffin, 2002; Potash, 2006) and cognitive 
impairment is one of the most frequently investigated intermediary phenotypes. 
The presence of neurocognitive dysfunctions in patients with bipolar disorder is 
well established. Although deficits are generally worse during periods of affective 
disturbance, two recent meta-analyses (Arts, Jabben, Krabbendam, & Van Os, 
2008; Robinson et al., 2006) provide evidence for trait-like cognitive dysfunctions 
in euthymic bipolar patients, in particular in the domains of executive functioning 
and declarative memory. If neurocognitive deficits truly represent markers of ge-
netic risk for bipolar disorder (Glahn, Bearden, Niendam, & Escamilla, 2004), 
cognitive alterations should be detectable in subjects with a genetic vulnerability to 
bipolar disorder, such as first-degree relatives of patients. In a recent systematic 
review and meta-analysis of 14 studies of relatives of bipolar patients, Arts and 
colleagues (Arts et al., 2008) concluded that individuals at risk differed on some 
cognitive measures from controls, but that effect sizes were rather small and pre-
sent only for the domains of executive control and immediate verbal memory. The 
evidence for cognitive alterations as intermediary phenotype associated with ge-
netic risk is much stronger for non-affective psychotic disorders such as schizo-
phrenia. Not only are cognitive deficits in bipolar disorder less severe than those 
found in schizophrenia (Krabbendam, Arts, van Os, & Aleman, 2005), relatives of 
patients with bipolar disorder appear to have, if present at all, milder cognitive 
alterations (Sitskoorn, Aleman, Ebisch, Appels, & Kahn, 2004) compared to rela-
tives of schizophrenia. These findings are in line with studies showing that in chil-
dren destined to develop schizophrenia or bipolar disorder, developmental cogni-
tive impairment is present in the former but not the latter group (Cannon et al., 
1997; Reichenberg et al., 2002). 
Any theory explaining the apparent genetic overlap between bipolar disorder and 
schizophrenia should be able to explain these rather different cognitive profiles in 
individuals at genetic and developmental risk for the two disorders. Thus, one way 
to explain the weaker presence of cognitive impairments in relatives of patients 
with bipolar disorder is to assume that most of the cognitive impairments seen in 
patients is related to the ongoing illness process and its treatment, but that some is 
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also due to genetic effects that are shared to a small degree with schizophrenia and 
measurable in the relatives of patients. In an attempt to explain the similarities and 
dissimilarities between bipolar disorder and schizophrenia, Murray and colleagues 
(Murray et al., 2004) suggested that bipolar disorder and schizophrenia share some 
susceptibility genes that can cause a predisposition to psychosis in general. When, 
in addition to this predisposition, neurodevelopmental impairment is present, a 
schizophrenia-like phenotype will emerge. The neurodevelopmental impairment 
predisposition will contribute to the expression of negative and deficit symptoms 
and, in association with these symptom domains (Dominguez, Viechtbauer, 
Simons, van Os, & Krabbendam, 2008) to the cognitive deficits characteristic of 
schizophrenia. In the absence of these neurodevelopmental impairments, however, 
a more affective psychotic phenotype like bipolar disorder will emerge. The hy-
pothesised distinction between good outcome psychotic disorder without devel-
opmental impairment (characterised by positive and affective symptoms) and poor 
outcome psychotic disorder with developmental impairment (with negative and 
cognitive symptoms) in fact goes back to the seminal publication by Robins and 
Guze (Robins & Guze, 1970) that hypothesised, albeit within the more narrow 
domain of schizophrenia alone, two broad dimensions separated along similar 
lines. The extension of this model to the continuum spanning affective and non-
affective psychosis, results in testable hypotheses regarding the cognitive profile of 
relatives of patients with bipolar disorder. Thus, if the distinction between psycho-
sis with developmental impairment and cognitive impairment on the one hand and 
psychosis without developmental impairment and positive symptoms on the other 
is also valid in bipolar disorder, than bipolar patient-relative dyads with more ex-
pression of cognitive impairment should have less expression of positive psychotic 
symptoms.  
 
To this end, three hypotheses were investigated: (i) the presence of a history of 
positive psychotic symptoms in patients with bipolar disorder will be associated 
with less likelihood of altered cognitive functioning in the proband relative, and, 
similarly, (ii) within the group of relatives of bipolar patients, presence of subclini-
cal positive psychotic symptoms will be associated with less likelihood of cognitive 
alterations. Further, if cognitive impairment in patients with bipolar disorder is 
mainly illness-related while in relatives, if present at all, it may be the genetic ex-
pression of developmental impairment that is weakly shared with schizophrenia, 
iii) neurocognition in patients and relatives should be at best weakly correlated. 
These hypotheses were investigated by comparing cognitive performance of bipo-
lar patients and that of their first-degree relatives with that of a group of healthy 
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controls, taking into account the possible moderating effect of the level of expres-
sion of positive psychotic symptoms in patients and relatives.  
 
Methods 
Subjects 
The individuals in this study were participants in the BIPOLCOG study, a study 
on cognitive functioning in bipolar disorder (BD) in which three groups were in-
vestigated i) patients with bipolar disorder, ii) healthy first-degree relatives of pa-
tients with bipolar disorder, and iii) healthy control participants. All subjects were 
between the ages of 18 and 60 years, fluent in Dutch, had an IQ>70 and were 
without a history of neurological disorders such as epilepsy and concussion with 
loss of consciousness. 
Patients were recruited through in-patient and out-patient mental health service 
facilities in South-Limburg, the Netherlands and through the local association of 
bipolar patients and their families. Initial inclusion criteria for patients were the 
lifetime prevalence of bipolar disorder according to the RDC (Research Diagnostic 
Criteria) (Spitzer, Endicott, & Robins, 1978). The computer program OPCRIT was 
used to derive and confirm diagnoses on the basis of current and lifetime recorded 
symptomatology listed in the Operational Criteria Checklist for Psychotic Illness 
(OCCPI) (Mc Guffin, Farmer, & Harvey, 1991). 
First-degree relatives, free from a lifetime history of BD or psychosis, were sam-
pled through participating patients and had at least one first-degree relative with a 
diagnosis of BD. Control subjects were recruited from the general population 
through a random mailing. First-degree relatives and controls were clinically and 
diagnostically interviewed with The Comprehensive Assessment of Symptoms and 
History (CASH: (Andreasen, Flaum, & Arndt, 1992)) and OPCRIT criteria to ex-
clude those presenting a diagnosis of BD or psychotic disorder. Healthy controls 
were additionally interviewed with the FIGS (Maxwell, 1992) in order to confirm 
the absence of family histories of psychotic or bipolar disorders. 
The initial sample consisted of 81 patients, 39 first-degree relatives and 61 healthy 
control subjects. Three patients were excluded because data on diagnosis were 
missing. Data on neuropsychological performance were missing for two patients. 
As a consequence, the risk set for the current study consisted of 76 patients with 
BD, 39 relatives and 61 controls.  
There were 45 patients with an RDC diagnosis of bipolar I disorder, 17 patients 
with an RDC diagnosis of schizoaffective disorder bipolar or manic type, 13 pa-
tients with an RDC diagnosis of bipolar II disorder and one patient with an RDC 
diagnosis of mania. In the group of relatives, 8 had an RDC diagnosis of major 
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depression in the past and one of hypomania. The other relatives were free from a 
history of psychiatric disorder. Three controls had a history of major depression.  
Forty-five patients were included without a participating first-degree relative. The 
remaining patients and relatives originated from 26 families, of which 16 families 
contributed one patient and one relative, six families contributed one patient and at 
least two relatives, two families contributed two patients, one family contributed 
two patients and five relatives and one family contributed two relatives. The 39 
participating relatives were 31 siblings, 5 sons and 3 daughters. 
 
Procedure 
Participants were examined during two sessions with an interval of approximately 
two months. The double session served to enhance statistical power. During both 
sessions, neuropsychological testing and psychiatric interviewing took place and 
questionnaires were filled out. In the first session, basic demographic information 
was collected from all subjects, and in the BD group information on illness charac-
teristics was obtained. Written informed consent, conforming to the local ethics 
committee guidelines, was obtained from all subjects. Neuropsychological tests and 
psychiatric interviews were conducted by trained psychologists, and each session 
took approximately two hours to complete.  
 
Psychopathology 
In each session, current depressive and manic psychopathology of all subjects was 
assessed using the 21-item Hamilton Rating Scale for Depression (Hamilton, 1960) 
and the Young Mania Rating Scale (Young, Biggs, Ziegler, & Meyer, 1978) respec-
tively. To further asses the presence of psychiatric symptoms at the time of testing, 
the extended Brief Psychiatric Rating Scale (BPRS-E: (Lukoff, Nuechterlein, & 
Ventura, 1986)) was administered. This scale assesses a wider range of current 
psychopathology, including symptoms of depression, mania, psychosis, anxiety, 
and withdrawal in the past two weeks.  
The Community Assessment of Psychic Experiences (CAPE), a 42-item self-report 
instrument, was used to assess dimensions of the subclinical psychosis and depres-
sive phenotype. In this questionnaire, 20 items measure positive psychotic experi-
ences, 14 items rate negative experiences and 8 cognitive depressive experiences. 
The frequency of the experience was rated on a four-point scale of “never”, 
“sometimes”, “often” and “nearly always”. For a detailed description of the CAPE, 
see http://www.cape42.homestead.com (M. Hanssen, Krabbendam, Vollema, 
Delespaul, & Van Os, 2006; Stefanis et al., 2002; Verdoux & van Os, 2002). The 
scale has been validated against clinical interview measures of schizotypy and psy-
chosis-proneness (Konings, Bak, Hanssen, van Os, & Krabbendam, 2006) and 
Thesis_Jabben_v3.pdf   72 30-6-2009   8:56:21
CHAPTER 4 
 
Page | 73  
 
discriminatory validity was shown contrasting different patient groups (M. S. 
Hanssen, Bijl, Vollebergh, & van Os, 2003). OPCRIT criteria were used to derive 
the presence of a history of positive psychotic symptoms in patients on the basis 
of current and lifetime recorded symptomatology listed in the OCCPI (Mc Guffin 
et al., 1991). Information was obtained from patients’ reports and medical files. 
 
Neurocognitive assessment 
Neurocognitive tests were administered by computer, using E-prime for Windows 
on a 15-inch monitor Toshiba Tecra laptop. The neurocognitive test battery in-
cluded tasks measuring various neurocognitive domains, guided by previous evi-
dence of impaired performance among these domains in BD patients and their 
relatives (Antila et al., 2007; Arts et al., 2007; Ferrier & Thompson, 2002; Murphy 
& Sahakian, 2001; Robinson et al., 2006).  
Overall intellectual functioning was estimated using three Groningen Intelligence 
Test (GIT) subtests (Mental Rotation, Word Analogies and Mental Arithmetic) 
(Luteijn & van der Ploeg, 1983), yielding results that are comparable to those of 
the Wechsler Adult Intelligence Scale (Wechsler, 1981). Verbal learning and mem-
ory was assessed with the standardized Dutch version of the Visual Verbal Learn-
ing Test (Rey, 1964). In three consecutive trials, 15 monosyllabic non-related 
words had to be memorized and reproduced. The total number of words recalled 
over the three trials was used as a measure of immediate recall. Delayed recall and 
recognition memory were measured after a 20 minute delay. 
Digit Span Forward and Digit Span Backward of the Wechsler intelligence Scale 
III (Wechsler, 2000) were used as measures of attention - working memory, re-
spectively. Sustained attention was measured with a continuous performance test, 
the CPT-HQ version, a variant of the CPT-AX. Subjects were instructed to re-
spond as quickly as possible by pressing the spacebar whenever target stimulus ‘Q’ 
was preceded by an ‘H’ on the screen. Outcome measures were expressed as the 
proportion correct detections, the reaction time of correct detections, and the 
proportion false alarms (Nestor, Faux, McCarley, Shenton, & Sands, 1990).  
The Tapping Speed test (Cogtest plc, London) is a finger tapping test alternating 
between the right and left hand, that was used as a simple measure of motor speed 
and manual dexterity. The Cogtest version is similar to the Finger Tapping Test or 
the Finger Oscillation Test of the Halstead Reitan Neuropsychological Battery 
(Reitan & Wolfson, 1985). Subjects were asked to tap a key on the keyboard with 
their index finger as fast as they could for 8 seconds in five trials for each hand. 
Outcome measures were the total number of taps with the index finger of each 
hand and the latency to each and every response, thereby generating an index of 
the variance in tapping speed. 
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The Flanker CPT (Cogtest plc, London) (Eriksen & Schultz, 1979; Posner, Inhoff, 
Friedrich, & Cohen, 1987) is a measure of selective visual control of attention. 
Subjects are instructed to respond by pressing the right or left mouse button de-
pending on whether the middle element in a display of five lines has an arrowhead 
pointing to the right or left. There are three trial types: i) neutral trials in which the 
flankers are just horizontal lines without arrowheads, ii) congruent trials in which 
all flankers have an arrowhead pointing in the same direction as the target, and iii) 
incongruent trials, in which flankers are pointing in opposite direction from the 
target. The test consists of 144 trials of neutral, congruent and incongruent flank-
ers, which are presented randomly. Outcome measures were the mean reaction 
time for correct responses (RT) and the sum of correct trials in each condition.   
The Strategic Target Detection Task (STDT: Cogtest plc, London) (Weintraub & 
Mesulam, 1987) is a task similar to the paper and pen ‘cancellation’-tests or the 
‘cross-out’ subtest of the WAIS III, where subjects are required to cross-out target 
stimuli embedded among distracters. In this computerized version, subjects are not 
told in advance which of the various stimuli is the target but have to learn by given 
feedback and thereby modifying their future responses. This is an aspect of the 
SDTD similar to the Wisconsin Card Sorting Test. Performance was scored by the 
mean reaction time for correct responses and the total number of correct and in-
correct responses and perseverative errors 
In the Set Shifting Test (SST: Cogtest plc, London) (Bilder, Turkel, Lipschutz-
Broch, & Lieberman, 1992), subjects are asked to respond as fast as possible to the 
direction in which a square appears on the computer screen by pressing the corre-
sponding key on the keyboard. In the first phase, the square appears randomly on 
either the left or the right side of the screen, in order to establish baseline reaction 
time. Subsequently, the participant learns the first ‘response set’, which is a simple 
right-right-left sequence. After some experience with this rule, reaction time usu-
ally decreases from the baseline reaction time as subjects learn to anticipate the 
next stimulus in the sequence. This provides a measure of set acquisition, or im-
plicit learning. Then, without prior warning, the response set is reversed (to left-
left-right). This shift in response set is usually associated with an increase in reac-
tion time, slower than the baseline reaction time. This is called the set shifting ef-
fect. The subject goes through 3 reversals altogether to obtain reliable measures. 
Outcome measures are reaction times and errors in the imitation and reversal con-
ditions.  
 
Statistical Analyses 
Before analyses, cognitive variables were inspected for outliers. Since observations 
in which a mechanical failure took place were already registered as missing, it was 
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decided to replace values with deviation more than three standard deviations from 
the mean with the closest value within the same group (Tabachnick & Fidell, 
1996). Statistical analyses were performed using STATA 10.0 (Statacorp, 2007).  
In order to reduce the number of dependent neuropsychological variables in the 
analyses (Krabbendam, Marcelis, Delespaul, Jolles, & van Os, 2001) a principal 
component analysis (PCA) followed by varimax rotation was performed on the 
neuropsychological variables and interpreted on the basis of scree plot and eigen-
values. Based on the component loadings, a summary measure for each compo-
nent was calculated, composed of the relative loading of each variable that loaded 
on this particular component. These scores were transformed to z-scores which 
were subsequently used as neurocognitive variables in the regression analyses. 
A dummy variable indicating bipolar vulnerability was constructed with value 1 for 
controls, value 2 for first-degree relatives and value 3 for patients, reflecting in-
creasing risk for BD (hereafter: group).  
Observations of subjects were clustered at the level of session and at the level of 
family. In order to take these different levels of clustering into account, the main 
effect of group on cognition was assessed with multilevel random regression analy-
ses, controlling for session and including a family random effect in the model, 
using the XTREG routine in STATA, with cognitive test values as dependent vari-
ables and bipolar liability as the independent variable. Analyses were repeated en-
tering residual depressive and manic symptom scores in the equation, examining 
the mediating effect of residual affective symptoms. All analyses were a priori ad-
justed for the possible confounding effects of age and sex by entering these vari-
ables into the equation. 
In order to investigate the first hypothesis, pairwise comparisons of all available 
patient-relative pairs within the same family were used to examine, using multilevel 
regression analyses, the relationship between a history of psychosis in the patients 
and neurocognition in the relatives. A history of psychosis was coded as a di-
chotomous (‘yes’ or ‘no’) variable defined by the life time presence of at least one 
positive psychotic symptom in OPCRIT (Mc Guffin et al., 1991).  
Subsequently, to investigate the second hypothesis, multilevel random regression 
analyses with Group X CAPE trait psychosis interactions were fitted to examine a 
possible moderating effect of subclinical positive psychotic symptoms on neuro-
cognitive performance within the group of relatives. Analyses were additionally 
adjusted for the possible confounding effect of education. For significant interac-
tions, the STATA LINCOM routine was used to calculate stratified effect sizes 
according to the appropriate linear combinations. Stratified effect sizes were calcu-
lated for CAPE trait psychosis scores of one and two standard deviations below 
and above average in relatives compared to controls. 
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The third hypothesis was investigated, similar to the first hypothesis, by examining 
pairwise associations between patients’ and relatives’ neurocognitive functioning.  
 
Results 
Demographic characteristics, psychiatric measures and neuropsychological test 
scores are presented in table 1. Five controls, one relative and six patients did not 
participate during the second session, as a result of which neurocognitive data on 
the second session were missing for these subjects.  
 
Principal Component Analyses 
Based on scree plot and eigenvalues of components after PCA, eight components 
were retained accounting for 70% of the variance. Components and component 
loadings are presented in table 2. The first component was interpreted to represent 
fine motor speed, the second set shifting – reaction time, the third attention - accuracy, the 
fourth attention - reaction time, the fifth verbal memory, the sixth set shifting - accuracy, the 
seventh mental flexibility, and the eighth attention - working memory.  
 
Group differences 
Being a patient predicted neurocognitive performance on all but two cognitive 
factors (table 3). First-degree relatives, however, only differed significantly from 
controls on set shifting - accuracy and set shifting - reaction time, though in opposite direc-
tions, as for accuracy relative status predicted a better performance whereas for 
reaction time being a relative was related to worse performance. 
After adjustment for residual mood symptoms, the effect size for the association 
between patient status and fine motor speed reduced significantly. A slight reduction 
in effect size was found for the association between patient status and cognitive 
performance in the domains of verbal memory and attention - working memory. In other 
cognitive domains, effect sizes did not change after adjustment for residual mood 
symptoms (table 3).  
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Table 1. Demographics, clinical characteristics and results of neurocognitive assessment 
 
All neurocognitive tests and psychiatric interviews were administered during both sessions, with the excep-
tion of STDT, SST and the CAPE, that were administered only in the second session. 
CPT, Continuous Performance Test; STDT, Strategic Target Detection Test; SST, Set Shifting Test. 
 
 
Control subjects (n=61) 
First-degree relatives 
(n=39) 
BD patients  
(n=76) 
Mean SD Mean SD Mean SD 
Gender M / F 23 / 38 20 / 19 37 / 39 
Age range 25 - 56 18 - 58 27 - 60 
Age (years) 45.3 8.7 40.7 12.2 44.7 7.9 
Educational level 5.8 1.7 6.3 2.0 5.5 2.2 
GIT IQ 119.5 9.6 117.6 14.0 113.2 11.7 
BPRS total score (24 - 57) 25.2 2.3 27.4 4.3 33.1 6.3 
HDRS total score (0 - 25) 0.34 1.44 1.03 2.32 4.05 4.45 
YMRS total score (0 - 9) 0.06 0.30 0.32 0.87 1.37 2.17 
CAPE psychosis 0.18 0.19 0.23 0.16 0.35 0.25 
Clinical characteristics:       
   age at onset     27.4 8.9 
   duration of illness     6.1 5.1 
   total number of episodes     8.4 6.2 
   number of hospitalizations     1.6 2.2 
   % previous psychotic      50,7% 
Verbal learning and memory       
Word List Learning       
   total immediate recall 26.0 5.5 26.7 6.5 22.6 6.9 
   delayed recall 8.5 2.6 9.2 3.3 6.8 3.1 
   recognition 13.9 1.1 13.9 1.3 13.0 2.2 
Attention and concentration       
  Digit Span forward 9.0 1.7 9.2 2.0 8.5 1.8 
  Digit Span backward 6.9 2.0 7.6 2.5 5.9 1.9 
   Flanker correct-neutral 45.7 3.0 46.3 1.9 43.9 5.3 
   Flanker correct-congruent 46.4 2.1 46.4 1.7 44.0 5.6 
   Flanker correct-incongruent 43.2 4.1 44.1 3.2 39.9 8.0 
   Flanker RT-neutral 634.2 53.0 623.4 58.5 679.6 86.5 
   Flanker RT-congruent 632.6 49.2 629.3 60.7 679.6 84.7 
   Flanker RT-incongruent 691.5 53.4 688.0 68.6 730.1 81.6 
   CPT-HQ RT correct detections 471.9 76.7 489.8 93.4 479.2 94.1 
   CPT-HQ % correct detections 98.9 2.5 97.1 9.0 95.4 6.7 
Executive functioning       
   STDT number correct 85.0 6.6 85.3 7.0 83.6 5.7 
   STDT number incorrect 24.3 11.0 22.1 6.4 24.8 10.3 
   STDT perseverative errors 4.1 3.3 4.7 2.5 4.6 2.9 
   STDT RT correct 701.9 199.2 656.0 225.8 732.9 256.7 
   SST basal RT 362.5 40.1 376.9 55.1 417.5 85.0 
   SST start imitation RT 378.9 47.9 406.0 57.1 429.8 65.8 
   SST  end imitation RT 344.4 61.6 349.6 72.7 386.5 81.4 
   SST  start reversal RT 385.1 48.9 419.1 50.3 442.6 72.8 
   SST end reversal RT 340.4 56.6 348.3 72.9 382.7 93.2 
   SST imitation errors 0.82 1.1 0.83 0.94 1.4 1.5 
   SST reversal errors 0.93 1.1 0.98 1.2 1.6 1.9 
Fine motor speed       
   Finger tap rate right 180.2 22.6 178.1 22.2 184.4 26.1 
   Finger  tap rate left 192.7 23.7 190.9 27.9 204.1 29.5 
   Finger tap total hits right 279.4 35.3 282.0 32.9 272.5 39.5 
   Finger tap total hits left 260.3 31.1 264.3 36.5 246.2 34.5 
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Table 2. Component composition and loadings after PCA with varimax rotation 
 
Eight components accounting for 70% of variance. Groupings for the different components are shaded. 
 
Pairwise comparisons 
Forty-two pairs of patient and sib within the same family were used to investigate 
pairwise associations. The presence of a history of positive psychotic symptoms in 
patients accounted for a significant proportion of the variance in neurocognitive 
functioning in the corresponding relatives in the domain of fine motor speed (ß=0.94, 
p=0.00). For set shifting - reaction time (ß=0.48, p=0.11), attention - accuracy (ß=0.21, 
p=0.12), verbal memory (ß=0.56, p=0.15) and attention - working memory (ß=0.74, 
p=0.10) the findings were suggestive of an association. Associations were consis-
tently in the direction that relatives of patients with a history of positive psychotic 
symptoms showed a better cognitive performance. The presence of a history of 
psychotic symptoms in patients did not predict neurocognitive functioning in cor-
responding relatives in domains of attention - reaction time (ß=0.22, p=0.51), set shift-
ing - accuracy (ß=-0.28, p=0.55), and mental flexibility (ß=-0.08, p=0.81). 
Component: 1   2 3 4   5 6 7 8 
WLT immed. recall -0.0184  0.0435 -0.0378 -0.0116  0.5718  0.0560  0.0066  0.0909 
WLT delayed recall -0.0200  0.0246 -0.0338 -0.0434  0.6165  0.0463 -0.0225 -0.0470 
WLT recog  0.0057 -0.1346  0.2839  0.0300  0.3886 -0.1480  0.0889 -0.2527 
CPT HQ - % corr  0.0803 -0.0501  0.3037  0.0726  0.0621 -0.1324  0.0685  0.1004 
CPT HQ - RT  0.0459  0.0027 -0.0596  0.1334  0.1197 -0.3263 -0.0328  0.1704 
Flanker count neu -0.0215  0.0286  0.4869 -0.0072 -0.0620  0.0373 -0.0122  0.0765 
Flanker count con  0.0266 -0.0164  0.4969  0.0372 -0.0097  0.0317 -0.0034  0.0236 
Flanker count inc  0.0215 -0.0125  0.4879 -0.0266 -0.0144  0.0839 -0.0367  0.0274 
Flanker RT neu -0.0176  0.0011  0.0433  0.5437 -0.0145  0.0269  0.0016 -0.0251 
Flanker RT con  0.0014 -0.0074  0.0181  0.5399  0.0016  0.0245  0.0080 -0.0467 
Flanker RT inc -0.0429 -0.0210 -0.0355  0.5552 -0.0525 -0.0162 -0.0185  0.0335 
STDT corr  0.1009 -0.0588 -0.0690  0.0361  0.1302 -0.0884 -0.4218  0.2241 
STDT incor  0.0232 -0.0238 -0.0891  0.0558  0.0207  0.0041  0.6260  0.0635 
STDT persv err  0.0010  0.0360  0.0613 -0.0553  0.0227 -0.0358  0.6049  0.0579 
STDT RT corr -0.1293  0.2185  0.1986 -0.0341  0.0746 -0.0494 -0.1448 -0.0617 
SST basal RT  0.0505  0.3195  0.0491  0.1275 -0.0848  0.0454 -0.0606 -0.0207 
SST start im RT  0.0238  0.4982 -0.0586  0.0151 -0.0049  0.1370  0.0304 -0.0197 
SST end im RT -0.0180  0.4911 -0.0163 -0.0170  0.0126 -0.0465  0.0252 -0.0018 
SST start rev RT  0.1005  0.3511 -0.0008  0.0127  0.0916 -0.0481 -0.0314  0.0204 
SST end rev RT -0.0429  0.4280  0.0424 -0.0194  0.0498 -0.1443  0.0505  0.0255 
SST im errors  0.0186  0.0050  0.0341  0.0327  0.0457  0.6016  0.0571 -0.0222 
SST rev errors -0.0060 -0.0091  0.0109  0.0102  0.0311  0.6251 -0.0557  0.0517 
TST tap rate right  0.4888 -0.0459 -0.0225 -0.0073  0.0529  0.0423 -0.0267  0.0176 
TST tap rate left  0.4553  0.0733  0.0500 -0.0399 -0.0910 -0.0408  0.0182 -0.0743 
TST hits right  0.4768 -0.0473  0.0007 -0.0027  0.0359  0.0279 -0.0197  0.0419 
TST hits left  0.4662  0.0665  0.0356 -0.0508 -0.1031 -0.0302  0.0162 -0.0584 
DS forward -0.0547 -0.0380  0.0977 -0.0162 -0.0895 -0.0735  0.0492  0.6747 
DS backward  0.0481  0.0483 -0.0648 -0.0049  0.1183  0.1294  0.0128  0.5855 
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Examination of pairwise associations between patients’ and relatives’ neurocogni-
tive functioning showed that cognitive performance in patients did not account for 
variance in cognitive performance in corresponding relatives (all Beta’s between 
0.13 and 0.11, p>0.21). 
 
Table 3.  Association between neurocognitive functioning and the group variable reflecting risk 
for bipolar disorder (controls were used as reference category) 
 
All analyses a priori adjusted for age, sex and session 
*For all outcome measures: higher values indicate better performance 
# ß = All Betas are standardised regression coeffients indicating the change in outcome associated with the 
risk for bipolar disorder  
HDRS, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale 
 
Does subclinical psychosis affect relative-control differences? 
There were significant two-way Group X CAPE trait interactions in the neurocog-
nitive domains of fine motor speed (ß=0.44, p=0.05, 95% confidence interval (CI): 
0.01, 0.87), set shifting - reaction time (ß=0.53, p=0.00, 95% CI: 0.23, 0.84), attention - 
reaction time (ß=0.39, p=0.04, 95% CI: 0.01, 0.76), and verbal memory (ß=0.46, p= 
0.02, 95% CI: 0.08, 0.83), indicating that the association between group and cogni-
tion was moderated by subclinical psychotic symptoms in the relatives. 
Stratified effect sizes (table 4) indicate that for relatives an above average subclini-
cal psychosis score predicted better fine motor speed compared to controls. A similar 
Outcome measure* Group  + Adjustment for HDRS and YMRS 
Fine motor  speed 
 Relatives  (1) ß#=  0.12 p= 0.55 ß=  0.20 p= 0.32 
 BD patients  (2) ß= -0.45 p= 0.01 ß= -0.13 p= 0.49 
Set shifting - RT 
 Relatives  (1) ß= -0.49 p= 0.01 ß= -0.49 p= 0.01 
 BD patients  (2) ß= -0.74 p= 0.00 ß= -0.73 p= 0.00 
Attention - accuracy 
 Relatives  (1) ß= -0.05 p= 0.79 ß= -0.05 p= 0.75 
 BD patients  (2) ß= -0.56 p= 0.00 ß= -0.46 p= 0.00 
Attention - RT 
 Relatives  (1) ß= -0.32 p= 0.10 ß= -0.30 p= 0.13 
 BD patients  (2) ß= -0.75 p= 0.00 ß= -0.72 p= 0.00 
Verbal memory 
 Relatives  (1) ß=  0.16 p= 0.38 ß=  0.19 p= 0.29 
 BD patients  (2) ß= -0.65 p= 0.00 ß= -0.53 p= 0.00 
Set shifting - accuracy 
 Relatives  (1) ß=  0.44 p= 0.05 ß=  0.42 p= 0.06 
 BD patients  (2) ß= -0.03 p= 0.88 ß= -0.13 p= 0.57 
Mental flexibility 
 Relatives  (1) ß= -0.04 p= 0.86 ß= -0.06 p= 0.79 
 BD patients  (2) ß=  0.02 p= 0.92 ß=  0.06 p= 0.80 
Attentional span and working memory 
 Relatives  (1) ß=  0.15 p= 0.44 ß= -0.15 p= 0.44 
 BD patients (2) ß= -0.63 p= 0.00 ß= -0.54 p= 0.00 
Thesis_Jabben_v3.pdf   79 30-6-2009   8:56:22
CHAPTER 4 
Page | 80 
 
interaction pattern was found for verbal memory. In relatives, a lower subclinical 
psychosis score predicted more cognitive alterations in attention - reaction time com-
pared to controls. For set shifting - reaction time, stratification showed that in relatives, 
an above average subclinical psychosis score predicted better cognitive perform-
ance than in controls, whereas a below average subclinical psychosis score was 
related to worse performance.  
 
Table 4. Group X CAPE trait psychosis interactions (in relatives, controls as reference category)   
 
All analyses adjusted for age, sex, session and education.  
For Attention - accuracy, Set Shifting - accuracy, Mental flexibility and Attention - Working memory,  
Group X CAPE trait interactions were non significant  (all Beta’s between -0.12 and 0.37, and p>0.38). 
*Effect sizes indicate the change in cognition scores associated with CAPE trait scores of -2 to +2 standard 
deviations below and above average in relatives compared to controls.  
#CI = 95% confidence interval 
 
Discussion 
Summary of findings 
The results of this study can be summarised as follows. Patients with bipolar dis-
order showed impaired performance on multiple cognitive domains, whereas cog-
nitive performance of their first-degree relatives was comparable to that of con-
trols on most cognitive tasks. The presence of a history of positive psychotic 
symptoms in patients was associated with less likelihood of cognitive alterations in 
relatives and the presence of subclinical psychotic symptoms within the group of 
relatives predicted less likelihood of cognitive alterations. Additionally it was found 
Outcome  measure 
CAPE subclinical psychosis 
- 2 SD* -1 SD mean  +1 SD +2 SD 
Fine motor speed ß= -0.62, p=0.15 
CI#: -1.49, 0.24 
ß= -0.19, p=0.49 
CI: -0.72, 0.35 
ß= 0.25, p=0.26 
CI: -0.18, 0.69 
ß= 0.69, p=0.05 
CI: 0.01, 1.37 
ß= 1.13, p=0.04 
CI: 0.08, 2.18 
Set shifting - RT ß= -1.00, p=0.00 
CI: -1.67, -0.33 
ß= -0.46, p=0.06 
CI: -0.94, 0.02 
ß= 0.07, p=0.76 
CI: -0.37, 0.51 
ß= 0.60, p=0.05 
CI: 0.01, 1.19 
ß= 1.14, p=0.01 
CI: 0.31, 1.96 
Attention - acc ß= -0.20, p=0.38 
CI: -0.65, 0.25 
ß= -0.05, p=0.74 
CI: -0.32, 0.23 
ß= 0.11, p=0.38 
CI: -0.13, 0.34 
ß= 0.26, p=0.17 
CI: -0.11, 0.63 
ß= 0.41, p=0.15 
CI: -0.16, 0.98 
Attention - RT ß= -0.78, p=0.03 
CI: -1.51, -0.06 
ß= -0.40, p=0.08 
CI: -0.84, 0.04 
ß= -0.01, p=0.95 
CI: -0.38, 0.36 
ß= 0.37, p=0.22 
CI: -0.22, 0.97 
ß= 0.76, p=0.11 
CI: -0.16, 1.68 
Verbal memory ß= -0.56, p=0.09 
CI: -1.43, 0.11 
ß= -0.20, p=0.43 
CI: -0.69, 0.29 
ß= 0.26, p=0.23 
CI: -0.16, 0.67 
ß= 0.71, p=0.03 
CI: 0.09, 1.33 
ß= 1.17, 0=0.02 
CI: 0.23, 2.11 
Set shifting - acc ß= 0.70, p=0.16 
CI: -0.27, 1.66 
ß= 0.53, p=0.09 
CI: -0.08, 1.14 
ß= 0.37, p=0.16 
CI: -0.14, 0.88 
ß= 0.20, p=0.61 
CI: -0.57, 0.97 
ß= 0.04, p=0.95 
CI: -1.13, 1.20 
Mental flexibility ß= 0.05, p=0.91 
CI: -0.83, 0.92 
ß= -0.04, p=0.90 
CI: -0.65, 0.57 
ß= -0.12, p=0.65 
CI: -0.67, 0.42 
ß= -0.21, p=0.57 
CI: -0.95, 0.53 
ß= -0.30, p=0.58 
CI: -1.35, 0.76 
Attentional span - 
working memory 
ß= 0.47, p=0.32 
CI: -0.45, 1.38 
ß= 0.26, p=0.36 
CI: -0.30, 0.83 
ß= 0.06, p=0.80 
CI: -0.40, 0.52 
ß= -0.14, p=0.69 
CI: -0.86, 0.57 
ß= -0.35, p=0.54 
CI: -1.45, 0.75 
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that cognition in patients did not account for variance in cognitive functioning in 
corresponding relatives. 
 
Neurocognitive functioning in bipolar patients and their relatives 
The finding of cognitive dysfunctions in bipolar patients is consistent with previ-
ous studies reporting deficits in verbal memory (Altshuler et al., 2004; Fleck et al., 
2003; Krabbendam et al., 2000; Martinez-Aran et al., 2004), attention (Bora, Vahip, 
& Akdeniz, 2006; Clark, Iversen, & Goodwin, 2002; Thompson et al., 2005) and 
executive functioning (Dixon, Kravariti, Frith, Murray, & McGuire, 2004; Frangou, 
Donaldson, Hadjulis, Landau, & Goldstein, 2005; Goswami et al., 2006; Zalla et 
al., 2004). Patients did not show impairment in all executive domains, as a deficit 
was found on set shifting – reaction time, but not on measures of mental flexibility. This 
is in line with a previous suggestion by Ferrier and colleagues (Ferrier, Stanton, 
Kelly, & Scott, 1999) who concluded that BD patients do not show a global 
dysexecutive syndrome but are more impaired on tasks requiring a stronger work-
ing memory component.  
First-degree relatives in this study performed significantly worse than controls only 
on set shifting – reaction time measures. This finding is consistent with that of Clark 
and colleagues (Clark, Sarna, & Goodwin, 2005), who also found deficits in rela-
tives on an attentional shift task but not in verbal memory. The absence of cogni-
tive alterations on other cognitive functions is inconsistent with studies reporting 
cognitive alterations in relatives in verbal memory (Ferrier, Chowdhury, Thomp-
son, Watson, & Young, 2004; Keri, Kelemen, Benedek, & Janka, 2001; McIntosh, 
Harrison, Forrester, Lawrie, & Johnstone, 2005), attention and psychomotor speed 
(Antila et al., 2007; Pierson, Jouvent, Quintin, Perez-Diaz, & Leboyer, 2000; Sobc-
zak et al., 2002). In a recent review and meta-analysis of studies on cognition in 
relatives, individuals at risk for bipolar disorder differed from controls, but effect 
sizes were small and significant only for executive control (Arts et al., 2007). 
 
Cognitive alterations and positive psychotic symptoms  
In line with our first hypothesis, the presence of a history of positive psychotic 
symptoms in patients with bipolar disorder co-occurred with less likelihood of 
altered cognitive functioning in the proband relative, albeit statistically significant 
for one domain only. Relatives of patients with a history of psychotic symptoms 
performed significantly better than relatives of patients without such history on a 
measure of fine motor speed, whereas for set shifting - reaction time, attention – accuracy, 
verbal memory and attention - working memory findings were suggestive of an association 
in the same direction. 
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The second hypothesis was also confirmed. Cognitive alterations, in partially over-
lapping domains of fine motor speed, set shifting - reaction time, attention -reaction time, and 
verbal memory, were more likely to occur in relatives with lower subclinical psychosis 
scores, whereas relatives with a higher degree of subclinical psychosis showed bet-
ter cognitive functioning compared to controls.  
This is, to our best knowledge, the first study investigating the association between 
positive psychotic symptoms in patients with bipolar disorder and cognitive func-
tioning in their proband relatives, and between subclinical psychotic symptoms and 
cognitive alterations within relatives. Several studies, however, have investigated 
the relationship between a history of psychosis and cognitive functioning in pa-
tients with bipolar disorder, but results are inconsistent (Albus et al., 1996; Glahn 
et al., 2007; Martinez-Aran et al., 2004; Selva et al., 2007). Some studies found that 
a history of psychosis was associated with impaired verbal memory (Martinez-Aran 
et al., 2004) and executive control functioning (Glahn et al., 2007), whereas other 
studies failed to find an association with neurocognition (Goldberg et al., 1993; 
Selva et al., 2007).  
It can be suggested that in patients, cognitive dysfunctions reflect the neuropsy-
chological consequences of the disorder and possible history of psychosis, which 
can lead to disrupted brain processing and resulting functioning. Studies in indi-
viduals at risk for bipolar disorder are entirely different, as they are not con-
founded by the influence of disease and treatment variables, and therefore repre-
sent a valuable strategy for studying the role of cognitive alterations as genetic 
vulnerability makers. Support for the third hypothesis, that cognition in patients 
and relatives are unrelated, is in line with the idea that cognitive impairment in 
patients is mainly illness-related and in relatives, if at all present, the genetic expres-
sion of developmental impairment.  
 
Based on the current study, the evidence for cognitive alterations as intermediary 
phenotype associated with genetic risk for bipolar disorder is not strong, at least 
not for the broad range of phenotypical expressions of bipolar disorder. It was 
found, however, that bipolar patient-relative dyads with more expression of cogni-
tive impairment had less expression of positive psychotic symptoms. Given the 
suggested genetic overlap between bipolar disorder and schizophrenia (Berrettini, 
2003; Cardno et al., 2002; Potash, 2006), these findings suggest that the hypothe-
sised distinction in schizophrenia between good outcome psychosis without devel-
opmental impairment (characterised by positive and affective symptoms) and poor 
outcome psychosis with developmental impairment (with negative and cognitive 
symptoms), (Myin-Germeys, Krabbendam, Jolles, Delespaul, & van Os, 2002; 
Robins & Guze, 1970) might be extended to the continuum spanning affective and 
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non-affective psychosis (Murray et al., 2004). The finding of a similar psychosis-
cognition association in bipolar disorder, as implied by the two pathways leading to 
non-affective psychotic disorders (Robins & Guze, 1970), is in line with the idea of 
a partially overlapping vulnerability to bipolar disorder and schizophrenia, and 
provides an explanation for the apparent differences in cognitive alterations in 
those at risk for the two disorders. Some of the cognitive variation in bipolar dis-
order appears to be due to genetic effects that is shared to a small degree with 
schizophrenia and is measurable in relatives of patients. Dissimilarities in cognitive 
alterations can be explained by additional developmental impairment in schizo-
phrenia, resulting in negative and deficit symptoms and the cognitive deficits char-
acteristic of schizophrenia (Murray et al., 2004). In the absence of these neurode-
velopmental impairments, a more affective psychotic phenotype may emerge.  
 
Methodological issues 
The present results must be regarded within the context of some methodological 
issues. First, a broad range of cognitive domains was investigated with recently 
developed tasks, what can make direct comparison of cognitive effect sizes be-
tween studies more difficult. However, the use of these different, recently devel-
oped tasks also has benefits, as replication of previous findings in similar cognitive 
domains with different tasks increases the strengths of the findings. Second, al-
though sample sizes were sufficiently large for group comparisons, the fact that 
not each patient had a participating sib may have caused a lack of power in the 
pairwise sib-patient analyses. This may have caused some associations to be only 
suggestive whereas with a larger relatives group, effects might have been more 
precise but similar in pattern. Finally, all patients were taking medication. However, 
patients were relatively stable when tested and studies on the cognitive effects of 
lithium (Engelsmann, Katz, Ghadirian, & Schachter, 1988; Honig, Arts, Ponds, & 
Riedel, 1999) and valproate (Devinsky, 1995; Senturk et al., 2007) are not consis-
tent. In addition, in the current paper the focus was on relatives who did not use 
medication.  
 
Conclusion 
Given the suggested genetic overlap bipolar disorder and schizophrenia, the cur-
rent findings suggest that the hypothesised distinction in schizophrenia between 
good outcome psychosis without developmental impairment (characterised by 
positive and affective symptoms) and poor outcome psychosis with developmental 
impairment (with negative and cognitive symptoms) might be extended to the 
continuum spanning affective and non-affective psychosis. This is in line with the 
idea of a partially overlapping vulnerability to bipolar disorder and schizophrenia 
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and provides an explanation for the apparent differences in cognitive alterations in 
those at risk for the two disorders. 
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Abstract 
Objective: Previous studies have reported associations between cognitive endo-
phenotypes of non-affective psychoses and the COMT gene, but only few studies 
examined the effects of COMT on cognitive performance in bipolar disorder. In 
this study it was investigated whether single markers in the COMT gene and their 
haplotypes were associated with bipolar liability and cognitive functioning. 
Method: Patients with bipolar disorder (n=68) and healthy controls (n=61) com-
pleted a neurocognitive test battery. Saliva swabs were used to obtain DNA from 
all participants. Results: The G allele of rs165599 was associated with bipolar 
liability (OR=1.70, p=0.07) and the risk alleles of rs165599 (β= -1.62, p=0.04) and 
rs737865 (β= -0.99, p=0.04) were associated with cognitive performance, indepen-
dent of bipolar diagnosis. Haplotypes were not associated with bipolar risk, and 
rs165599 appeared to be a stronger predictor of bipolar disorder status than haplo-
types. Conclusion: The finding that the minor allele of rs165599 is overrepre-
sented in bipolar disorder and is associated with reduced verbal memory perfor-
mance suggests that this SNP at the downstream position of the COMT gene 
might be involved in COMT regulation, leading to increased bipolar disorder sus-
ceptibility and the cognitive impairments associated with this disorder. Larger stu-
dies are required to investigate possible superallelic effects of COMT on cognitive 
functioning. 
Thesis_Jabben_v3.pdf   90 30-6-2009   8:56:24
CHAPTER 5 
 
Page | 91  
 
Introduction 
Bipolar disorder is a complex psychiatric disorder that is highly heritable (Cardno 
et al., 1999). Although several genes have been implicated in the disorder, few 
consistent results have emerged. A common underlying genetic susceptibility for 
bipolar disorder and schizophrenia has been suggested, and there is evidence for 
overlap between both disorders on several domains (Murray et al., 2004). One area 
of overlap is the presence of cognitive dysfunction, as deficits in verbal declarative 
memory and executive functioning are not only present in schizophrenia 
(Heinrichs & Zakzanis, 1998) but also in euthymic, stable bipolar patients (Arts, 
Jabben, Krabbendam, & Van Os, 2008; Robinson et al., 2006). These cognitive 
impairments may reflect the underlying genetic vulnerability for the schizophrenia 
and bipolar disorder (Gottesman & Gould, 2003; Hasler, Drevets, Gould, Gottes-
man, & Manji, 2006). 
 
Recent linkage evidence has pointed to several candidate susceptibility genes impli-
cated in both bipolar disorder and schizophrenia (Berrettini, 2003; Craddock, 
O'Donovan, & Owen, 2005). One candidate gene is located on 22q11 and codes 
for the enzyme catechol-O-methyltransferase (COMT). COMT has an important 
function in dopamine transmission in the brain, in particular in the prefrontal cor-
tex (Weinberger et al., 2001). Findings of impaired frontal executive functions in 
schizophrenia and in bipolar disorder, together with studies showing that variation 
in the COMT genotype is associated with cognitive functioning, suggest that 
COMT might be a putative susceptibility gene for both schizophrenia and bipolar 
disorder (Badner & Gershon, 2002). 
 
The COMT gene, particularly the Val158Met polymorphism (rs4680), has been 
extensively tested for an association with schizophrenia. Although some studies 
showed a positive association between the Val allele and schizophrenia (Chen et 
al., 2004; Egan et al., 2001; Shifman et al., 2002), two recent meta-analyses suggest 
that the evidence for the involvement of COMT in schizophrenia is limited (Fan et 
al., 2005; Munafo, Bowes, Clark, & Flint, 2005). The COMT rs4680 Met allele has 
been associated with a better cognitive performance on executive prefrontal tasks 
in schizophrenia patients in some studies (Bilder et al., 2002; Egan et al., 2001; 
Malhotra et al., 2002; Mata et al., 2006; McIntosh, Harrison, Forrester, Lawrie, & 
Johnstone, 2005). Results are, however, highly inconsistent, both in terms of find-
ing associations and the type of cognitive task and allele involved. 
 
COMT is less investigated in bipolar disorder but there is some evidence that it 
may be related to vulnerability for the disorder. Although several studies investigat-
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ing the association between bipolar disorder vulnerability and COMT provided 
negative results (Gutierrez et al., 1997; Kunugi et al., 1997; Prata et al., 2006; Ser-
retti, Rotondo, Lorenzi, Smeraldi, & Cassano, 2006), in other studies the low activ-
ity Met allele has been associated with the rapid cycling variant of bipolar disorder 
(Kirov et al., 1998; Papolos et al., 1996) and a greater number of positive symp-
toms (Goghari & Sponheim, 2008). Significant associations have been found be-
tween COMT SNP rs165599 and risk for bipolar disorder (Burdick et al., 2007; 
Funke et al., 2005; Shifman et al., 2004), whereas an association with Val158Met 
(rs4680) was found in the study of Funke and colleagues (Funke et al., 2005) but 
not other studies (Burdick et al., 2007; Dickerson et al., 2006; Shifman et al., 2004).  
 
While most studies have investigated the effect of single nucleotide polymor-
phisms (SNPs) on functioning, it has been shown that the combination of SNPs in 
the gene may modulate the activity of the gene (Nackley et al., 2006). Investigation 
of haplotypes combining functional SNPs within the gene may provide a more 
effective research strategy in studying the genetics of human brain function 
(Meyer-Lindenberg et al., 2006).  
A three-SNP (G-G-G) haplotype (rs737865, rs4680, rs165599) has been found to 
confer risk to bipolar disorder and schizophrenia (Shifman et al., 2004), a finding 
consistent with results from the study of Funke and colleagues (Funke et al., 2005), 
revealing a potentially protective haplotype for psychotic and affective disorders 
containing the opposite alleles: G-A-A-A (-287A/G, rs737865, rs4680, rs165599). 
 
Only very few studies have investigated COMT in relation to cognitive functioning 
in bipolar disorder. The Val/Val genotype of COMT Val158Met was associated 
with a larger cognitive impairment in bipolar patients in the study of Dickerson 
and colleagues (Dickerson et al., 2006), whereas this SNP was not associated with 
cognitive functioning in other studies (Burdick et al., 2007; Szoke et al., 2006). 
Genetic variation at COMT SNP rs165599 has been found to be associated with 
prefrontal aspects of a verbal learning test (Burdick et al., 2007).  
In the current study the role of COMT in bipolar disorder was further investigated. 
We aimed at coding the SNPs at either ends of the COMT gene that are part of 
the previously identified risk haplotype (Shifman et al., 2004), and its intermediate 
markers (see figure 1). Thus, we investigated a whole section of the COMT gene 
allowing us to investigate haplotypes that may have stronger associations with a 
phenotype and possible super allelic effects. Seven markers were genotyped (the 
P2 promoter region SNP rs2075507, rs737865, rs6269, rs4818, rs4633, Val158Met 
(rs4680), and rs165599) and it was examined whether single SNPs and their haplo-
types were associated with bipolar liability and cognitive functioning. 
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Figure 1: The COMT gene, locations of genotyped markers are indicated 
 
 
 
 
 
Methods 
Subjects 
The individuals in this study were participants in the BIPOLCOG study (Jabben, 
Arts, Krabbendam, & Van Os, 2009) a study on cognitive functioning in bipolar 
disorder (BD) in which three groups were investigated i) patients with an RDC 
diagnosis of BD (Research Diagnostic Criteria) (Spitzer, Endicott, & Robins, 
1978), ii) healthy first-degree relatives of patients with BD, and iii) healthy control 
participants without a family history of psychotic or bipolar disorders. For the 
purpose of the current study, only patients and controls were used in the analyses. 
All subjects were between the ages of 18 and 60 years, fluent in Dutch, had an 
IQ>70 and were without a history of neurological disorders such as epilepsy and 
concussion with loss of consciousness. The initial sample consisted of 81 patients 
and 61 healthy control subjects. Four patients were excluded because data on diag-
nosis or neuropsychological performance were missing. Nine patients did not give 
consent for the collection of DNA material. As a consequence, the risk set for the 
current study consisted of 68 patients with bipolar disorder and 61 controls. All 
subjects were Caucasian white. 
Of the 68 patients RDC diagnoses were: bipolar I disorder (n=41), schizoaffective 
disorder bipolar or manic type (n=17), bipolar II disorder (n=9), and mania (n=1). 
Three controls had a history of major depression, now in full remission.  
 
Procedure 
In a cross-sectional study design, basic demographic information and DNA sam-
ples were collected from the subjects. Neuropsychological testing and psychiatric 
interviewing was done by trained psychologists. Current depressive and manic 
psychopathology of all subjects was assessed using the 21-item Hamilton Rating 
Scale for Depression (Hamilton, 1960) and the Young Mania Rating Scale (Young, 
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Biggs, Ziegler, & Meyer, 1978) respectively. In the BD group additional informa-
tion on illness characteristics was collected. Written informed consent, conforming 
to the local ethics committee guidelines, was obtained from all subjects.  
 
Neurocognitive assessment 
Neurocognitive tests were administered by computer, using E-prime for Windows 
on a 15-inch monitor Toshiba Tecra laptop. The neurocognitive test battery in-
cluded tasks measuring various neurocognitive domains, guided by previous evi-
dence of impaired performance among these domains in BD patients (Antila et al., 
2007; Arts, Jabben, Krabbendam, & Van Os, 2007; Ferrier & Thompson, 2002; 
Murphy & Sahakian, 2001; Robinson et al., 2006) 
Overall intellectual functioning was estimated using three Groningen Intelligence 
Test (GIT-2) subtests  (Mental Rotation, Word Analogies and Mental Arithmetic) 
(Luteijn & Barelds, 2004), yielding results that are comparable to those of the 
Wechsler Adult Intelligence Scale III (Wechsler, 2000a).  
The standardized Dutch version of the Visual Verbal Learning Test (Rey, 1964) 
was administered as measure of verbal memory. In three consecutive trials, 15 
monosyllabic non-related words had to be memorized and reproduced. The total 
number of words recalled over the three trials was used as a measure of immediate 
recall. Delayed recall was measured after a 20 minute delay.  
Digit Span Forward and Digit Span Backward of the Wechsler intelligence Scale 
III (Wechsler, 2000b) were used as measures of attention  and working memory, 
respectively.  
The Flanker CPT (Cogtest plc, London (Eriksen & Schultz, 1979; Posner, Inhoff, 
Friedrich, & Cohen, 1987) is a measure of selective visual control of attention. 
Subjects are instructed to respond by pressing the right or left mouse button de-
pending on whether the middle element in a display of five lines has an arrowhead 
pointing to the right or left. There are three trial types: i) neutral trials in which the 
flankers are just horizontal lines without arrowheads, ii) congruent trials in which 
all flankers have an arrowhead pointing in the same direction as the target, and iii) 
incongruent trials, in which flankers are pointing in opposite direction from the 
target. In this study the outcome measure was the sum of correct trials in the in-
congruent condition. 
Sustained attention was measured with a continuous performance test, the CPT-
HQ version, a variant of the CPT-AX (Nestor, Faux, McCarley, Shenton, & Sands, 
1990). The outcome measure was the proportion of correct detections. 
The Strategic Target Detection Task (STDT: Cogtest plc, London (Weintraub & 
Mesulam, 1987) is a task similar to the paper and pen ‘cancellation’-tests or the 
‘cross-out’ subtest of the WAIS III, where subjects are required to cross-out target 
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stimuli embedded among distracters. In this computerized version, subjects are not 
told in advance which of the various stimuli is the target but have to learn by trial-
and-error on the basis of feedback. The target stimulus changes without prior no-
tice and subjects have to find out which target is the new correct one, an aspect of 
the STDT similar to the Wisconsin Card Sorting Test. The total number of correct 
responses was used as the outcome measure. 
The Tapping Speed test (Cogtest plc, London) is a finger tapping test alternating 
between the right and left hand, which was used as a simple measure of motor 
speed. The Cogtest version is similar to the Finger Tapping Test or the Finger 
Oscillation Test of the Halstead Reitan Neuropsychological Battery (Reitan & 
Wolfson, 1985). Subjects were asked to tap a key on the keyboard with their index 
finger as fast as they could for 8 seconds in five trials for each hand. Outcome 
measure was the mean tap-rate for the subject’s dominant hand. 
 
COMT-genotyping 
Buccal cell samples were collected with sterile swabs (Omniswab, Whatman®). 
DNA was extracted using QIAamp DNA Mini Kits (Qiagen). In total, seven SNPs 
within the COMT gene were determined. Six SNPs were genotyped using 
TaqMan® SNP Genotyping assays (Applied Biosystems): rs4680 (assay ID 
C__25746809_50), rs4633 (assay ID C___2538747_20), rs4818 (assay ID 
C___2538750_10), rs6269 (assay ID C___2538746_1_), rs165599 (assay ID 
C___2255335_10) and rs737865 (assay ID C___2255420_10). SNP rs2075507 
(formerly designated as rs2097603) was genotyped using a Custom TaqMan® SNP 
Genotyping assay designed with File Builder Software version 3.1 (Applied Biosys-
tems). All assays were run on a 7900HT Fast Real-Time PCR System (Applied 
Biosystems).  
 
Statistical analyses  
Single SNP effects:  
The association between bipolar status and neurocognitive performance was esti-
mated using multiple linear regression models with bipolar status entered as an 
independent indicator variable adjusted for age and sex,  regressed on to each neu-
rocognitive test, in turn, using STATA 10.0 (Statacorp, 2007). 
Single SNP associations were next examined a) comparing allele frequencies be-
tween cases and controls and b) regressing them on to the quantitative cognitive 
tests, comparing parameters using asymptomatic, likelihood ratio test.  
To examine the effect measure modification of bipolar status on the single SNP 
effects we entered an interaction term in the model SNP-bipolar status.  
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Haplotype Associations:  
Multimarker haplotypes were imputed using the standard EM (expectation maxi-
mization) algorithm using the 7 SNPs haplotypes, the linkage disequilibrium meas-
ures and haplotype architecture were validated using Haploview 4.1 (Barrett et al, 
2005). The conditional associations of the haplotypes with the dependant variables; 
bipolar status and each cognitive test were performed (with standard errors as-
sessed by permutation methods). In order to determine whether one haplotype 
panel had a stronger effect on cognition than other imputed panels haplotype spe-
cific comparisons were carried out.  
 
Results  
Demographic characteristics of the study sample are presented in table 1. Alle-
lic/genotype frequencies are presented in table 2. All SNPs were in Hardy 
Weinberg equilibrium (data not shown).  
 
Single SNP effects  
Patients performed significantly worse than controls on most cognitive tests (Betas 
between -0.18 and -0.35 and p-values <0.04). For STDT (β= -0.09, p=0.35) and 
TST (β= -0.14, p=0.11) the performance of patients and controls did not differ 
significantly but effect sizes were in the expected direction (Jabben et al., 2008). 
Investigation of the association between the single SNPs and disorder status 
showed no significant allelic or genotypic associations with bipolar disorder status 
(see table 2). However, a trend towards an overrepresentation of the G allele of 
rs165599 in the bipolar group was found: χ2=3.27, p=0.07, OR=1.70. After bon-
ferroni adjustment this association was no longer significant: p=0.49. Repeating 
the analyses restricted to patients with a diagnosis of bipolar I disorder did not 
change the results.  
 
Associations between SNPs and cognitive performance are presented in table 3. 
The minor allele of rs165599 was significantly associated with a worse Word List 
Learning Test - immediate recall performance. This significance reduced after Bon-
ferroni adjustment: p=0.29. The minor allele of rs737865 was associated with a 
worse Word List Learning - delayed recall performance and with a worse Flanker 
CPT performance. These associations reduced after Bonferroni adjustment (WRT 
p=0.31; Flanker CPT p=0.15). For Digit Span, trends were found towards an as-
sociation of the minor allele of rs2075507 with a better cognitive performance, but 
these trends disappeared after Bonferroni adjustment (DS forward: p=0.73; DS 
backward: p=0.79).  
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Table 1. Demographics, symptom and neurocognition scores per group 
 
 
Table 2. Genotype and allele frequencies of COMT polymorphisms  
 
SNP, Single nucleotide polymorphism; MAF, minor allele frequency. Minor and major alleles are denoted 
by 1 and 2, respectively: rs2075507, 1 = G, 2 = A; rs737865, 1 = C, 2 = T; rs6269, 1 = G, 2 = A; 
rs4633, 1 = C, 2 = T; rs4818, 1 = G, 2 = C; rs4680, 1 = G, 2 = A; rs165599, 1 = G, 2 = A. 
 
 
Investigation of SNP/status interactions showed a near significant 
rs2075507/status interaction for Flanker CPT performance (β patients = 7.05, β 
controls = -0.41 Z-score GxE= -1.81, p=0.07), the minor allele being associated 
with a better performance in the patient group. Although not significant, notably 
large SNP/status interactions were found for rs737865 (β patients = -1.57, β con-
trols = -0.27, Z-score GxE= 1.43, p=0.15) and rs165599 (β patients = -0.93, β 
controls= 0.21 Z-score GxE= 1.10, p=0.27) on the delayed recall condition of the 
 Controls  
(n=61) 
BD patients  
(n=68) 
   
Gender M/F 23 / 38 33 / 35 
Age (SD) 45.3 (8.7) 45.1 (7.8) 
Educational level (SD) 5.8 (1.7) 5.5 (2.2) 
GIT IQ (SD) 119.5 (9.6) 113.0 (12.1) 
   
SYMPTOMS Mean (SD) Mean (SD) 
BPRS 25.0 (1.7) 33.5 (6.3) 
HDRS 0.2 (0.8) 3.8 (4.0) 
YMRS 0.1 (0.3) 1.6 (2.4) 
   
NEUROCOGNITION   
Verbal learning and memory   
Word List Learning   
   total immediate recall 25.7 (4.9) 22.9 (5.4) 
   delayed recall 8.6 (2.5) 7.2 (3.0) 
Attention and concentration   
Digit Span   
   forward 9.0 (1.9) 8.3 (1.9) 
   backward 6.6 (1.9) 5.5 (1.9) 
Flanker CPT 42.1 (5.1) 38.5 (9.0) 
CPT-HQ %correct 98.8 (2.4) 95.1 (6.5) 
Executive functioning   
Strategic Target Detection 84.4 (10.7) 83.0 (6.1) 
Fine motor  speed   
Finger Tapping Test 180.8 (22.2) 188.1 (36.1) 
 Patients Controls P-value 
SNP n genotype MAF n Genotype MAF genotype allele 
  1/1 1/2 2/2   1/1 1/2 2/2    
rs2075507 67 7 37 23 0.381 61 12 28 21 0.426 0.30 0.48 
rs737865 68 8 28 32 0.324 60 7 23 30 0.308 0.94 0.79 
rs6269 68 11 36 21 0.427 61 13 23 25 0.402 0.22 0.69 
rs4633 68 12 38 18 0.456 61 15 25 21 0.451 0.24 0.94 
rs4818 68 11 35 22 0.419 61 13 24 24 0.410 0.38 0.88 
rs4680 67 12 37 18 0.455 59 15 24 20 0.458 0.26 0.97 
rs165599 68 5 30 33 0.294 61 2 20 39 0.197 NA 0.07 
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Word List Learning Test, the minor allele of both SNPs being associated with a 
worse cognitive performance in the patient group.  
 
Table 3. Cognitive performance – minor allele associations 
 
For all variables a higher score indicates a better neurocognitive performance. 
WLT, word list learning – immediate recall; WRT, word list learning – delayed recall; CPT, Continuous 
Performance Test; DS, Digit Span; STDT, Strategic Target Detection Test; TST, Tapping Speed Test 
 
 
Haplotype effects  
Linkage disequilibrium (LD) between the seven SNPs is presented in table 4. All 
SNPs were in LD and one haplotype block was inferred, consisting of all seven 
markers. Haplotype frequencies in the total sample and in patients and controls are 
presented in table 5.  
 No significant differences were found in the haplotype frequencies between pa-
tients and controls (see table 5). Permuted p values were calculated to compare 
haplotypes and single markers regarding their association with disorder status. 
Rs165599 was most strongly associated with status (χ2=3.27, p=0.39), over haplo-
types: ATGCGGG (χ2=1.93, p=0.70), GTGCGGA (χ2=1.68, p=0.78), 
GTGCGGG (χ2=1.07, p=0.97) and GTATCAA (χ2=1.06, p=0.97). 
 
Table 4. Linkage Disequilibrium D’ and D’ confidence interval  
 
 
Overall omnibus haplotype testing, investigating whether a haplotype structure 
model is a better predictor of cognitive functioning than a random model (no hap-
lotypes having different effects), showed no significant associations for the various 
cognitive tests (WLT: F=1.45, p=0.17; WRT: F=1.38, p=0.20; CPT: F=0.21, 
p=0.99, DS forward: F=0.51, p=0.88; DS backward: F=0.96, p=0.48; Flanker 
CPT: F=1.34, p=0.22; STDT: F=0.81, p=0.62; TST: F=0.53, p=0.87).  
SNP WLT WRT CPT - HQ DS_forward DS_backward Flanker - CPT STDT TST 
 β p  β p β p β p β p β p β p β p 
rs2075507  0.90 0.21  0.71 0.15  0.12 0.47  0.70 0.10  0.62 0.11  3.33 0.11  0.75 0.87 1.17 0.81 
rs737865 -0.53 0.45 -0.99 0.04 -0.13 0.42 -0.46 0.28 -0.28 0.47 -4.75 0.02  4.97 0.29 4.39 0.38 
rs6269  0.04 0.95  0.21 0.65 -0.05 0.74 -0.16 0.70  0.08 0.82 -1.26 0.52 -0.26 0.95 2.63 0.58 
rs4633 -0.21 0.75 -0.04 0.93 -0.03 0.85 -0.15 0.71 -0.02 0.95 -0.49 0.80  0.25 0.96 4.37 0.36 
rs4818 -0.00 1.00  0.21 0.65 -0.05 0.75 -0.08 0.84  0.11 0.76 -1.16 0.56 -0.32 0.94 3.00 0.53 
rs4680 -0.26 0.71 -0.05 0.92 -0.03 0.86 -0.16 0.71 -0.01 0.98 -0.67 0.74  0.16 0.97 4.14 0.40 
rs165599 -1.62 0.04 -0.74 0.18 -0.00 0.98 -0.49 0.31  0.08 0.85 -2.49 0.29  3.90 0.46 0.14 0.98 
 rs2075507 rs737865 rs6269 rs4633 rs4818 rs4680 
rs737865 0.96 (0.81-0.99) -     
rs6269 0.36 (0.15-0.53) 0.60 (0.45-0.72) -    
rs4633 0.37 (0.16-0.53) 0.58 (0.41-0.72) 0.98 (0.92-1) -   
rs4818 0.36 (0.15-0.53) 0.58 (0.42-0.70) 0.97 (0.94-1) 1 (0.95-1) -  
rs4680 0.38 (0.17-0.54) 0.63 (0.45-0.75) 0.98 (0.94-1) 0.98 (0.94-1) 0.98 (0.92-1) - 
rs165599 0.22 (0.02-0.52) 0.25 (0.07-0.42) 0.36 (0.14-0.54) 0.57 (0.35-0.73) 0.36 (0.14-0.54) 0.61 (0.39-0.76) 
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Table 5. Haplotype estimated frequencies 
 
 Total sample  Patients  Controls  Chi square P value 
Block 1      
G-T-A-T-C-A-A 0.241 0.215 0.270 1.062 0.30 
A-T-A-T-C-A-A 0.190 0.190 0.189 0.000 0.99 
A-C-G-C-G-G-A 0.127 0.108 0.149 0.951 0.33 
A-C-G-C-G-G-G 0.110 0.124 0.095 0.529 0.47 
G-T-G-C-G-G-A 0.083 0.062 0.107 1.676 0.20 
A-C-A-T-C-A-A 0.063 0.067 0.058 0.097 0.76 
G-T-A-T-C-A-G 0.042 0.052 0.031 0.687 0.41 
A-T-G-C-G-G-A 0.039 0.048 0.030 0.573 0.45 
A-T-A-C-C-G-G 0.030 0.028 0.032 0.041 0.84 
G-T-G-C-G-G-G 0.029 0.039 0.017 1.065 0.30 
A-T-G-C-G-G-G 0.013 0.023 0.003 1.928 0.17 
 
 
However, haplotype specific comparisons indicated that there were (near) signifi-
cant differences in effects of some haplotypes on cognitive performance: For DS 
backward: GTGCGGG (used as the reference haplotype) p=0.06; for WLT: 
ATACCGG β= -5.16, p=0.06; for WRT: GTGCGGA β= 3.86, p=0.01 and 
ACATCAA β= -0.10, p=0.07; for Flanker CPT: GTATCAG β= -13.90, p=0.04, 
GTATCAA β= 0.45, p=0.08 and ACGCGGA β= -7.65, p=0.09; and for TST: 
ATATCAA β= -8.23, p=0.06. 
 
Discussion  
In this study several SNPs and haplotypes along the COMT gene were investigated 
for an association with bipolar disorder and cognitive functioning. Marker 
rs165599 was found to be associated with bipolar risk and variation in rs165599 
and rs737865 was associated with cognitive performance, independent of bipolar 
diagnosis. The common functional variant Val158Met was not associated with 
diagnosis nor with cognitive functioning. Haplotypes were not associated with 
bipolar risk, and rs165599 appeared to be a stronger predictor of bipolar disorder 
status than haplotypes.  
 
Rs165599  
The results of this study suggest a specific marker effect of rs165599 on disorder 
status, the G allele being overrepresented in subjects diagnosed with bipolar disor-
der. This is in line with previous studies reporting a significant association between 
the risk allele of SNP rs165599 and bipolar status (Burdick et al., 2007; Funke et 
al., 2005). Also in the study of Shifman and colleagues (Shifman et al., 2004) SNP 
rs165599 was found to be associated with both schizophrenia and bipolar disorder 
status in an Israeli sample, over rs4680 and rs737865.  
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The risk allele of rs165599 was associated with a worse verbal memory perform-
ance in the current study, but this effect was not specific for bipolar patients. This 
finding is in accordance with previous studies in bipolar (Burdick et al., 2007) and 
schizophrenia patients (Chan et al., 2005) showing a significant effect of rs165599 
on verbal memory performance. 
 
Rs737865 and Rs2075507 
Distribution of alleles of rs737865 and rs2075507 did not differ between bipolar 
patients and controls, suggesting that these markers are not associated with risk for 
bipolar disorder. COMT rs737865, however, was associated with delayed verbal 
memory performance and performance on a selective attention task (Flanker 
CPT), independent of diagnosis. This marker was similarly associated with worse 
performance on an n-back task in a previous study (Diaz-Asper et al., 2008), but 
not with any of the cognitive measures in the study of Burdick and colleagues 
(Burdick et al., 2007).  
For rs2075507 a trend towards an association with performance on the test for 
attention/working memory could be reported, the risk allele being associated with 
a better cognitive performance. In addition to this, a near significant COMT/status 
interaction on the Flanker CPT was found with patients carrying the risk (G) allele 
having a better cognitive performance. This is in line with findings from a previous 
study in schizophrenia patients (Diaz-Asper et al., 2008), in which a significant 
COMT/diagnosis interaction in the opposite direction was found, with A-A pa-
tients performing worse on a CPT.  
 
Val158Met (rs4680) 
In most studies, the impact of COMT on disorder and executive functioning has 
been explained through variations in the functional Val158Met polymorphism that 
is involved in dopaminergic prefrontal activity. Val158Met has been associated 
with schizophrenia risk (Egan et al., 2001; Li et al., 1996) and with prefrontal cog-
nitive functioning irrespective of psychiatric diagnoses (Egan et al., 2001; Goldberg 
et al., 2003; Malhotra et al., 2002). In the current study, Val158Met was not associ-
ated with bipolar disorder status nor with cognitive functioning. This is in line with 
two previous studies (Burdick et al., 2007; Szoke et al., 2006) investigating cogni-
tive performance in bipolar patients. Dickerson and colleagues, however, did find 
that theVal158Met polymorphism affects verbal memory performance in patients 
with bipolar disorder (Dickerson et al., 2006). It has been suggested that discrep-
ancies in finding associations with Val158Met, both regarding diagnosis and asso-
ciation with cognition, can be explained by the influence of haplotypic variation, 
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thus, by complex interactions between alleles at various loci within the COMT 
gene that may modulate the effect of Val/Met.  
 
COMT haplotypes 
One haplotype block consisting of all 7 markers was inferred in this study. These 
haplotypes (see table 5) contain the three haplotypes ACCG, ATCA and GCGG 
(rs6269-rs4633-rs4818-rs4680) in the central locus of the COMT gene previously 
found in the study of Nackley and colleagues (Nackley et al., 2006). 
None of the haplotypes was associated with bipolar disorder status. Interestingly, 
when contributions to disorder status were compared between haplotypes and 
single markers, SNP rs165599 was the strongest predictor of group status, above 
several haplotypes.  
Previously a risk GGG (rs737865, rs4680, rs165599) and a protective GAAA hap-
lotype (-287, rs737865, rs4680, rs165599) have been described for bipolar disorder 
(Funke et al., 2005; Shifman et al., 2004). We could not replicate these findings in 
the current study, but in both previous studies, singular SNP rs165599 was associ-
ated with bipolar risk.  
 
In exploratory analyses we examined associations between COMT haplotypes and 
cognitive test performance. Although omnibus models, comparing the predictive 
value of haplotype structure models with a non-haplotype model on cognitive 
performance showed no overall significant differences, (trends towards) significant 
associations between specific COMT haplotypes and cognitive functioning were 
found in this study. This indicates that some haplotype panels had a stronger effect 
on cognition than other panels, suggesting that COMT is relevant for cognitive 
functioning.  
 
Limitations 
The main limitation of the current study is its small sample size. This may have 
caused the study to be underpowered and makes results difficult to interpret. It can 
be suggested that some near significant associations may not reach significance due 
to a lack of power. In addition to this, most associations did not survive the strin-
gent correction for multiple corrections. However, the finding that rs165599 is 
associated with risk for bipolar disorder and with verbal memory performance is a 
replication of previous findings, and the exploratory results from our haplotype 
analyses suggest that this part of the COMT gene is involved in cognitive perform-
ance. These results may contribute to hypotheses on possible super allelic effects 
that have to be tested in larger studies. 
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Conclusions  
The current findings suggests that rs165599 at the down stream position of the 
COMT gene might be involved in COMT regulation, leading to increased bipolar 
disorder susceptibility and cognitive impairments associated with this disorder. 
Exploratory results from the haplotype analyses suggest that this part of the 
COMT gene is involved in neurocognitive functioning but larger studies are 
needed to discover possible super allelic effects. 
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Abstract 
Objective: To investigate whether cognitive alterations associated with vulnerabil-
ity to psychosis, are associated with expression of psychopathology and functional 
outcome in groups at different levels of risk for psychotic illness. Method: Neuro-
cognition, psychopathology and functional outcome were measured in subjects 
with variable risk for psychosis: i) 29 patients with psychotic disorder, ii) 46 sub-
jects at familial risk, iii) 41 subjects at psychometric risk, and iv) 54 control sub-
jects. Results: Dose-response relationships between cognitive dysfunction and 
increasing risk for psychosis were found. Cognitive alterations were predicted by 
negative symptoms in patients and by positive psychotic experiences in the familial 
risk group. In both at risk groups, cognitive speed was associated with functional 
outcome. Conclusion: Some cognitive impairments serve as neutral endopheno-
typic marker across the psychosis continuum. However, other cognitive alterations 
associated with transmission of psychosis may have a direct impact on the pathway 
from risk to psychopathology and alterations in functioning. 
 
Key words:  psychosis; high-risk; endophenotypes; neurocognition; outcome  
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Introduction 
Cognitive dysfunction is a core symptom of schizophrenia, as alterations in the 
domains of attention, executive functioning and memory (Dollfus et al., 2002; 
Heinrichs & Zakzanis, 1998; Zalla et al., 2004) have been reported consistently in 
patient-control comparisons. Cognitive dysfunctions represent a stable trait as 
deficits persist during clinical remission (Hughes et al., 2003). Subtle cognitive 
alterations in similar domains are also measurable in persons at genetically (Farao-
ne et al., 1995; Faraone et al., 1999; Keefe et al., 1994; Krabbendam, Marcelis, 
Delespaul, Jolles, & van Os, 2001) and psychometrically (Dinn, Harris, Aycicegi, 
Greene, & Andover, 2002; Voglmaier, Seidman, Salisbury, & McCarley, 1997) 
defined risk for the disorder, with apparently larger effect sizes in the former com-
pared to the latter. This suggests that cognitive impairments in schizophrenia may 
represent the expression of vulnerability to psychotic disorder and can be con-
strued as a psychosis endophenotype (Gottesman & Gould, 2003).  
Research in patients shows that cognitive impairment is weakly associated with 
symptoms and more strongly with functional outcome. In schizophrenia, symp-
toms may be grouped into several symptom dimensions in order to reduce phe-
nomenological heterogeneity. Research on the association between cognition and 
symptom dimensions demonstrates that cognitive deficits are associated with nega-
tive symptoms, and to a lesser extent with symptoms pertaining to the disorganiza-
tion domain (Baxter & Liddle, 1998; Bilder et al., 2000; Lucas et al., 2004). In addi-
tion, it has been suggested that different symptoms profiles may be associated with 
different patterns of cognitive alterations (Liddle & Morris, 1991; O'Leary et al., 
2000). With regard to the positive symptoms of psychosis, most studies report little 
evidence of an association with cognitive dysfunction, although this is likely due in 
part to ceiling effects in samples with uniformly high levels of positive symptoms 
or failure to distinguish between persistent and transitory positive symptoms 
(Brazo et al., 2002; Malla, Norman, Manchanda, & Townsend, 2002; O'Leary et al., 
2000; Penades, Gasto, Boget, Catalan, & Salamero, 2001). Cognitive impairment 
has often been associated with poorer functional outcome in schizophrenia. In 
reviews of the literature on this topic, Green (Green, 1996; Green, Kern, & 
Heaton, 2004) concluded that functional outcome was relatively independent of 
symptom improvement and more associated with stable characteristics such as 
cognitive functioning. Thus, verbal memory, card sorting/executive functioning 
and verbal fluency impacted on various measures of functional outcome (Green, 
1996; Green et al., 2004). In recent studies, however, in particular processing speed 
(Lysaker, Bryson, Davis, & Bell, 2005; Milev, Ho, Arndt, & Andreasen, 2005) and 
attention (Dickinson & Coursey, 2002; Milev et al., 2005) were associated with 
functional outcome in patients, depending on which outcome measure was used.  
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Previous research suggests that the psychosis phenotype may be expressed as a 
continuous distribution of experiences (Johns & van Os, 2001; van Os, Hanssen, 
Bijl, & Ravelli, 2000) taking on the form of psychometric psychosis proneness 
which is transmitted at relatively stable levels in families in the general population 
(Hanssen, Krabbendam, Vollema, Delespaul, & Van Os, 2006). Previous work has 
demonstrated that measures of psychometrically defined psychosis proneness in 
the general population are weakly associated with cognition (Krabbendam, Myin-
Germeys, Hanssen, & van Os, 2005; Tien, Costa, & Eaton, 1992), suggesting the 
link with alterations in cognition is also continuously distributed and present out-
side the realm of clinical disorder.  
Given the fact that cognitive alterations in patients with psychotic disorder have 
been associated with both illness (symptoms) and disability (functional outcome), 
the question rises if and to what degree a similar impact on illness-related and dis-
ability-related measures may exist in at-risk groups with similar, though attenuated 
levels of cognitive alterations. If associations between cognition and symptoms and 
disability are limited to patient groups, a causally contributing mechanism of cogni-
tive impairment to the pathway from at-risk state to clinical disorder is unlikely. 
However, if the association between cognitive alterations and expression of symp-
tomatology and disability can be demonstrated in at-risk groups, cognitive altera-
tions may represent more than neutral indicators of genetic risk and also contribute 
to social disability outside the realm of clinical disorder. 
 
Aims of the study 
To investigate whether cognitive alterations, associated with psychosis liability, are 
more than neutral indicators of genetic risk for psychosis, by examining whether 
associations exist with expression of psychopathology and functional outcome in 
groups with different levels of risk for psychosis. 
 
Material and methods 
Subjects 
The individuals in this study were participants in a larger study, the ‘Cognitive 
Functioning in Psychosis’ (CoP) study in which four groups were investigated i) 
patients with history of non-affective psychoses, ii) first-degree relatives of patients 
with non-affective psychosis (familial risk group) iii) subjects scoring high (>75th 
pct.) on the positive dimension of psychosis-proneness measured by the Commu-
nity Assessment of Psychic Experiences (CAPE) (Stefanis et al., 2002) (psychomet-
rically defined risk group), and iv) subjects with an average score (40th – 60th per-
centile) on the CAPE (control group). All subjects were between the ages of 18 
and 55 years, fluent in Dutch, and without a history of neurological disorders such 
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as epilepsy and concussion with loss of consciousness. Written informed consent, 
conforming to the local ethics committee guidelines, was obtained from all sub-
jects. Patients were recruited from catchment areas of the Community Mental 
Health Centre and Psychiatric Hospital in an area in the South of the Netherlands. 
Initial inclusion criteria for patients were the lifetime prevalence of a period of 
psychosis (at least two weeks) in clear consciousness, according to the RDC (Re-
search Diagnostic Criteria) (Spitzer, Endicott, & Robins, 1978). 
Relatives (free from a lifetime history of psychosis) were sampled through partici-
pating patients or through associations for relatives of patients with psychotic 
symptoms. Subjects at psychometrically defined risk and healthy control subjects 
were recruited from an earlier longitudinal study conducted in the city of Sittard 
(Continuum of Mental Disorders study, COMED) (Hanssen et al., 2003). The 
original CoP study included 45 patients, 47 non-psychotic first degree relatives, 41 
subjects at psychometrically defined risk for psychosis and 54 healthy controls with 
an average level of psychotic experiences.  
Three patients were excluded because data on diagnosis or symptomatology were 
missing. Data on neuropsychological performance were missing for 10 patients 
and 1 relative because of withdrawal of consent. The computer program OPCRIT 
was used to confirm diagnoses, on the basis of current and lifetime recorded symp-
tomatology listed in the OCCPI (Mc Guffin, Farmer, & Harvey, 1991). Three pa-
tients were excluded because they did not meet criteria for a psychotic disorder 
using RDC criteria. As a consequence, the research sample of the current paper 
consisted of 29 patients with psychosis, 46 non-psychotic first degree relatives, 41 
subjects at psychometric risk for psychosis and 54 control subjects with an average 
level of psychotic experiences. According to RDC criteria there were 22 patients 
(76%) with a diagnosis of narrow schizophrenia, 5 patients (17%) with a diagnosis 
of unspecified functional psychosis, and 2 patients (7%) with a diagnosis of 
schizoaffective disorder. 
Patients and first-degree relatives originated from 38 families, of which 14 families 
contributed one case or one relative, 12 families contributed one case and one 
relative, four families contributed more than one relative, 7 families contributed 
one case and at least two relatives and one family contributed two patients and two 
relatives. 
 
Neuropsychological assessment 
The Stroop Colour Word Test (SCWT) and the Trail Making Task (TMT) were 
used to measure speed of information processing, selective attention and cognitive 
set shifting. The shortened version of the SCWT was used, which involves three 
cards displaying forty stimuli each: colour names, coloured patches and colour 
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names printed in inconsistent ink colours (cards I, II and III respectively). A modi-
fied version of the TMT (Vink & Jolles, 1985) was used in this study and consisted 
of three parts. In part A, subjects had to draw lines to connect consecutively num-
bered circles. In part B, the same had to be done for lettered circles. In part C, 
subjects connected the same number of consecutively numbered and lettered cir-
cles by alternating between the two sequences. 
The word naming and colour naming tasks of the SCWT and the number tracking 
and letter tracking tasks of the TMT were used as measures of processing speed. 
The interference task of the SCWT (card III) can be considered as a measure of 
selective attention and inhibition, the number/letter shifting task of the TMT a 
measure of set shifting. Both can be considered functions of executive control. 
Semantic fluency was used to evaluate psychomotor speed although it can also be 
considered as a measure of strategy-driven retrieval from semantic memory. The 
subjects were required to name as many animals as possible in 1 minute.  
To obtain a global level of general intellectual functioning two subtests of the 
Groningen Intelligence Test (GIT) were employed, a widely used Dutch intelli-
gence test (Luteijn & van der Ploeg, 1983). This test yields results that are compa-
rable to those of the Wechsler Adult Intelligence Scale-Revised (Wechsler, 1981). 
The standardized scores of two subtests for visuo-spatial reasoning and verbal 
logical reasoning were used as measures of global intellectual functioning. 
 
Psychiatric assessment 
CAPE.  The Community Assessment of Psychic Experiences (CAPE), a 42-item 
self-report instrument, was used to assess dimensions of the subclinical psychosis 
phenotype. In this questionnaire, 20 items measure positive psychotic experiences, 
14 items rate negative experiences and 8 cognitive depressive experiences. The 
frequency of the experience was rated on a four-point scale of “never”, “some-
times”, “often” and “nearly always”. For a detailed description of the CAPE, see 
(Hanssen et al., 2006; Stefanis et al., 2002; Verdoux & van Os, 2002) 
(http://www.cape42.homestead.com). The CAPE was used to select the psycho-
metrically defined risk group and the control subjects.  
SAPS and SANS.  Presence of positive and negative symptoms in subjects were 
quantified using the Scale for Assessment of Positive Symptoms (SAPS) (An-
dreasen, 1984) and the Scale for Assessment of Negative Symptoms (SANS) (An-
dreasen, 1983). The organization of the SAPS/SANS scale reflects the traditional 
concept in which the phenomenological heterogeneity of schizophrenia is reduced 
in two broad dimensions: positive and negative symptoms. However, numerous 
studies have indicated that the symptomatology of schizophrenia is better de-
scribed by a three dimensional model, with at least three dimensions describing the 
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phenomenology of the disease. Liddle and colleagues (Liddle, 1987) calculated 
three different clusters of symptoms that are derived from these scales through 
factor and principal component analyses in previous research: psychosis (delusions, 
hallucinations), negative (affective flattening and blunting, alogia, avolition, anhedo-
nia) and disorganization (positive formal thought disorder, inappropriate affect, bi-
zarre behaviour) (Andreasen, Arndt, Miller, Flaum, & Nopoulos, 1995). 
Functional outcome.  Functional outcome of subjects was measured using the WHO 
Life Chart Schedule (WHO, 1992). This is a semi-structured instrument, designed 
to assess the long-term course of schizophrenia in the domains of psychopa-
thology, treatment, residence and work. For the purpose of investigating functional 
outcome in this study, the number of months of independent community living 
and occupational functioning in the past two years were used as dependent vari-
ables. 
All ratings were conducted by trained interviewers on the basis of a standard clini-
cal interview, observed behaviour during the interview and review of all available 
clinical material. 
 
Analyses 
Before analysis the cognitive variables were checked for outliers. Values with de-
viation more than three standard deviations from the mean were replaced with the 
closest value within the same group (Tabachnick & Fidell, 1996).  
Statistical analyses were performed using STATA 9.0. (Statacorp, 2005). A four-
level group variable was constructed to reflect increasing risk for psychosis, ac-
cording to strength of association with cognitive variables in the literature as dis-
cussed above (0=controls, 1=psychometrically defined risk group, 2=familial risk 
group, 3=patients); control subjects were used as the reference category. Regres-
sion models of neuropsychological dependent variables were examined to assess 
the effect of group membership on cognitive performance. The group variable was 
entered as a dummy variable to investigate possible dose-response relationships 
between cognitive variables and the four-level variable reflecting psychosis risk. 
The non-independence of observations within families was addressed by adjusting 
variance estimates in all analyses by use of the command ‘robust’ in STATA. By 
this procedure robust estimates of variance are computed, producing estimators 
for clustered data, whereby observations that are not independent across groups 
(i.e., families) are allowed. For those analyses that showed a dose-response rela-
tionship between group and cognitive test, the overall association was reported as 
well.   
In order to reduce the number of dependent neuropsychological variables in our 
analyses, Principal Component Analysis was performed on the neuropsychological 
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variables. Factors with eigenvalues greater than unity were retained, and the result-
ing factor structure was examined using the scree test and clinical interpretation. 
The relationship between symptomatology and cognitive functioning was investi-
gated using multiple regression models. Symptomatology was measured using the 
three dimensions of schizophrenia symptomatology derived from the SAPS and 
SANS scales. For each dimension, a four-level variable, hereafter referred to as 
“dimensional load”, reflecting tertiles of values greater than 0 was constructed. 
Associations between the dimensional load variables and cognition were investi-
gated in each group. Multiple linear regression, adjusted for symptomatology, was 
also used to investigate the association between cognitive functioning and func-
tional outcome. Analyses were adjusted a priori for the effects of age, sex and edu-
cational level and repeated with additional adjustment for intellectual functioning. 
Effect sizes were expressed as standardized regression coefficients.  
Power analysis 
A power analysis revealed that the power to detect a large effect size in the com-
parison of cognitive functioning between patients and controls in the current study 
was 94%. The power to detect a moderate effect size between subjects at psycho-
metric risk and controls was 66% and between relatives and controls 70%.  
 
Results  
Subject characteristics are presented in Table 1. In Table 2, the mean scores per 
group on the neuropsychological tests, measures of psychopathology, and outcome 
variables are summarized.  
 
Table 1. Demographic characteristics of the subjects  
 
 
Controls (0) 
n=54 
 
Psychometric 
risk group (1) 
n=41 
 
Familial risk 
group (2) 
n=46 
 
Patients (3) 
n=29 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Gender M/F 21/33 16/25 17/29 23/6 
Age (years) 47.2 (7.6) 44.3 (9.8) 40.5 (11.7) 32.9 (10.2) 
Education (years) 13.5 (3.3) 12.9 (3.5) 13.1 (3.6) 12.3 (2.8) 
GIT visuo-spatial - standardized score 7.2 (1.8) 6.9 (1.8) 7.3 (2.2) 6.0 (2.3) 
GIT verbal logical - standardized score 7.5 (1.8) 6.7 (2.0) 6.9 (2.2) 6.3 (1.9) 
 
 
Cognitive functioning and increasing risk for psychosis 
Multiple regression analyses showed a dose-response relationship between cogni-
tive functioning and psychosis risk for TMT A, TMT B, TMT C and Fluency, 
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cognitive performance decreasing with increasing psychosis vulnerability (see Table 
3). For these task a summary linear trend could be reported (TMT A: ß=0.25, 
p=0.03, TMT B: ß=0.34, p=0.00, TMT C: ß=0.24, p=0.01, and Fluency: ß=-0.23, 
p=0.00). Additional adjustment for intellectual functioning did not substantially 
change the results, except for the SCWT III, where a dose-response relationship 
was found only after additional adjustment (psychometrically defined risk group: 
ß=0.09, p=0.11, familial risk group 2: ß=0.11, p=0.07, patients: ß=0.41, p=0.01).  
 
Table 2. Summary of performance on neuropsychological tasks and symptom scores per group  
 
a Higher scores indicating poorer performance 
b Higher scores indicating better performance 
 
Being a patient predicted performance on all neuropsychological tests, patients 
performing significantly worse than controls on all of the tests, with the exception 
of SCWT card I. On this task, the psychometrically defined risk group performed 
significantly worse (ß=0.23, p=0.02), whereas no differences were found for the 
familial risk group and patients compared to the controls. On TMT B and TMT C, 
not only the patient group, but also the familial risk group differed significantly 
from the group of control subjects (see Table 3). On SCWT card III, the psycho-
metrically defined risk group also differed from the controls in addition to the 
patients (ß=0.11, p=0.04). After adjustment for intellectual functioning, a trend 
towards a difference between the familial risk group and the group of controls was 
apparent for TMT A (ß=0.14, p=0.06), SCWT III (ß=0.11, p=0.07) and Fluency 
 Controls (0) 
 
Psychometrically 
defined risk group (1) 
Familial risk group 
(2) 
Patients (3) 
n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) 
Neurocognition 
SCWT (sec)
a
 
  Card I 54 17.1  (3.6) 41 19.1  (4.9) 46 16.8  (3.2) 28 17.2 (3.1) 
  Card II 54 22.2  (4.4) 41 23.2  (4.4) 46 22.6  (5.5) 28 25.7 (6.5) 
  Card III 54 36.4  (7.6) 41 39.3  (9.4) 46 37.5  (8.3) 28 50.2 (28.1) 
TMT (sec)
a
 
  Trial a 54 32.7  (9.6) 41 33.9  (10.8) 46 33.4  (10.6) 29 39.0 (19.7) 
  Trail b 54 30.9  (9.1) 40 32.4  (11.7) 46 36.6  (20.1) 29 45.6 (32.1) 
  Trial c 54 56.2  (29.9) 41 58.3  (34.0) 46 65.6  (37.6) 28 75.2 (58.8) 
Fluency
b
 54 26.9  (6.8) 40 25.7  (6.8) 46 25.1  (5.6) 29 21.4 (5.6) 
Psychopathology 
SAPS total 54 1.1  (2.2) 41 2.9  (4.5) 46 2.5  (4.9) 29 27.8 (17.3) 
SANS total 54 1.5  (2.4) 41 1.9  (2.8) 46 2.0  (4.0) 29 10.7 (11.2) 
Dimensional loading 
    -positive  54 0 41 0.2  (0.5) 46 0.2  (0.6) 29 2.0 (1.1) 
    -negative 54 0.7  (0.9) 41 0.8  (1.0) 46 0.7  (0.9) 29 2.1 (1.1) 
    -disorganization 54 0.6  (0.9) 41 1.1  (1.1) 46 0.9  (1.1) 29 2.3 (1.0) 
Functional status 
Work - months  
(24 = max) 
53 22.9  (4.2) 41 21.7  (5.7) 44 21.4  (6.8) 28 8.3  (9.8) 
Independent living 
(24 = max) 
54 23.9  (0.5) 41 23.9  (0.5) 46 24.0  (0.0) 28 16.9  (8.1) 
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(ß=-0.14, p=0.07). After adjustment for intellectual functioning, the psychometri-
cally defined risk group no longer differed significantly from the controls on 
SCWT III. 
 
Table 3. Associations between cognitive functioning and the group variable reflecting risk for 
psychosis (Controls were used as reference category)  
 
 
 Note: all analyses adjusted for age, sex and years of education 
 
On TMT B and TMT C, not only the patient group, but also the familial risk group 
differed significantly from the group of control subjects (see Table 3). On SCWT 
card III, the psychometrically defined risk group also differed from the controls in 
addition to the patients (ß=0.11, p=0.04). After adjustment for intellectual func-
tioning, a trend towards a difference between the familial risk group and the group 
of controls was apparent for TMT A (ß=0.14, p=0.06), SCWT III (ß=0.11, 
p=0.07) and Fluency (ß=-0.14, p=0.07). After adjustment for intellectual function-
ing, the psychometrically defined risk group no longer differed significantly from 
the controls on SCWT III. 
 
Risk for psychosis and summary measure of cognitive impairment: cognitive speed 
Principal component analysis of the neuropsychological variables resulted in a one-
factor solution accounting for 54 % of the total variance. All the neuropsychologi-
cal variables loaded on this factor (factor loadings from 0.33 to 0.42) which was 
termed “cognitive speed”, as performance on all used tests was highly dependent 
on speed of information processing. Higher scores on the factor indicate poorer 
performance. Group was significantly associated with this factor (ß=0.29, p=0.00) 
and a monotonic dose-response relationship between cognitive speed and risk for 
psychosis was found after adjustment for intellectual functioning (psychometrically 
defined risk group: ß=0.10, p=0.14, familial risk group: ß=0.16, p=0.02, patients: 
ß=0.33, p=0.00), performance decreasing with increasing psychosis risk.  
 Psychometrically defined risk group (1) Familial Risk group (2) Patients (3) 
β t p-value β t p-value β t p-value 
TMT a  0.07 0.93 0.36 0.10 1.29 0.20 0.34 2.22 0.03 
TMT b  0.05 1.11 0.27 0.20 2.20 0.03 0.40 2.72 0.01 
TMT c  0.03 0.44 0.66 0.17 1.99 0.05 0.26 2.24 0.03 
 
SCWT I  0.23 2.43 0.02 0.00 0.01 0.99 0.06 0.67 0.50 
SCWT II  0.08 1.04 0.30 0.05 0.59 0.55 0.24 2.34 0.02 
SCWT III  0.11 2.03 0.04 0.11 1.85 0.07 0.46 2.94 0.00 
 
Fluency  -0.06 -0.73 0.47 -0.13 -1.60 0.11 -0.28 -3.29 0.00 
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Cognitive functioning and psychopathology 
Examination of the association between the dimensional loading variables and the 
summary measure of cognitive speed indicated that in the psychometrically defined 
risk group, a trend towards a significant association in the expected direction was 
only found between negative symptoms and cognitive speed (ß=0.25, p=0.09) (see 
Table 4). No significant associations were found for dimensional loading of posi-
tive symptoms and disorganization. In the familial risk group, positive, but not 
negative dimensional loading was associated with cognitive speed (ß=0.30, 
p=0.03). In the group of patients, a strong and significant positive association be-
tween symptomatology and cognitive speed was found for negative dimensional 
loading only (ß=0.48, p=0.00) (Table 4).  
 
Table 4. Associations between psychopathology and cognitive speed  
Cognitive speed 
Psychometrically defined risk 
group (1) 
Familial risk group (2) Patients (3) 
β t p-value β t p-value β t p-value 
    Positive 0.13 0.89 0.38 0.30 2.27 0.03 0.17 0.95 0.35 
    Negative 0.25 1.77 0.09 -0.02 -0.15 0.88 0.48 3.18 0.00 
    Disorganization 0.03 0.23 0.82 0.23 1.62 0.11 0.15 0.87 0.39 
 
Note: All analyses adjusted for age, sex and years of education 
 
Cognitive functioning and functional outcome  
In the psychometrically defined risk group, there was a trend towards a negative 
association (ß=-0.34, p=0.1) between cognitive speed and number of months at 
work. This trend towards significance became stronger after entering dimensional 
loading measures in the equation (ß=-0.38, p=0.09). The various psychopathology 
dimensional loading variables were not significantly associated with occupational 
functioning in this group.  
A strong and significant negative association was found between number of 
months at work and cognitive speed in the familial risk group (ß=-0.45, p=0.01), 
indicating that a reduction of cognitive speed was associated with reduced occupa-
tional functioning. Entering the dimensional loading variables in the equation did 
not change this association, but negative dimensional loading was also independ-
ently associated with occupational functioning (ß=-0.42, p=0.01). In the patient 
group, the association between occupational functioning and cognitive speed was 
neither large nor significant (ß=0.10, p=0.64), and also psychopathology dimen-
sional loading measures were not associated with occupational functioning. In 
none of the groups was cognitive speed associated with independent community 
living (all Beta’s between –0,27 and 0.17, p>0.20). 
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Discussion 
Findings 
The results of this study can be summarized as follows. Cognitive performance 
was associated with the degree of genetic liability to psychosis. There was a dose-
response relationship between cognitive dysfunction and increasing risk for psy-
chosis for speed of information processing, selective attention, and set shifting 
(executive control), in which the degree of cognitive impairment (order: patients - 
familial risk - psychometric risk - controls) paralleled the degree of risk for psycho-
sis.  Negative symptoms were associated with cognitive functioning only at the 
disorder end of psychosis risk, whereas in the familial risk group, cognitive altera-
tions were associated with positive symptoms. In the familial and psychometrically 
defined risk groups, but not in patients, there was an association between cognitive 
performance and occupational functioning.  
 
Cognitive vulnerability markers across a continuum of risk 
The finding that cognitive functioning was associated with the level of risk for 
psychosis is in accordance with previous studies indicating impaired cognitive per-
formance in relatives (Krabbendam et al., 2001; Kremen & Hoff, 2004) and, to a 
lesser degree, in psychometrically defined at-risk subjects (Dinn et al., 2002; Krab-
bendam et al., 2005; Siever & Davis, 2004; Tien et al., 1992). In a review on cogni-
tive performance in relatives of schizophrenia patients (Kremen & Hoff, 2004) 
impairments were found on measures of perceptual motor speed, sustained atten-
tion, concept formation, declarative memory and verbal fluency which is overlap-
ping with frequently reported cognitive deficits in schizophrenia patients 
(Heinrichs & Zakzanis, 1998). In a study by Hoff and colleagues (Hoff et al., 2005) 
non-psychotic relatives were particularly impaired on measures of psychomotor 
speed, verbal fluency and cognitive inhibition. In a quantitative meta analysis (Sit-
skoorn, Aleman, Ebisch, Appels, & Kahn, 2004) in relatives, the largest effect sizes 
were found for verbal recall and visuomotor speed (TMT B) and smallest on the 
SCWT which parallels the current data in that the strongest associations were 
found on the TMT and no clear associations existed with SCWT. Psychometrically 
defined vulnerable subjects showed impairment relative to controls on domains of 
executive function, working memory, verbal learning and attention (Siever & Da-
vis, 2004). Verbal fluency was associated with psychometric psychosis proneness in 
a previous study (Krabbendam et al., 2005), where it was shown that in a general 
population sample, higher levels of psychometrically defined risk were associated 
with worse verbal fluency. The present findings add credence to the suggestion 
that cognitive deficits in schizophrenia might be putative endophenotypes for the 
disorder (Faraone et al., 1999). By including four groups with increasing levels of 
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risk for psychosis and using group as a linear variable of continuous schizophrenia 
liability, it was assumed that the differences between groups are equal, and this may 
not be the case. However, testing linear hypotheses of schizophrenia risk using at-
risk groups has been proven a useful and statistically powerful way to identify 
markers of familial risk (Faraone et al., 1999; Sharma et al., 1997). Assuming that 
the groups in this study reflect the expression of a graded genetic predisposition to 
the disorder, the present study demonstrates that cognition can be usefully con-
strued as a vulnerability marker across a continuum of psychosis risk (Johns & van 
Os, 2001; van Os et al., 1999). 
 
Cognitive performance and psychopathology 
The finding of an association between negative symptoms and cognitive speed in 
patients are in accordance with previous research showing that severity of negative 
symptoms is associated with several neuropsychological deficits, especially in the 
domains of verbal memory, verbal fluency, psychomotor speed and executive 
function (Bilder et al., 2000; Heydebrand et al., 2004; Keefe et al., 2006). The cur-
rent results indicate that in subjects at familial risk for psychosis, cognitive alterati-
ons are also associated with psychopathology, as in the familial risk group the posi-
tive symptom dimension was associated with cognitive speed. The contrast bet-
ween the patient and the familial risk group is interesting, and confirms that in 
non-patients, the subtle low-grade expression of experiences resembling the positi-
ve symptoms of psychosis are a reliable indicator of risk for psychotic disorder, 
both in terms of genetic transmission  (Hanssen et al., 2006; Kendler et al., 1993) 
and of future transition to disorder (Chapman, Chapman, Kwapil, Eckblad, & 
Zinser, 1994; Hanssen, Bak, Bijl, Vollebergh, & van Os, 2005; Poulton et al., 2000), 
whereas once the illness becomes established, negative symptoms appear to be a 
more reliable indicator of vulnerability. 
In addition to negative symptoms, disorganization was associated with cognitive 
functioning in patients in previous studies (Brazo et al., 2002; O'Leary et al., 2000; 
Van der Does, Dingemans, Linszen, Nugter, & Scholte, 1996). However, there is 
evidence that different symptom dimensions may be associated with different pat-
terns of neuropsychological functioning (Bilder et al., 2000; O'Leary et al., 2000), 
and information processing speed was mainly associated with negative symptoms 
in previous research (Van der Does et al., 1996). It has been suggested that the 
negative symptom dimension is associated with more widespread cognitive im-
pairment and disorganization more with higher order processing (O'Leary et al., 
2000). Post-hoc analyses suggested that the lack of association with disorganization 
was not caused by the use of a summary cognitive factor of cognitive speed, as 
Thesis_Jabben_v3.pdf   119 30-6-2009   8:56:28
CHAPTER 6 
Page | 120 
 
disorganization was similarly not associated with performance on TMT C, SCWT 
card III and Fluency, tasks that are considered measures of higher control. 
 
Cognitive performance and outcome 
Previous research has consistently reported an association between cognitive func-
tioning and outcome in patients (Green, 1996; Green et al., 2004). The current 
findings in patients did not support this as cognitive speed was not associated with 
the outcome measures used. However, the absence of an association was due to a 
lack of variation in the outcome measures used, as in the Netherlands only very 
few patients are in competitive employment given the fact that there is a powerful 
financial disincentive for patients to seek employment. Similar findings were re-
ported from France, where a similar disincentive exists (Verdoux, Liraud, Assens, 
Abalan, & van Os, 2002). 
An important finding in the current study was that alterations in cognitive speed in 
the familial and the psychometrically defined at-risk group were associated with 
variation in occupational functioning. Post-hoc analyses showed that this associa-
tion was not present in controls, suggesting that the decrease in occupational func-
tioning was not simply the consequence of poorer cognitive functioning but is 
associated with social disability in the context of vulnerability to psychosis. 
Processing speed has been identified as a critical factor in mediating employment 
outcome in previous research (Lysaker et al., 2005; Milev et al., 2005) and the pre-
sent results underline the importance of cognitive speed in vocational outcome not 
only in clinical samples but also in those at-risk for the disorder. 
   
Neutral indicators of genetic risk or markers of early disability? 
In addition to previous findings that cognitive dysfunctions in patients with psy-
chotic disorder have been associated with both illness (symptoms) and disability 
(functional outcome) the present findings show that cognitive alterations, as indi-
cators of psychosis vulnerability, also impact on the expression of psychopa-
thology and functional outcome in at-risk groups. The presence of these associa-
tions in at-risk groups suggests that cognitive endophenotypes in psychosis are not 
always neutral indicators of genetic risk and that its transmission can be associated 
with clinical risk, expressed in psychopathology and social disability across all levels 
of risk. 
 
Limitations 
The results of the present study should be viewed in the light of several methodo-
logical issues. First, the cognitive assessment was limited to a few measures that all 
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reflected cognitive speed. Therefore the findings have been confined to the se-
lected tests, and future research will be necessary to investigate whether the results 
can be generalized to other cognitive domains. 
Second, although investigating subclinical phenotypes, psychometric instruments 
developed for clinical use were applied to asses presence and severity of symptoms 
(SAPS and SANS). This may have caused an underestimation of the association 
between symptoms and cognition in the at-risk groups. Furthermore, the subclini-
cal psychosis group was defined on the basis of positive psychotic experiences and 
it can be argued that this may have caused little variation in subclinical negative 
symptoms. This seems unlikely however, as positive and negative symptoms are 
highly associated (Stefanis et al., 2002), in particular in non-clinical groups.  
Some researchers have suggested that a three-dimension model of schizophrenia 
psychopathology is too limited, and in addition to these three symptom dimen-
sions a depression dimension has been reported in schizophrenia (Holthausen, 
Wiersma, Knegtering, & Van den Bosch, 1999). Although its relationship with 
cognitive functioning has not been studied extensively yet, depression has consis-
tently been found to affect cognitive functioning, and two studies on cognitive 
functioning in schizophrenia that included depressive symptoms reported that 
these symptoms were associated with a reduced performance on cognitive meas-
ures (Holthausen et al., 1999; Rocca et al., 2005). Thus part of the reported psy-
chopathological associations may be reducible in part to the effect of depression. 
Depressive symptomatology may also explain part of the observed association 
between cognitive functioning and outcome in the at risk groups. 
Fourth, the outcome assessment in this study was limited to a few outcome meas-
ures and the used measures were not very detailed. Number of months at work 
and of independent living were used as the dependent variable and it can be argued 
that a more sensitive measure of outcome might have produced more powerful 
results with respect to the association between cognition and outcome. This might 
have caused the outcome variables to show a ceiling effect, but the use of such 
objective indices of outcome has some clear advantages. The fact that only patients 
were interviewed about their functioning may also pose a weakness, given that 
schizophrenia may be associated with reduced insight (Amador & David, 2004). 
However, the use of objective indices of outcome in the current study probably 
minimized the influence of any impairment of insight.  
Finally, some families only contributed one patient or one relative; it would have 
been better to include only pairs of patients and their relatives from the same fami-
ly, as this would increase power and control for within-family confounders. 
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Abstract 
Objective: To investigate the contribution of processing speed in the prediction 
of various domains of outcome in psychosis. Method: Data were drawn from the 
UK700 Case Management Trial of 708 patients with chronic psychotic illness. 
Regression analyses were applied to investigate cross-sectional and longitudinal 
associations between processing speed at baseline and measures of service use, 
social outcome and subjective outcome, taking into account current psychopa-
thology and adjusting for baseline values of the outcome measure. Results: Cross-
sectionally, processing speed was associated with all three domains of outcome, 
although only associations in the social and subjective outcome domain remained 
significant after controlling for psychopathology and the effects differed between 
and within domains of outcome. Prospectively, only the subjective outcome meas-
ure of number of met and unmet needs (CAN) was weakly associated with baseline 
neurocognitive performance after adjustment for baseline needs. Other associa-
tions disappeared after adjustment for the baseline measure of outcome and/or 
baseline psychopathology. Conclusion: The finding of weak cross-sectional asso-
ciations in the absence of specific and unconfounded longitudinal associations 
suggests that processing speed is an independent dimension of disease severity 
rather than a causal factor impacting on social outcome. Nevertheless, longitudinal 
change in patient reported needs may be weakly sensitive to baseline cognitive 
impairment.  
 
Key Words: functional outcome; psychosis; processing speed; symptoms 
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Introduction 
Given the substantial heterogeneity in course among individuals with a diagnosis 
of schizophrenia, identifying course predictors remains crucially important. In the 
search for predictors of outcome, the roles of various clinical and demographic 
characteristics have been investigated (Breier, Schreiber, Dyer, & Pickar, 1992; 
Lieberman et al., 1996; R. M. G. Norman et al., 2005; Robinson, Woerner, 
McMeniman, Mendelowitz, & Bilder, 2004), and there is now an impressive quan-
tity of literature showing the importance of neurocognitive deficits in functional 
outcome in schizophrenia in terms of statistical associations (Green, 1996; Green, 
Kern, Braff, & Mintz, 2000). In particular neurocognitive functioning in domains 
of verbal memory, vigilance and executive functioning has been emphasized to be 
important predictor of functional outcome (Green et al., 2000), although other 
studies also demonstrated the importance of processing speed in the prediction of 
everyday functioning (Dickinson, Iannone, Wilk, & Gold, 2004; Milev, Ho, Arndt, 
& Andreasen, 2005). 
It has been suggested that outcome in psychosis is more strongly associated with 
stable characteristics, such as cognitive functioning, than to the much more varia-
ble positive symptoms of psychosis (Bryson & Bell, 2003; Green, 1996). However, 
there is evidence that the symptoms of psychosis do impact on various measures 
of outcome (van Os et al., 1999) and studies comparing neurocognitive and symp-
tom measures in their relative associations with subsequent outcome do not entire-
ly support the conclusion that cognition is a better predictor than symptomatology 
(Addington, Saeedi, & Addington, 2005; Dickinson & Coursey, 2002; Milev et al., 
2005; R. M. Norman et al., 1999). Some researchers proposed that it is not so 
much the absolute level of symptoms at the time of an acute episode, that at base-
line typically are uniformly high and therefore not discriminative, but rather the 
level of subsequent persistence of symptoms that predict outcome (R. M. Norman 
et al., 1999). Therefore, it is important to investigate symptoms and neurocognition 
in the same group of patients in a stable phase of the illness so the prognostic 
value of both indices can be compared.  
A large proportion of studies investigating the relationship between cognition and 
outcome use a cross-sectional design, while reports on longitudinal relationships 
between predictors and baseline-adjusted outcome are essential to evaluate their 
true long-term prognostic value (A. Malla & Payne, 2005). In a review of longitu-
dinal studies (Green, Kern, & Heaton, 2004), it was concluded that there was con-
siderable support for longitudinal associations between neurocognition and com-
munity outcome. Other longitudinal studies, however, found that neurocognition 
at onset was only weakly associated with outcome at follow-up compared to the 
much stronger cross-sectional associations, indicating that neurocognition explains 
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less of the variance in outcome than cross-sectional studies would suggest (A. K. 
Malla, Norman, Manchanda, & Townsend, 2002; Milev et al., 2005; Stirling et al., 
2003). Moreover, only few studies examined neurocognition in relation to changes in 
functional outcome, by taking into account baseline level of functioning. If base-
line levels of the outcome measure are not taken into account, “predictive” asso-
ciations with follow-up measures may merely reflect associations that were already 
apparent at baseline, and serve as passive indicators of disease severity (van Os, 
Wright, & Murray, 1997). 
The inconsistency of findings may also partly be due to the fact that outcome is 
not a unitary concept, and different domains of outcome may differ in their cogni-
tive and symptom correlates. For example, one study suggested that the used cog-
nitive measures were only prognostic of the subjective outcome domain of quality 
of life, whereas the objective outcome measure of rehospitalisation was better 
predicted by demographic and clinical variables (Sota & Heinrichs, 2004). Also, 
different symptoms differentially influence outcome. A previous analysis of the 
current data (van Os et al., 1999) revealed that reductions in psychopathology were 
associated longitudinally with improvement in outcome, but the size of associa-
tions was different for the various dimensions of symptoms and functioning.  
 
The aim of the current study was to clarify the role of processing speed as a pro-
spective predictor of various domains of outcome in a large sample of stable pa-
tients with chronic psychotic illness. Extending a previous analysis of the same 
data (van Os et al., 1999), in which the impact of psychopathology dimensions on 
outcome was assessed, this study investigated the relative importance of processing 
speed in the prediction of functional outcome. First, the cross-sectional relation-
ship between processing speed and various measures of outcome was investigated, 
in order to evaluate whether processing speed was associated with baseline meas-
ures of the outcomes examined over and above measures of symptomatology. 
Secondly, the prognostic value of processing speed on functional outcome was 
examined by investigating longitudinally whether processing speed at baseline was, 
over and above symptomatology, associated with baseline-adjusted outcome meas-
ures at follow-up. 
 
Methods 
Sample 
Data were drawn from the baseline and year 2 assessments of the UK700 Case 
Management Trial, a 2-year randomised controlled trial comparing the efficacy of 
different intensities of case management in psychotic patients (Burns et al., 1999; 
Metcalfe et al., 2005). The rationale and detailed methodology of the UK700 study 
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have been reported elsewhere (UK700Group, 1999a, 1999b). The 708 patients in 
the UK700 study were recruited at the point of discharge from the hospital or in 
the community. Criteria for inclusion were: 1) presence of a psychotic illness ac-
cording to the Research Diagnostic Criteria (Spitzer, Endicott, & Robins, 1978), 2) 
aged between 16 and 65 years, 3) hospitalized for psychotic symptoms at least 
twice, the most recent admission within the past 2 years, 4) absence of obvious 
organic brain damage or a primary diagnosis of substance abuse. 
Subjects were interviewed at baseline and at one and two year follow-up.  Baseline 
assessments took place prior to randomisation and involved the collection of 
socio-demographic data and a clinical and neuropsychological assessment. Clinical 
assessments were also carried out one year and two years after randomisation. For 
the present study data were drawn from the baseline and year 2 follow up assess-
ment. 
 
Neuropsychological assessment 
A short neuropsychological assessment took place at baseline and consisted of the 
Trail Making Test (TMT) parts A and B (Reitan, 1958) and the National Adult 
Reading Test (NART) (Nelson & Willison, 1991). The TMT is primarily a test of 
visual conceptual and visuomotor tracking and can be considered a measure of 
processing speed (Lezak, 1995). In part A, subjects had to draw lines to connect 
consecutively numbered circles. In part B, subjects connected the same number of 
consecutively numbered and lettered circles by alternating between the two se-
quences. It therefore, reflects more complex information processing than part A. 
The score is the time to complete each part of the test.  
Additionally, level of premorbid intelligence was estimated using the NART. This 
reading test makes minimal demands on current cognitive capacity and is relatively 
resistant to neurological and psychiatric disorder. Therefore, it can be considered a 
useful measure of premorbid intellectual functioning in the group of patients with 
a psychotic illness.  
 
Psychopathology assessment 
At baseline, the Operational Criteria Checklist for Psychotic Illness (OCCPI) (Mc 
Guffin, Farmer, & Harvey, 1991) was completed for all patients and the computer 
program OPCRIT was used to derive diagnoses. For the present study, the RDC 
diagnostic system was used (Spitzer et al., 1978).  
At baseline and at follow up, current psychopathology was measured using the 
Comprehensive Psychopathology Rating Scale (Jacobsson et al., 1978). For the 
purpose of this research the symptom dimensions derived from previous factor 
analysis were used (van Os et al., 1999). Four psychopathology dimensions were 
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retained, reflecting depressive, manic, negative and positive symptoms. Standard-
ised factor scores were calculated and had a mean of zero and a standard deviation 
of 1. 
 
Functional outcome assessment 
Functional outcome was assessed at baseline and at two year follow-up. Service use 
was assessed by the number of hospital admissions and by the number of days 
spent in hospital over the past two years, measured using a slightly modified ver-
sion of the Life Chart Schedule (WHO, 1992).  
Social outcome was assessed using measures of employment, independent living 
and social disability. The number of months in employment and independent liv-
ing over the past two years were measured using the Life Chart Schedule (WHO, 
1992). Employment was composed of fulltime and part-time jobs, sheltered jobs, 
retirement or being a student. Independent community living was defined as the 
total number of months in independent community living over the past two years. 
Social disability was assessed using the WHO Disability Assessment Schedule 
(DAS) (Jablensky, Schwartz, & Tomov, 1980; WHO, 1992). The two ‘overall be-
haviour’ items and the nine ‘social roles’ items were used to rate the level of social 
disability, higher scores indicating higher rates of disability. 
Subjective outcome was measured by reported quality of life and needs for care. 
Quality of Life (QoL) was rated using a structured self-report interview (Lanca-
shire Quality of Life Profile (Oliver, Huxley, Priebe, & Kaiser, 1997) based on the 
Lehman Quality of Life Interview (Lehman, Ward, & Linn, 1982). It consists of 
100 items assessing QoL and life satisfaction in nine areas (subscales). The mean of 
the subscales was used as the dependent variable, higher scores reflecting better 
QoL. The Camberwell Assessment of Need (CAN) (Phelan et al., 1995) assesses 
22 areas of need, each area including four sections. In the current study only the 
first section was used; this establishes whether there is a need, by asking about 
difficulties in that area. Responses are rated on a three point scale (0 = no serious 
need; 1 = no/moderate problem because of continuing intervention (met need); 2 
= current serious problem (unmet need)). The number of met and the number of 
unmet needs were used as dependent variables. Needs were scored as viewed by 
the patient, thus constituting a subjective outcome. 
 
Statistical analyses 
For convenience of interpretation of the data, TMT variables were recoded so that a 
higher score on neurocognitive variables indicated a better performance. First, to 
investigate the extent of the relationship between the processing speed variables and 
symptomatology partial correlations were calculated, adjusting the symptom dimen-
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sions for each other. For the investigation of cross-sectional associations between 
cognitive variables and outcome, multiple linear regressions, a priori adjusted for the 
basic confounders age, sex, educational qualifications, ethnicity, and centre, were 
applied. Separate models were used for each of the three neurocognitive variables. 
Functional outcome at baseline was used as dependent variable, and the neurocogni-
tive measure and the basic confounders as independent variables. In case of signifi-
cant or near significant associations (p-values ≤ 0.10), psychopathology dimensions 
were additionally entered into the equation simultaneously in order to investigate 
whether the cognitive variable had prognostic value in addition to current symp-
toms.  
Likewise, for the investigation of longitudinal associations between cognition at 
baseline and outcome at follow-up, multiple linear regression analyses, a priori ad-
justed for age, sex, educational qualifications, ethnicity, centre and case management 
intervention, were applied. First, a single neurocognitive variable was entered as 
predictor of functional outcome at follow up. In case of significant or near signifi-
cant associations (p-values ≤ 0.10), analyses were repeated, adjusted for the equiva-
lent of the outcome variable at baseline, in order to examine the true association 
with change in the functional outcome variable over time. If a (near) significant 
association remained, psychopathology dimensions at baseline were additionally 
entered into the equation in order to examine whether the neurocognitive variable 
had longitudinal prognostic value in addition to symptoms. Finally, a sensitivity 
analysis was done, in which the cross-sectional and longitudinal analyses were re-
peated excluding patients with an RDC diagnosis of affective or unspecified psycho-
sis in order to examine whether correlations were confounded by the inclusion of 
individuals with a diagnosis other than schizophrenia spectrum disorders. Effect 
sizes were expressed as standardised regression coefficients (ß).  
 
Results 
Demographic characteristics 
Seven-hundred and eight patients entered the study. Mean age of participants at 
study entry was 38.3 years (SD 11.6); there were more men (57%) than women 
(43%). Just over half (52%) of the patients was white, 28% was African-Caribbean 
and 20 % pertained to other ethnic groups. Forty-five percent of the participant 
had no educational qualifications, 32% was classified as CSE/GCSE/O level and 
23% had an A level or degree. The most common RDC diagnosis at study entry 
was schizophrenia (49%) followed by schizoaffective disorder (38%). Other pa-
tients were diagnosed as suffering from affective or non-specified psychosis. 
Of the seven-hundred and eight patients who entered the study, 15% did not 
complete TMT A, 38% did not complete TMT B, and 38% of the participants did 
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not complete the NART. Characteristics of the patients with missing data are de-
scribed in detail elsewhere (Gilvarry, Barber, van Os, & Murray, 2001). Briefly, 
patients who did not complete TMT were more likely to have negative symptoms, 
positive symptoms, to have less education and to be older. Those with missing 
TMT B scores were additionally more likely to be from lower socioeconomic 
groups. Patients not completing the NART were less likely to be white, more likely 
to be older, less educated and to show more negative, and more positive symptoms 
(Gilvarry et al., 2001). Summary scores of neurocognitive and functional outcome 
variables are presented in table 1.  
Regarding the extent of the relationship between predictor variables of processing 
speed and symptom dimensions, partial correlation analyses revealed that TMT A 
was significantly associated with positive symptoms (r=0.12, p=0.05) and there 
was a trend towards an association with negative symptoms (r=0.07, p=0.09). No 
significant correlations were found for the other symptom dimensions (depression: 
r=0.02 and mania: r=0.05). TMT B was significantly associated with negative 
(r=0.20, p=0.00) and positive (r=0.14, p=0.01) symptoms, but not with mania (r=-
0.03) and depression (r=0.01).  
 
 
Table 1. Neurocognitive and functional outcome measures: summary 
 
 Baseline Follow up Change scores 
 n Mean (SD) n Mean (SD) n Mean (SD) 
Neuropsychological tasks 
TMT A 599 60.8 (39.5)     
TMT B 437 119.20 (62.2)     
Nart 586 106.40 (10.5)     
Service use (range) 
Number of hospital admissions (0-13) 707 1.9 (1.2) 703 1.1 (1.5) 703 -0.8 (1.7) 
Time in hospital (0-730) 707 108.9 (112.6) 703 81.3 (125.4) 703 -28.0 (141.4) 
Social outcome (range) 
Employment, months (0-24) 705 3.1 (6.6) 685 2.6 (6.5) 683 -0.3 (6.5) 
Independent living, months (0-24) 707 16.8 (7.6) 698 15.7 (9.3) 698 -1.0 (7.0) 
DAS total score (0-4.8) 696 1.2 (0.9) 596 1.1 (0.8) 587 -0.1 (0.9) 
Subjective outcome (range) 
QoL (1.2-6.8) 689 4.3 (0.7) 526 4.6 (0.7) 513  0.3 (0.8) 
CAN number of needs (0-14) 699 6.0 (3.0) 585 6.5 (3.1) 579  0.4 (3.5) 
CAN number of unmet needs (0-14) 699 2.6 (2.3) 585 2.0 (2.4) 579 -0.7 (2.9) 
 
 
Cross-sectional associations between cognition and outcome  
In the outcome domain of service use, multiple regression analysis showed a trend 
towards a significant association between number of hospital admissions and per-
formance on TMT B (ß=-0.10, p=0.07) (Table 2), a better test performance pre-
dicting fewer hospital admissions. Entering psychopathology dimensions into the 
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equation reduced the strength of this association (ß=-0.08, p=0.17). For time in 
the hospital a weak trend towards an association was found with TMT A (ß=-0.08, 
p=0.07) that was reduced only marginally after correcting for current psychopa-
thology (ß=-0.08, p=0.09). 
 
Regarding social outcome, a significant cross-sectional association was found be-
tween performance on TMT B and employment; a better cognitive performance 
was associated with a longer duration of employment (ß=0.12, p=0.02). Entering 
dimensions of psychopathology in the equation reduced the association (ß=0.08, 
p=0.13). TMT A was significantly associated with months in independent living (ß 
=0.11, p=0.01) and this association remained significant after entering psychopa-
thology dimensions in the equation (ß =0.10, p=0.02). The trend towards an asso-
ciation between TMT B and independent living was reduced after entering psy-
chopathology (ß =0.04, p=0.50). The outcome measure of social disability, meas-
ured with the DAS, was associated with TMT A and NART (see table 2). After 
adjustment for psychopathology, however, only the association with NART re-
mained equally large and significant (TMT A: ß=-0.03, p=0.45, TMT B: ß=-0.01, 
p=0.90, NART: ß =-0.12, p=0.01). 
In the subjective outcome domain, QoL score was significantly associated with 
NART performance (ß=-0.10, p=0.04); better NART performance was associated 
with a lower QoL score. This association was reduced but not nullified after ad-
justment for current psychopathology (ß=-0.08, p=0.08). For TMT performance 
no association with QoL was found. Number of met needs (CAN) was associated 
with none of the neurocognitive measures. The number of unmet needs (CAN) 
showed a significant association with TMT B (see table 2), worse cognitive per-
formance being associated with an increased number of unmet needs. Adjustment 
for psychopathology dimensions only marginally reduced the strength of this asso-
ciation (ß=-0.12, p=0.02). 
 
Longitudinal associations between cognition and outcome  
Longitudinally, no significant associations were found for service use measures: 
number of hospital admissions and time in the hospital at follow up were not asso-
ciated with TMT or NART performance at baseline (see table 2).  
As to the social outcome domain, no longitudinal association was found between 
neurocognitive predictors and months of employment. The trend towards a sig-
nificant positive association between independent living at follow-up and TMT A 
performance at baseline (ß=0.08, p=0.09) was reduced after adjustment for inde-
pendent living at baseline (ß=0.01, p=0.73). Social disability (DAS) at follow-up 
was associated with TMT performance at baseline (see table 2). However, after 
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adjustment for social disability at baseline these associations were much reduced 
(TMT A: ß=-0.03, p=0.50, TMT B: ß=-0.07, p=0.17). 
Regarding subjective outcome, no association was found between the neurocogni-
tive variables at baseline and QoL at follow-up (see table 2). Number of met needs 
(CAN) however, showed a significant negative association with TMT A and B, 
impaired neurocognitive performance at baseline being associated with an in-
creased number of needs at follow-up. Adjustment for the number of met needs at 
baseline did not reduce these associations (TMT A: ß=-0.08, p=0.09, TMT B: ß=-
0.16, p=0.00) nor did additional adjustment for psychopathology (TMT A: ß=-
0.07, p=0.10, TMT B: ß=-0.17, p=0.00). A similar pattern was found for the num-
ber of unmet needs at follow-up. 
 
Table 2. Associations between neurocognitive variables and outcome measures  
 
Note: all analyses adjusted for age, sex, educational qualifications, ethnicity and centre 
 
Repeating cross-sectional and longitudinal analyses, excluding patients with an 
RDC diagnosis of affective or unspecified psychosis, did not change the pattern of 
results. 
  Estimates cross-sectional Estimates longitudinal 
  ß p-value ß p-value 
Service use 
Hospital admissions TMT A  0.02 0.69  0.06 0.15 
 TMT B -0.10 0.07  0.03 0.60 
 Nart -0.04 0.40  0.08 0.13 
      
Time in hospital TMT A -0.08 0.07  0.04 0.33 
 TMT B -0.00 0.95  0.04 0.50 
 Nart  0.01 0.83  0.02 0.77 
Social outcome 
Employment TMT A  0.04 0.32 -0.03 0.52 
 TMT B  0.12 0.02  0.05 0.35 
 Nart  0.03 0.60  0.08 0.14 
      
Independent living TMT A  0.11 0.01  0.08 0.09 
 TMT B  0.09 0.10  0.08 0.16 
 Nart  0.01 0.92  0.03 0.56 
      
Social disability TMT A -0.09 0.03 -0.08 0.09 
 TMT B -0.09 0.08 -0.11 0.05 
 Nart -0.11 0.02 -0.06 0.31 
Subjective outcome 
QoL TMT A  0.02 0.67  0.02 0.67 
 TMT B -0.07 0.21 -0.04 0.50 
 Nart -0.10 0.04  0.07 0.28 
      
CAN Needs TMT A -0.04 0.40 -0.09 0.05 
 TMT B -0.08 0.11 -0.19 0.00 
 Nart -0.05 0.37 -0.10 0.08 
      
CAN unmet Needs TMT A  0.01 0.90 -0.11 0.02 
 TMT B -0.14 0.01 -0.21 0.00 
 Nart -0.08 0.10 -0.03 0.56 
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Discussion 
The findings can be summarised as follows. Cross-sectionally, processing speed 
was associated with all three domains of outcome, although only the associations 
in the social and subjective outcome domain remained significant after controlling 
for psychopathology. Generally, processing speed but not premorbid intellectual 
performance was associated with objective outcome measures of hospital admis-
sions, independent living and employment, whereas both the measures of premor-
bid intellectual functioning and processing speed were associated with subjective 
appraisal of outcomes, although not consistently so. The present results suggest 
that processing speed is associated with social and subjective outcomes over and 
above psychopathology, but not to services use.  
The prospective prognostic value of processing speed and premorbid intelligence 
on functional outcome was less evident. Only the subjective outcome measure of 
number of met and unmet needs (CAN) was weakly associated with baseline proc-
essing speed performance after adjustment for the baseline level of needs. 
The finding of weak cross-sectional associations in the absence of specific and 
unconfounded longitudinal associations suggests that processing speed is an inde-
pendent dimension of disease severity rather than a causal factor impacting on 
aspects of social outcome.  
 
Associations with service use 
In the current study no clear cross-sectional or longitudinal association between 
processing speed and hospitalization was found. In a previous study (Fujii & Wylie, 
2002) TMT B performance was prognostic of  total duration of hospital inpatient 
status. Other prospective studies, however, did also not find an association be-
tween cognitive measures and hospitalization during the follow up period (Sota & 
Heinrichs, 2004; Stirling et al., 2003). Previous analyses on the current data set 
showed that reduction of positive and manic symptoms was strongly associated 
with a reduction in the number of hospital admissions (van Os et al., 1999), which 
is in accordance with the suggestion of Green (Green, 1996) that psychotic symp-
toms may be a better predictor of clinical outcome measures of psychosis.  
 
Associations with social outcome 
Cross-sectionally, cognitive speed was weakly associated in the expected direction 
with all three measures of social outcome. However, only the association with 
independent living remained significant after adjustment for current symptoms. 
The absence of an association between processing speed and months at work is in 
contradiction with other studies that did find a significant association between 
neurocognition and work performance in schizophrenia (Addington, McCleary, & 
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Munroe-Blum, 1998; Lysaker, Bryson, Davis, & Bell, 2005; Milev et al., 2005). 
Social disability was associated with premorbid intellectual functioning, also after 
controlling for psychopathology, suggesting that premorbid intellectual functioning 
explained variance in social outcome in addition to the four psychopathology di-
mensions that were previously reported to be strongly and independently associ-
ated with social disability (van Os et al., 1999). 
The lack of longitudinal associations between processing speed, premorbid intel-
lectual functioning and changes in the measures of social outcome is in accordance 
with a previous study (Verdoux, Liraud, Assens, Abalan, & van Os, 2002) in which 
no associations between cognitive variables and social outcome measured by em-
ployment and independent living were found. Other studies, however, did report 
an association between neurocognitive functioning and vocational functioning 
(Bryson & Bell, 2003; Gold, Goldberg, McNary, Dixon, & Lehman, 2002; McGurk 
& Meltzer, 2000). Previous analyses of this dataset showed that symptomatology 
was associated with social outcome since a reduction in positive and negative 
symptoms was associated with more time living independently and a reduction in 
all four psychopathology dimensions was associated with improvement in social 
disability (van Os et al., 1999).  
 
Associations with subjective outcome  
In cross-sectional analyses, premorbid intellectual functioning, measured by 
NART, was weakly though significantly associated with Quality of Life, in the 
direction that a better premorbid intelligence was associated with a lower appraisal 
of QoL. This is consistent with the results of Prouteau et al. (Prouteau et al., 2005) 
who reported a similar relationship between neurocognitive functioning and self-
rated quality of life. Although, this appears to be a paradoxical finding as, generally, 
a better cognitive performance is associated with better outcome, it has been hy-
pothesized that people with worse neuropsychological functioning have a lesser 
capacity for complex self-referencing. They therefore can directly translate im-
provements in their objective psychosocial status into enhanced subjective experi-
ence without being hindered by external or premorbid self-referencing (Brekke, 
Kohrt, & Green, 2001). Longitudinally, subjective QoL was not predicted by neu-
rocognitive measures at baseline, which is in accordance with a previous study in 
which positive and negative symptoms were more important predictors of QoL 
than neurocognitive functioning in the long run (Addington et al., 2005). Previous 
research also taking into account depressive symptomatology, indicated that meas-
ures of subjective outcome were strongly associated with depression and to a lesser 
extent with negative symptoms (Smith et al., 1999; van Os et al., 1999).  
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Number of unmet needs (CAN) showed a weak association in the hypothesised 
direction with TMT B performance when measured at the same point in time, 
independent from psychopathology.  Longitudinally the number of met and unmet 
needs on the CAN was strongly predicted by TMT performance at baseline, even 
after controlling for baseline levels of the outcome variable and for baseline psy-
chopathology. This in accordance with a previous study that also found that need 
for care was predicted by speed of processing (Holthausen et al., 2007). 
 
Methodological considerations 
The results of the present study should be viewed in the light of several methodo-
logical issues. First, the current study only considered processing speed, while pre-
vious research has demonstrated the importance of other cognitive domains, for 
example verbal memory and executive functioning, in the prediction of functional 
outcome. Also, as different domains of outcome may differ in their cognitive cor-
relates, a more extensive cognitive assessment will be required to investigate 
whether the same results will apply for other cognitive domains. However, previ-
ous research indicated that the attention/speed domain is one of the cognitive 
domains most relevant to functional outcome in schizophrenia (Lysaker et al., 
2005; Milev et al., 2005) and that cognitive abnormalities in schizophrenia are me-
diated through a single common cognitive factor (Dickinson et al., 2004). Second, 
as mentioned in the results section, a proportion of the subjects did not complete 
the neuropsychological testing. There is reason to assume that these missing data 
are not random, as patients who did not complete the testing were most adversely 
affected by their illness. This may have biased the research population to be less 
impaired than the original sample thereby causing less variation in outcome and its 
predictors. Third, in the current study a relatively chronic population was studied. 
This may have caused less variation in outcome than when first episode patients 
would have been investigated, and the results may not generalise to first episode 
patients. However, much of the work suggesting true predictive power of baseline 
cognition, summarised by Green (Green, 1996), was on chronic patients. Fourth, 
the current sample consisted of patients with a diagnosis of psychosis in general, 
and did not focus on one diagnostic category. A categorical approach does not 
capture the broad heterogeneity of psychosis and schizophrenia and therefore it 
was suggested that outcome may be best investigated using a dimensional ap-
proach to psychopathology of psychosis (Carlsson, Nyman, Ganse, & Cullberg, 
2006; Rosenman, Korten, Medway, & Evans, 2003). The previously reported ab-
sence of any pattern of interaction with diagnostic category in the current sample 
(van Os et al., 1999) and the stability of findings when repeated in schizophrenia 
and schizoaffective diagnoses only, appears to justify this approach. Finally, al-
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though the current results did not show a consistent relationship between process-
ing speed, premorbid intellectual functioning and outcome, previous results in the 
UK700 study, examining the effect of different intervention types on outcome, 
showed a significant interaction effect between type of case management and bor-
derline-intelligence status (Tyrer, Hassiotis, Ukoumunne, Piachaud, & Harvey, 
1999). Patients with borderline intellectual functioning treated with intensive case 
management had a mean of only 47 days in hospital compared with 105 days for 
those treated with standard care. No differential effects of intervention type were 
found for the group with normal intelligence (Tyrer et al., 1999). Similar gains for 
borderline IQ patients, treated with intensive case management were shown in 
satisfaction with services, total costs and needs (Hassiotis et al., 2001). Therefore, 
neurocognition, at least at the level of basic intelligence, is a relevant factor in the 
selection of appropriate treatment and this finding should not be obscured by the 
lack of any important associations between neurocognition and outcome in the 
current study.  
 
Conclusion 
The current findings suggest that, cross-sectionally, processing speed is associated 
with measures of social and subjective outcome, but not consistently so, as the 
effects of the predictors differ between and within domains of outcome. Prospec-
tively, the evidence for an association between change in outcome and neurocogni-
tion is highly inconsistent; after adjustment for the baseline levels only the number 
of met and unmet needs measured by the CAN were weakly sensitive to baseline 
neurocognitive performance. This is in contradiction with studies supporting longi-
tudinal associations between cognition and community outcome (Carlsson et al., 
2006; Green et al., 2004), but in accordance with other studies reporting a relation-
ship between cognition and outcome when measured concurrently, but not pro-
spectively (Addington et al., 2005). The present results are in accordance with pre-
vious findings that neurocognition is longitudinally more associated with subjective 
measures of outcome (Sota & Heinrichs, 2004). Altogether, the associations be-
tween processing speed and outcome, cross-sectionally and longitudinally, are not 
substantially stronger than the associations with psychopathology.  
 
Acknowledgements 
The UK700 trial was funded by grants from the UK Department of Health and 
NHS Research and Development. 
Thesis_Jabben_v3.pdf   138 30-6-2009   8:56:31
CHAPTER 7 
 
Page | 139  
 
References 
Addington, J., McCleary, L., & Munroe-Blum, H. (1998). Relationship between cognitive and social dysfunction in 
schizophrenia. Schizophr Res, 34(1-2), 59-66. 
Addington, J., Saeedi, H., & Addington, D. (2005). The course of cognitive functioning in first episode psychosis: 
changes over time and impact on outcome. Schizophr Res, 78(1), 35-43. 
Breier, A., Schreiber, J. L., Dyer, J., & Pickar, D. (1992). Course of illness and predictors of outcome in chronic 
schizophrenia: implications for pathophysiology. Br J Psychiatry, 161(S18), 38-43. 
Brekke, J. S., Kohrt, B., & Green, M. F. (2001). Neuropsychological functioning as a moderator of the relationship 
between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr 
Bull, 27(4), 697-708. 
Bryson, G., & Bell, M. D. (2003). Initial and final work performance in schizohrenia: cognitive and symptom 
predictors. J Nerv Ment Dis, 191(2), 87-92. 
Burns, T., Creed, F., Fahy, T., Thompson, S., Tyrer, P., & White, I. (1999). Intensive versus standard case man-
agement for severe psychotic illness: a randomised trial. UK 700 Group. Lancet, 353(9171), 2185-2189. 
Carlsson, R., Nyman, H., Ganse, G., & Cullberg, J. (2006). Neuropsychological functions predict 1- and 3-year 
outcome in first-episode psychosis. Acta Psychiatr Scand, 113(2), 102-111. 
Dickinson, D., & Coursey, R. D. (2002). Independence and overlap among neurocognitive correlates of commu-
nity functioning in schizophrenia. Schizophr Res, 56(1-2), 161-170. 
Dickinson, D., Iannone, V. N., Wilk, C. M., & Gold, J. M. (2004). General and specific cognitive deficits in 
schizophrenia. Biol Psychiatry, 55, 826-833. 
Fujii, D. E., & Wylie, A. M. (2002). Neurocognition and community outcome in schizophrenia: long-term predic-
tive validity. Schizophr Res, 59, 219-223. 
Gilvarry, C. M., Barber, J. A., van Os, J., & Murray, R. M. (2001). Neuropsychological performance of psychotic 
patients in community care: results from the UK700 study. Acta Psychiatr Scand Suppl(408), 81-91. 
Gold, J. M., Goldberg, R. W., McNary, S. W., Dixon, L. B., & Lehman, A. F. (2002). Cognitive correlates of job 
tenure among patients with severe mental illness. Am J Psychiatry, 159(8), 1395-1402. 
Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? Am J 
Psychiatry, 153(3), 321-330. 
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in 
schizophrenia: Are we measuring the "Right Stuff"? Schizophr Bull, 26(1), 119-136. 
Green, M. F., Kern, R. S., & Heaton, R. K. (2004). Longitudinal studies of cognition and functional outcome in 
schizophrenia: implications for MATRICS. Schizophr Res, 72(1), 41-51. 
Hassiotis, A., Ukoumunne, O. C., Byford, S., Tyrer, P., Harvey, K., Piachaud, J., et al. (2001). Intellectual function-
ing and outcome of patients with severe psychotic illness randomised to intensive case management. Re-
port from the UK700 trial. Br J Psychiatry, 178, 166-171. 
Holthausen, E. A., Wiersma, D., Cahn, W., Kahn, R. S., Dingemans, P. M., Schene, A. H., et al. (2007). Predictive 
value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res, 149(1-3), 
71-80. 
Jablensky, A., Schwartz, R., & Tomov, T. (1980). WHO collaborative study of impairments and disabilities associ-
ated with schizophrenic disorders: a preliminary communication. Objective and methods. Acta Psychiatr 
Scand, suppl. 285(62), 152-163. 
Jacobsson, L., von Knorring, L., Mattsson, B., Perris, C., Edenius, B., Kettner, B., et al. (1978). The comprehesive 
psychopathological rating scale--CPRS--in patients with schizophrenic syndromes. Inter-rater reliability and 
in relation to Martens' S-scale. Acta Psychiatr Scand Suppl(271), 39-44. 
Lehman, A. F., Ward, N. C., & Linn, L. S. (1982). Chronic mental patients: the quality of life issue. Am J Psychiatry, 
139(10), 1271-1276. 
Lezak, M. (1995). Neuropsychological assessment (third ed.). New York: Oxford University Press. 
Lieberman, J. A., Koreen, A. R., Chakos, M., Sheitman, B., Woerner, M., Alvir, J. M., et al. (1996). Factors influ-
encing treatment response and outcome of first-episode schizophrenia: implications for understanding the 
patholophysiology of schizophrenia. J Clin Psychiatry, 57(S 9), 5-9. 
Lysaker, P. H., Bryson, G. J., Davis, L. W., & Bell, M. D. (2005). Relationship of impaired processing speed and 
flexibility of abstract thought to improvements in work performance over time in schizophrenia. Schizophr 
Res, 75(2-3), 211-218. 
Malla, A., & Payne, J. (2005). First-episode psychosis: psychopathology, quality of life, and functional outcome. 
Schizophr Bull, 31(3), 650-671. 
Malla, A. K., Norman, R. M., Manchanda, R., & Townsend, L. (2002). Symptoms, cognition, treatment adherence 
and functional outcome in first-episode psychosis. Psychol Med, 32(6), 1109-1119. 
Mc Guffin, P., Farmer, A., & Harvey, I. (1991). A polydiagnostic application of operational criteria in studies of 
psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry, 48, 764-770. 
McGurk, S. R., & Meltzer, H. Y. (2000). The role of cognition in vocational functioning in schizophrenia. 
Schizophr Res, 45(3), 175-184. 
Thesis_Jabben_v3.pdf   139 30-6-2009   8:56:32
CHAPTER 7 
 
Page | 140 
 
Metcalfe, C., White, I. R., Weaver, T., Ukoumunne, O. C., Harvey, K., Tattan, T., et al. (2005). Intensive case 
management for severe psychotic illness: is there a general benefit for patients with complex needs? A sec-
ondary analysis of the UK700 trial data. Soc Psychiatry Psychiatr Epidemiol, 40(9), 718-724. 
Milev, P., Ho, B. C., Arndt, S., & Andreasen, N. C. (2005). Predictive values of neurocognition and negative 
symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. 
Am J Psychiatry, 162(3), 495-506. 
Nelson, H. E., & Willison, J. R. (1991). The Revised National Adult Reading Test Manual (2nd ed.). Windsor, UK: 
NFER-Nelson. 
Norman, R. M., Malla, A. K., Cortese, L., Cheng, S., Diaz, K., McIntosh, E., et al. (1999). Symptoms and cogni-
tion as predictors of community functioning: a prospective analysis. Am J Psychiatry, 156(3), 400-405. 
Norman, R. M. G., Malla, A. K., Manchanda, R., Harricharan, R., Takhar, J., & Northcott, S. (2005). Social sup-
port and three-year symptom and admission outcomes for first-episode psychosis. Schizophr Res, 80, 227-
234. 
Oliver, J. P., Huxley, P. J., Priebe, S., & Kaiser, W. (1997). Measuring the quality of life of severely mentally ill 
people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol, 32(2), 76-83. 
Phelan, M., Slade, M., Thornicroft, G., Dunn, G., Holloway, F., Wykes, T., et al. (1995). The Camberwell Assess-
ment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental 
illness. Br J Psychiatry, 167(5), 589-595. 
Prouteau, A., Verdoux, H., Briand, C., Lesage, A., Lalonde, P., Nicole, L., et al. (2005). Cognitive predictors of 
psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabili-
tation program. Schizophr Res, 77(2-3), 343-353. 
Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain dysfunction. Percept Mot 
Skills, 8, 271-276. 
Robinson, D. G., Woerner, M. G., McMeniman, M., Mendelowitz, A., & Bilder, R. M. (2004). Symptomatic and 
functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry, 
161(3), 473-479. 
Rosenman, S., Korten, A., Medway, J., & Evans, M. (2003). Dimensional vs. categorical diagnosis in psychosis. 
Acta Psychiatr Scand, 107, 378-384. 
Smith, T. E., Hull, J. W., Goodman, M., Hedayat-Harris, A., Willson, D. F., Israel, L. M., et al. (1999). The relative 
influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaf-
fective disorder. J Nerv Ment Dis, 187(2), 102-108. 
Sota, T. L., & Heinrichs, R. W. (2004). Demographic, clinical, and neurocognitive predictors of quality of life in 
schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry, 45(5), 415-421. 
Spitzer, R. L., Endicott, J., & Robins, E. (1978). Research diagnostic criteria: rationale and reliability. Arch Gen 
Psychiatry, 35(6), 773-782. 
Stirling, J., White, C., Lewis, S., Hopkins, R., Tantam, D., Huddy, A., et al. (2003). Neurocognitive function and 
outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr Res, 
65(2-3), 75-86. 
Tyrer, P., Hassiotis, A., Ukoumunne, O., Piachaud, J., & Harvey, K. (1999). Intensive case management for 
psychotic patients with borderline intelligence. UK 700 Group. Lancet, 354(9183), 999-1000. 
UK700Group. (1999a). Comparison of intensive and standard case management for patients with psychosis. 
Rationale of the trial. UK700 Group. Br J Psychiatry, 174, 74-78. 
UK700Group. (1999b). Predictors of quality of life in people with severe mental illness. Study methodology with 
baseline analysis in the UK700 trial. Br J Psychiatry, 175, 426-432. 
van Os, J., Gilvarry, C., Bale, R., van Horn, E., Tattan, T., White, I., et al. (1999). To what extent does sympto-
matic improvement result in better outcome in psychotic illness? UK700 Group. Psychol Med, 29(5), 1183-
1195. 
van Os, J., Wright, P., & Murray, R. M. (1997). Risk factors for emergence and persistence of psychosis. In M. 
Weller & D. Van Kammen (Eds.), Progress in Clinical Psychiatry (pp. 152-206). London: W. B. Saunders 
Company LTD. 
Verdoux, H., Liraud, F., Assens, F., Abalan, F., & van Os, J. (2002). Social and clinical consequences of cognitive 
deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophr Res, 56(1-2), 149-
159. 
WHO. (1992). WHO Coordinated Multi-Center Study on the Course and Outcome of Schizophrenia. 
 
 
 
Thesis_Jabben_v3.pdf   140 30-6-2009   8:56:32
 Page | 141  
 
CHAPTER 8 
EPILOGUE 
Thesis_Jabben_v3.pdf   141 30-6-2009   8:56:32
CHAPTER 8 
 
Page | 142 
 
EPILOGUE 
 
The sharp categorical distinction between schizophrenia and bipolar disorder as 
represented in psychiatric diagnostic manuals does not fit the clinical reality in 
which symptoms often overlap. In addition to overlapping symptomatology, sev-
eral other findings challenge the traditional Kraepelinian dichotomy: schizophrenia 
and bipolar disorder show overlap in epidemiological features and possibly even 
share part of their genetic background. 
An important domain which may yield further insight into the nature of the simi-
larities between the disorders is the presence of cognitive dysfunctions. The studies 
described in this thesis have focused on the aetiological and predictive value of 
cognitive functioning in bipolar disorder and schizophrenia. The results are dis-
cussed within a continuum view of severe mental illness. 
 
In the first part of this thesis, the overlap and differences in the role of cognition 
as marker of the genetic vulnerability for schizophrenia and bipolar disorder was 
studied. First, the evidence of neurocognitive functioning as endophenotypic 
marker in bipolar disorder was evaluated using meta-analytic techniques. Second, 
in order to investigate shared and non-shared characteristics in the cognitive do-
main, neurocognitive functioning in patients with schizophrenia was compared 
directly to that of bipolar disorder. This study also compared neurocognitive per-
formance between the relatives of both patient groups. The subjects in this com-
parison came from the Maastricht site of the GROUP study and the BIPOLCOG 
study.  
Third, a consistent finding in schizophrenia is the lack of any significant associa-
tions between neurocognitive dysfunction and the positive symptoms of psychosis. 
This thesis investigated whether a similar pattern of associations is present in bipo-
lar disorder, since this could provide further evidence regarding the suggested 
overlap between both disorders. This was done in the BIPOLCOG study. Finally, 
in the same study, the endophenotypic nature of neurocognitive dysfunction was 
further explored by examining the role of the COMT gene, both in relation to 
disorder vulnerability and cognitive functioning.  
 
In the second part of this thesis the role of neurocognition as predictor of social 
and community functioning was evaluated. First, the relative predictive value of 
cognition and symptoms on functional outcome was explored in a combined 
group of patients with affective and non-affective psychosis in the UK700 study. 
In this sample it was further investigated whether cognition has true long-term 
prognostic value in relation to changes in outcome. Second, in a different sample 
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recruited in the context of the CoP study, we examined whether neurocognitive 
alterations associated with the liability have predictive value for functional outcome 
in groups at different levels of psychosis-risk in. Finally, the relative influence of 
neurocognition on psychosocial functioning was compared between the schizo-
phrenia sample from the GROUP study and bipolar disorder patients in the 
BIPOLCOG study.  
 
Neurocognition as intermediary phenotype in severe mental illness 
Both bipolar disorder and schizophrenia are complex disorders in which genes and 
environment interact in causing the illness. Due to the genetic complexity of these 
disorders and the imprecision of psychiatric diagnoses as phenotype for under-
standing its genetic bases, genetic research in psychiatry so far has failed to be suc-
cessful. In the last decade, the endophenotype approach has gained interest. An 
endophenotype, or genetic vulnerability marker or intermediary phenotype, is an 
indicator of genetic risk, mediating between genotype and phenotype (disorder). 
An endophenotype is assumed to be more directly linked to susceptibility genes, 
and is generally less complex and easier to measure than the disease phenotype 
(Gottesman & Gould, 2003) and may therefore help to elucidate the genetic aeti-
ology of psychiatric disorders. For an endophenotype to be useful it must be (Has-
ler, Drevets, Gould, Gottesman, & Manji, 2006): 1) associated with illness, 2) herit-
able, 3) state independent, 4) co-segregated with the illness within families, 5) also 
present in unaffected relatives at a higher rate than in the general population. In 
the broad domain of severe mental illness, cognitive impairment may be one of the 
most promising candidate endophenotypes. 
Neurocognitive impairment is a core deficit of schizophrenia (Heinrichs & Zakza-
nis, 1998) and there is convincing evidence that neurocognitive functioning, in 
particular in domains of verbal memory, attention and executive functioning, can 
be regarded an endophenotype for this disorder (Sitskoorn, Aleman, Ebisch, Ap-
pels, & Kahn, 2004; Snitz, Macdonald, & Carter, 2006). Studies investigating cogni-
tive functioning in bipolar patients and their relatives have provided no decisive 
answer to the question whether this is also the case for bipolar disorder. 
 
Is neurocognition a marker of the genetic vulnerability for bipolar disorder? 
It has long been assumed that cognitive deficits in bipolar disorder are limited to 
episodes of affective disturbance and that functioning would return to normal 
when patients are in remission. However, evidence is accumulating that neurocog-
nitive alterations persist in euthymic bipolar patients. In this thesis, this was further 
examined by means of a quantitative meta-analysis of 28 studies investigating cog-
nition in euthymic bipolar patients. The results showed that euthymic bipolar pa-
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tients were impaired with large effect sizes in the domains of executive function 
(working memory), mental speed and verbal memory (chapter 2), suggesting that 
cognitive impairment is a core deficit in bipolar disorder, similar to schizophrenia. 
However, for cognitive functioning to be a marker of the genetic liability for bipo-
lar disorder, cognitive alterations should also be detectable in healthy first-degree 
relatives of bipolar patients. A Meta-analysis of 14 studies on this topic indicated 
that the evidence for this was weak: effect sizes were small and bipolar relatives 
only differed significantly from controls in the domain of executive functioning 
(chapter 2). In a recent systematic review of the literature Balanza-Martinez and 
colleagues drew a similar conclusion by stating that ‘the evidence in support of the 
presence of cognitive deficits in first-degree relative of bipolar patients is quite 
sparse’ (Balanza-Martinez et al., 2008). However, the current finding of large defi-
cits in executive functioning in bipolar patients, and small, but intermediate cogni-
tive alterations in bipolar relatives, suggests that this cognitive domain may be a 
trait marker for the genetic liability for bipolar disorder. 
 
Different cognitive profiles in bipolar disorder and schizophrenia? 
Whereas cognitive dysfunction is a core deficit in bipolar disorder, similar to 
schizophrenia, the evidence for neurocognition as endophenotype in bipolar dis-
order is only weak. Given the suggested overlap between the two disorders, inves-
tigating shared and non-shared characteristics in the cognitive domain in schizo-
phrenia and bipolar disorder could provide further evidence regarding their mutual 
relationship and the differences in cognitive functioning as genetic vulnerability 
marker for these disorders.  
A previous review of studies comparing cognitive functioning in schizophrenia and 
bipolar disorder patients showed that deficits were qualitatively similar, but quanti-
tatively more marked in schizophrenia patients compared to those diagnosed with 
bipolar disorder (Krabbendam, Arts, van Os, & Aleman, 2005). In this thesis, cog-
nitive performance of schizophrenia patients and their healthy siblings from the 
GROUP study was compared to that of bipolar patients and their relatives from 
the BIPOLCOG study. Results showed that the two patient groups had a similar 
pattern of deficits but that dysfunctions were more severe in schizophrenia com-
pared to bipolar disorder, and that schizophrenia relatives performed worse than 
bipolar relatives on several domains (chapter 3). This indicates that not only are 
cognitive deficits in bipolar disorder less severe than those found in schizophrenia, 
the relatives of patients with bipolar disorder appear to have, if present at all, 
milder cognitive alterations compared to relatives of schizophrenia patients.  
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Extending the aetiological model of schizophrenia to bipolar disorder 
Within the domain of schizophrenia, a distinction is made between ‘poor outcome’ 
psychosis with developmental impairment and cognitive impairment on the one 
hand and ‘good outcome’ psychosis without developmental impairment and posi-
tive symptoms on the other (Robins & Guze, 1970). It has been hypothesised that 
different mechanisms are involved in the development of these heterogeneous 
psychopathological expressions of non-affective psychosis, and that they are asso-
ciated with different endophenotypic pathways (Myin-Germeys, Krabbendam, 
Jolles, Delespaul, & van Os, 2002).  
The negative syndrome, or poor outcome form of psychosis, is characterized 
mainly by negative symptoms, cognitive impairment, a chronic and deteriorating 
course, and poor response to neuroleptic medication. Due to the presence of a 
developmental impairment in this subtype structural brain abnormalities are more 
prevalent. Cognitive impairment is strongly associated with the negative symptoms 
of psychosis but not with the positive symptoms, and is often regarded an endo-
phenotypic marker of the negative syndrome. The positive syndrome, or good 
outcome form of schizophrenia, is characterized mainly by positive symptoms, has 
a more episodic course and good response to neuroleptic treatment, and is more 
reactive to environmental risk factors (Andreasen, 1985). Altered emotional reac-
tivity to stressors is hypothesized to be an endophenotypic marker of the good 
outcome subtype of psychosis (Myin-Germeys & van Os, 2007). The idea of two 
different pathways involved in the aetiology of non-affective psychosis is sup-
ported by evidence from studies showing no (or even reverse) associations be-
tween cognitive performance and stress-sensitivity (Morrens et al., 2007; Myin-
Germeys et al., 2002).                                                                                                                            
Given the suggested overlap between schizophrenia and bipolar disorder, it was 
investigated in this thesis whether the above-mentioned two-pathway model is also 
valid in bipolar disorder. Thus, if the distinction between psychosis with develop-
mental impairment and cognitive impairment on the one hand and psychosis with-
out developmental impairment and positive symptoms on the other applies to 
bipolar disorder, than bipolar patient-relative dyads with more expression of cogni-
tive impairment should have less expression of positive psychotic symptoms. The 
association between positive psychotic symptoms and cognitive performance in 
bipolar patient-relative pairs was examined in the BIPOLCOG study. The results 
showed that a history of psychotic symptoms in bipolar patients was suggestive of 
less likelihood of cognitive alterations in their relatives, and, that the presence of 
subclinical psychotic symptoms within the group of relatives predicted better cog-
nitive performance (chapter 4). The finding of similar psychosis-cognition associa-
tions in bipolar disorder as in schizophrenia, suggests that the hypothesised dis-
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tinction in schizophrenia between good outcome psychosis without developmental 
impairment (characterised by positive symptoms) and poor outcome psychosis 
with developmental impairment (characterised by cognitive symptoms) (Myin-
Germeys et al., 2002; Robins & Guze, 1970), might be extended to the continuum 
spanning affective and non-affective psychosis (Murray et al., 2004). These find-
ings provide further support for the idea of a partially overlapping vulnerability to 
bipolar disorder and schizophrenia. 
 
Is COMT a susceptibility gene in bipolar disorder? 
In an attempt to link endophenotypes to the underlying susceptibility genes, pre-
vious studies have reported associations between cognitive endophenotypes of 
non-affective psychoses and the catechol-O-methyltransferase (COMT) gene. 
COMT has an important function in dopamine transmission in the brain, in par-
ticular in the prefrontal cortex (Weinberger et al., 2001), and it has been suggested 
to be a putative susceptibility gene for both schizophrenia and bipolar disorder 
(Badner & Gershon, 2002). Although COMT has been frequently investigated in 
schizophrenia, less is known about its role in bipolar disorder. In this thesis we 
investigated COMT single markers and haplotypes for an association with bipolar 
risk and cognitive functioning. In the BIPOLCOG study, cognitive functioning 
was measured in patients with bipolar disorder and healthy controls. Participants’ 
DNA was obtained using saliva swabs. COMT SNP rs165599 was associated with 
bipolar risk and with cognitive performance, independent of bipolar diagnosis and 
rs165599 appeared to be a stronger predictor of bipolar disorder status than haplo-
types (chapter 5). Variation in rs165599 and rs737865 was associated with cogni-
tive performance, independent of bipolar diagnosis. (chapter 5). These findings 
suggests that rs165599 at the down stream position of the COMT gene might be 
involved in COMT regulation, leading to increased bipolar disorder susceptibility 
and cognitive impairments associated with this disorder. Exploratory results from 
the haplotype analyses suggest that this part of the COMT gene is involved in neu-
rocognitive functioning but larger studies are needed to discover possible super 
allelic effects. 
 
Neurocognitive functioning as predictor of outcome 
Neurocognition may not only represent an indicator of familial vulnerability in 
severe mental illness, it may also be a predictor of poor psychosocial functioning in 
patients. Cognitive impairment in schizophrenia has been shown to be associated 
with functional outcomes such as an inability to maintain employment, difficulty in 
social relationships and difficulty in independent living. In schizophrenia patients, 
neurocognitive deficits are a better predictor of functional outcomes than positive 
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symptoms are (Green, Kern, & Heaton, 2004), although the influence of negative 
symptoms may also be important (Milev, Ho, Arndt, & Andreasen, 2005).  
 
Cross-sectional associations 
There is rather consistent evidence for cross-sectional associations between neuro-
cognitive functioning and functional outcome in schizophrenia (Green, 1996), and 
cognitive speed is one of the cognitive domains consistently associated with out-
come (Ojeda, Pena, Sanchez, Elizagarate, & Ezcurra, 2008). In order to compare 
the relative influence of neurocognition and symptomatology on outcome, both 
measures should be assessed in the same group of patients. We investigated the 
influence of processing speed on different measures of outcome in a large sample 
of patients with chronic (both affective and non-affective) psychotic disorder in 
the UK700 study and showed that cognitive speed was associated with measures of 
social outcome and subjective outcome, but not with services use (chapter 7). Al-
though these associations remained significant after adjustment for symptomatol-
ogy scores, the associations between cognitive speed and outcome were not sub-
stantially stronger than with measures of symptomatology (chapter 7).  
In general, the results from this thesis are in agreement with previous studies re-
porting associations between neurocognitive functioning and outcome in psychotic 
disorders, but the current findings indicate that persisting symptoms should not be 
ruled out as an important predictor of functioning (Milev et al., 2005; Norman et 
al., 1999). 
 
Is there long term predictive value? 
Whereas cross-sectional associations between cognition and outcome are often 
reported, to investigate whether cognition has true long-term prognostic value, 
longitudinal studies are warranted. In a review, Green and colleagues concluded 
that there is considerable support for longitudinal associations between cognition 
and outcome (Green, Kern et al., 2004), but other studies suggested that longitudi-
nally less variance in outcome is explained than cross-sectional associations suggest 
(Milev et al., 2005; Stirling et al., 2003). Importantly, many longitudinal studies did 
not take into account the baseline level of functioning, which is necessary to exam-
ine whether cognition can predict a change in outcome. 
In the large sample of patients with chronic (both affective and non-affective) 
psychotic disorder from the longitudinal UK700 study, we investigated whether 
processing speed predicted changes in outcome. Although processing speed and 
outcome measures were associated when measured concurrently, no consistent 
prospective associations were found between speed and outcome measures after 
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controlling for baseline functioning (chapter 7). This suggests that the true longi-
tudinal predictive value of processing speed on outcome appears to be limited.  
 
More than neutral indicators of risk? 
If associations between cognition and disability are limited to patient groups, a 
causally contributing mechanism of cognitive impairment to the pathway from at-
risk state to clinical disorder is unlikely. However, if the association between cogni-
tive alterations and expression of disability can be demonstrated in at-risk groups, 
cognitive alterations may represent more than neutral indicators of genetic risk and 
also contribute to social disability outside the realm of clinical disorder. We there-
fore investigated associations between cognition and functional outcome in groups 
at risk for non-affective psychosis in the CoP study, and showed that alterations in 
cognitive speed were significantly associated with variation in occupational func-
tioning in first-degree relatives of patients and in a psychometrically defined risk 
group (chapter 6). This suggests that the association with social disability exists in 
the context of a vulnerability to non-affective psychosis and that cognitive endo-
phenotypes are more than just neutral indicators of genetic risk.  
 
Differential associations in schizophrenia and bipolar disorder 
Whereas the influence of neurocognitive functioning on outcome is frequently 
studied in non-affective psychotic disorders like schizophrenia, only a few studies 
have been conducted in bipolar disorder due to the long held assumption that 
bipolar patients will regain full syndromal and functional recovery in between 
mood episodes. We now know, however, that 60% of bipolar patients continue to 
exhibit problems in work or social functioning during remission (MacQueen, Ha-
jek, & Alda, 2005). By exploring associations between symptomatology, cognitive 
functioning and psychosocial functioning in patients from both the GROUP and 
the BIPOLCOG study, we were able to investigate to what degree neurocognitive 
functioning represents a predictor of the poor functioning that is characteristic of 
both schizophrenia and bipolar disorder (chapter 3). It was found that in patients 
with schizophrenia, neurocognitive test performance on tests for verbal memory, 
sustained and divided attention were all significantly associated with a global meas-
ure of psychosocial functioning. After adjustment for current symptoms, associa-
tions with verbal memory and reaction time on a sustained attention test remained 
significant, but negative symptoms were equally strong associated with psychoso-
cial outcome (chapter 3). In bipolar disorder patients, only reaction times on a 
selective attention test were associated with psychosocial functioning, and depres-
sive symptoms were more strongly related to outcome (chapter 3).  
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This and preliminary evidence from other studies (Laes & Sponheim, 2006; Marti-
nez-Aran et al., 2002) suggests that cognition-outcome associations may be strong-
er in schizophrenia than in bipolar disorder and emphasize the importance of resi-
dual subsyndromal depressive symptoms in relation to functioning in bipolar dis-
order. 
 
Explaining similarities and differences in neurocognitive performance 
The findings from this thesis suggest that although the presence of multiple cogni-
tive deficits is shared between schizophrenia and bipolar disorder, schizophrenia is 
associated with more severe and more generalized deficits, which seem to reflect 
the genetic vulnerability as well as impact on daily life to a greater extent than in 
bipolar disorder. Therefore, any theory explaining the overlap between schizo-
phrenia and bipolar disorder should be able to deal with the finding of a) differ-
ences in severity of cognitive impairment between patients, b) different cognitive 
profiles in individuals at genetic risk for the two disorders, and c) differential influ-
ence of cognition on functional outcome.  
In an attempt to explain similarities and differences between bipolar disorder and 
schizophrenia, Murray and colleagues (Murray et al., 2004) suggested that shared 
susceptibility genes predispose to psychosis in general. If due to the (inter)action 
between other genes and/or early environmental insults, additional neurodeve-
lopmental impairment is present, schizophrenia will develop. In the absence of 
such developmental impairments an affective psychosis phenotype like bipolar 
disorder will emerge. According to this model bipolar disorder and schizophrenia 
are aetiologically distinct in the presence of a developmental impairment in the 
former but not in the latter (see picture 1).  
This suggests that the cognitive dysfunctions in schizophrenia and bipolar disorder 
are partly due to different origins. The additional presence of neurodevelopmental 
impairment in schizophrenia might cause the more severe neuropsychological 
impairment observed in schizophrenia patients, that, due to its genetic liability, is 
also observable in their relatives.  
Several findings are in line with the suggestion that a neurodevelopmental impair-
ment is involved in the aetiology of schizophrenia but less clearly in bipolar dis-
order: The presence of  premorbid cognitive impairments in pre-schizophrenia 
children but not in pre-bipolar subjects (Cannon et al., 2002), findings of lower 
premorbid IQ estimation in schizophrenia as compared to bipolar disorder (Gil-
varry et al., 2000) and other developmental delays as well as pregnancy and birth 
complications that are found in schizophrenia (Verdoux et al., 1997) but not in 
bipolar disorder (Scott, McNeill, Cavanagh, Cannon, & Murray, 2006) are in sup-
port of this idea. 
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SHARED GENES
developmental impairment developmental impairment
negative/deficit symptoms
cognitive impairment
affective psychosis
SCHIZOPHRENIA BIPOLAR DISORDERPsychosis
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Picture 1. Aetiological model for schizophrenia and bipolar disorder (adapted from Murray et al. 
2004). 
 
The cognitive deficits observed in bipolar disorder on the other hand, are more 
likely to be mainly the consequence of the disease process and its treatment. In 
bipolar patients a greater number of episodes, greater length of illness and higher 
number of hospitalizations, is associated with more severe neurocognitive dysfunc-
tion (Robinson & Ferrier, 2006) and cognitive deficits are more strongly associated 
with clinical symptoms and their fluctuations than they are in patients with schi-
zophrenia (van Gorp, Altshuler, Theberge, Wilkins, & Dixon, 1998). Studies show-
ing that the presence of neurocognitive alterations is more marked in schizophre-
nia relatives than in bipolar relatives add further credence to the idea that the cog-
nitive dysfunctions may be partly due to different origins.  
Recently, Goodwin and colleagues (Goodwin, Martinez-Aran, Glahn, & Vieta, 
2008) reviewed the literature on the causes of cognitive impairment in bipolar dis-
order and concluded that the evidence was more in favor of a neurodegenerative 
model than of a neurodevelopmental model. Thus, cognitive deficits in bipolar 
patients very likely reflect the neuropsychological consequences of the disorder, 
leading to disrupted brain processing and resulting functioning.  
 
Subgroups 
Most of the cognitive impairment in bipolar patients appears to be due to the on-
going illness process and its treatment, but the finding of similar psychosis-
cognition associations in bipolar disorder as in schizophrenia suggests that some 
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cognitive variation may also be due to genetic effects that are shared between both 
disorders and may be measurable in the relatives of patients with bipolar disorder.  
There is evidence that the severity of cognitive impairment is heterogeneous in 
patients with bipolar disorder (Martino et al., 2008) and there may be subgroups 
within the bipolar population that are distinguished by their cognitive perform-
ance. It has been suggested that some bipolar patients show performance deficits 
similar to schizophrenia patients and have relatives who also show clear cognitive 
alterations (Balanza-Martinez et al., 2005). Altshuler and colleagues found a bi-
modal pattern of performance in bipolar patients on a test of executive function-
ing, the cognitive domain for which the strongest evidence as endophenotypic 
marker exists (Altshuler et al., 2004). Half of the bipolar patients performed similar 
to controls whereas the other half was comparable to schizophrenia patients, sug-
gesting that the dysfunctions that are found in bipolar disorder patients might be 
due to a small group with more severe impairment.  
What defines these subgroups in bipolar disorder remains to be elucidated, but in 
the context of a continuum model spanning affective and non-affective psychosis 
it can be hypothesized that bipolar patients with worse cognitive performance and 
affected relatives are more towards the non-affective side of the psychosis spec-
trum regarding symptomatology and aetiology. For this subgroup cognitive deficits 
may indeed be a marker of the genetic vulnerability for the disorder. Based on the 
findings in schizophrenia that social disability exists in the context of disorder 
vulnerability (chapter 6), it can further be hypothesized that in these patients cogni-
tive deficits may be associated with functional outcome to a degree comparable to 
schizophrenia. Previous findings that bipolar patients with higher levels of cogni-
tive impairment had lower psychosocial functioning and premorbid IQ, and a 
higher history of obstetric complications (Martino et al., 2008), are in line with this 
suggestion.  
 
Implications for future classification systems 
The validity of the Kraepelinian dichotomy is increasingly being challenged, as 
there appears to be only sparse evidence for a valid contrast between schizophre-
nia and bipolar disorder. Studies showing quantitative instead of qualitative differ-
ences in neurocognitive functioning in bipolar disorder and schizophrenia (chapter 
3), similar psychosis-cognition associations in bipolar disorder as are found in 
schizophrenia (chapter 4), and findings of similar relationships between neurocog-
nition and psychopathology across diagnostic categories (Smith, Barch, & Cser-
nansky, 2008) suggest that there is variation in cognition across traditional diagnos-
tic boundaries and support the idea that bipolar disorder may be on a continuum 
with schizophrenia. It has been proposed that currently, the most useful approach 
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to classification of severe mental illness is the combined use of categorical and 
dimensional representations of psychopathology (Allardyce, Gaebel, Zielasek, & 
van Os, 2007; van Os, 2008), in which individuals can be classified according to 
individual scores on psychopathology dimensions rating positive, negative, disor-
ganization, cognitive, depressive and manic symptoms.  
The findings from this thesis suggest that any dimensional representation of psy-
chopathology should include variation in neurocognitive functioning in addition to 
other symptom dimensions, given the importance of neurocognition in terms of 
the biology, functioning and treatment of severe mental illness. It is currently being 
argued that cognitive impairment should be included in the diagnostic criteria for 
schizophrenia, since this would increase clinical awareness of cognitive impairment 
and could increase the ‘point of rarity’ with affective psychoses (Keefe, 2008). 
Investigation of the current level of neurocognitive functioning of patients, how-
ever, does not lead to significant diagnostic differences between bipolar and schi-
zophrenia patients as there exists quantitative rather than qualitative variation in 
neurocognitive functioning, providing no specificity in diagnostic terms. However, 
current and previous findings suggest that there are valid developmental neuro-
cognitive contrasts between both disorders than can be used in future classification 
systems (van Os, 2008). These qualitative differences may contribute to diagnostic 
specificity when methods to properly measure and discriminate premorbid and 
current level of cognitive functioning can be developed.  
 
Clinical implications 
The present findings have several clinical implications.  
First, our results indicate that cognitive deficits are not only a core feature of schi-
zophrenia but can also be present in euthymic bipolar patients. Informing patients 
about the nature of the cognitive impairment in bipolar disorder is necessary since 
patients often attribute their cognitive problems to medication use, which in turn 
may lead to medication non-adherence. However, relapses resulting from medica-
tion non-adherence appear to have a more adverse impact on cognitive function-
ing than the use of medication does (Goodwin et al., 2008). 
Second, the finding that cognitive deficits are of functional significance in both 
schizophrenia and bipolar disorder implicates that this domain requires clinical 
attention. Cognitive enhancement strategies are likely to be beneficial in both dis-
orders. In schizophrenia this has been recognized, given the development of the 
large initiative on the Measurement and Treatment Research to Improve Cognition 
in Schizophrenia (MATRICS) (Green, Nuechterlein et al., 2004). Knowledge of 
cognitive enhancement strategies in bipolar disorder, on the other hand, is scarce 
due to assumption that cognitive functioning in bipolar disorder would return to 
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normal during remission. In schizophrenia, moderate improvements of neurocog-
nitive functioning have been reported after treatment with second generation anti-
psychotic medication (Harvey & Keefe, 2001; Keefe et al., 2004) but the transla-
tion of its effects to real life functioning appears to be limited. Not much is known 
about the potential cognitive benefits of pharmacological treatment in bipolar dis-
order, but exploratory evidence shows advantageous effects of treatment with 
lamotrigine (Goldberg & Young, 2008).  
Behavioral interventions, like cognitive remediation therapies for improving cogni-
tive functioning and subsequent psychosocial functioning have been developed. In 
schizophrenia, moderate improvements in cognitive performance and a small but 
significant beneficial effect on psychosocial functioning were shown when remedi-
ation therapy was combined with psychiatric rehabilitation (McGurk, Twamley, 
Sitzer, McHugo, & Mueser, 2007). In bipolar disorder, psychosocial interventions 
and/or cognitive remediation strategies have not yet been investigated, but it 
seems a reasonable assumption that these interventions may also contribute to 
cognitive improvement in bipolar disorder. 
Third, this thesis showed that in both schizophrenia and bipolar disorder the pres-
ence of subsyndromal symptomatology is an important predictor of functional 
outcome and thus should not be neglected in treatment. Particularly in bipolar 
disorder, low-level depressive symptoms should be carefully monitored and 
treated, given their continuing influence on clinical course, impaired cognitive 
functioning, and difficulties in daily life functioning. 
 
Directions for future research 
The findings in this thesis suggest that in patients more towards the affective side 
of the psychosis continuum, cognitive impairment is more likely to be the conse-
quence of the disease process and its treatment. What factors contribute to cogni-
tive dysfunction in these patients remains to be investigated, but it is likely that it 
involves the combined action of iatrogenic and neurotoxic influences. Given that 
true euthymic periods may be more uncommon in bipolar disorder than was pre-
viously thought (Harvey, 2008), the influence of (minor) affective symptoms on 
cognitive performance should also be taken into account (Clark, Iversen, & 
Goodwin, 2002; Ferrier, Stanton, Kelly, & Scott, 1999). Longitudinal studies can 
provide a prospective framework in which the various determinants of cognitive 
performance in bipolar disorder can be further studied. 
There is some evidence that, at least in subgroups of bipolar patients with more 
severe cognitive deficits, executive functioning is associated with the genetic vulne-
rability for bipolar disorder. It should be investigated what characterizes these 
subgroups, but it can be hypothesized that these bipolar patients are phenotypically 
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and aetiologically more towards the non-affective side of the psychosis spectrum; 
thus, have a larger degree of neurodevelopmental impairment that can be detected 
through the presence of more premorbid cognitive deviations and a stronger pre-
dictive role of neurocognitive functioning on functional outcome. Based on this, it 
seems more informative to investigate symptom dimensions instead of diagnostic 
constructs. In addition to this, future research is needed to separate cognitive dys-
functions that are related to the underlying vulnerability for severe mental illness 
from those that are more strongly linked to the disease processes.  
 
Now there is evidence that cognitive deficits are present in at least part of the bi-
polar disorder patients, the predictive value of cognitive impairment on functional 
outcome in bipolar disorder should be more thoroughly investigated in longitudi-
nal studies. In addition to this, effort should be undertaken to treat these cognitive 
deficits and the possible negative influence on functioning. Treatment intervention 
studies, aimed at investigating the influence of cognitive remediation in bipolar 
disorder and its outcome, may be a useful step in improving the negative conse-
quences of cognitive dysfunction on disease outcome.  
Future studies should aim at identifying (shared) endophenotypes for the symptom 
dimensions of schizophrenia and bipolar disorder, and attempt to link these mark-
ers to underlying susceptibility genes. The current findings suggest the involvement 
of the COMT gene in bipolar disorder, and exploratory results from haplotype 
analyses suggest that a whole part of the COMT gene is involved in cognitive per-
formance. However, larger study samples are needed to investigate possible haplo-
typic effects. In addition to this, environmental influences should be taken into 
account to investigate interactions between genes and environment in the aetiology 
of affective and non-affective psychoses.  
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SUMMARY 
 
The presence of neurocognitive impairment is a core feature of schizophrenia, and 
it has been suggested that it may similarly be a trait characteristic in patients diag-
nosed with bipolar disorder. In schizophrenia, cognitive impairment is assumed to 
be a marker of the genetic vulnerability, or endophenotype, for the disorder, but it 
also appears to have predictive value regarding the functional outcome of schizo-
phrenia patients. Given the suggested overlap between schizophrenia and bipolar 
disorder this thesis, Exploring neurocognition across the psychosis continuum, evaluates the 
aetiological and predictive value of cognitive impairment in both schizophrenia 
and bipolar disorder and discusses their similarities and differences in the context 
of a continuum view of severe mental illness.  
 
Chapter 1 of this thesis discusses the phenomenology and aetiology of both bipo-
lar disorder and schizophrenia. It gives an overview of diverse findings of overlap 
between the two illnesses and describes how these findings are increasingly chal-
lenging the traditional Kraepelinian dichotomy in which the two disorders are 
strictly separated. Neurocognitive impairment is presented as a core feature of 
both schizophrenia and bipolar disorder and the evidence for neurocognitive func-
tioning as a marker of genetic vulnerability for both disorders is reviewed. It is 
argued that a direct comparison of both patient groups and their relatives is neces-
sary to gain more information on the role of neurocognitive functioning as endo-
phenotype in both disorders. Findings that cognitive impairments are a major pre-
dictor of functional outcome in schizophrenia are discussed, and it is suggested 
that to investigate true long term predictive value, longitudinal studies, controlling 
for baseline level of functioning, are necessary. It is further argued that studying 
similar cognition – outcome associations in bipolar disorder could give us more 
clues as to the nature of the overlap between bipolar disorder and schizophrenia  
 
Chapter 2 evaluates the evidence for neurocognitive functioning as an endophe-
notypic marker in bipolar disorder in a meta-analysis of studies investigating neu-
rocognitive functioning in euthymic bipolar disorder patients and their first-degree 
relatives. It was shown that bipolar patients have cognitive impairments, particu-
larly in the domains of executive functioning, verbal memory and mental speed, 
for which large effect sizes were found. Relatives of bipolar disorder patients dif-
fered from controls on some cognitive measures but effect sizes were rather small 
and significant only in the domain of executive control. The finding of large defi-
cits in executive functioning in bipolar patients, and small, but intermediate cogni-
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tive alterations in bipolar relatives, suggests that this cognitive domain may be a 
trait marker for the genetic liability for bipolar disorder. 
  
In Chapter 3 the possible role of neurocognitive functioning as a marker of ge-
netic vulnerability for both schizophrenia and bipolar disorder is investigated. In a 
direct comparison between both patient groups and between their relatives, the 
shared and non-shared cognitive characteristics were evaluated. Results showed 
that schizophrenia and bipolar patients were impaired in overlapping cognitive 
domains but that the impairments were more severe in patients with schizophre-
nia, and that schizophrenia relatives were cognitively more impaired than bipolar 
relatives on tasks of verbal memory and reaction time components of selective 
attention. In addition to this, associations between symptomatology, cognitive 
functioning and psychosocial outcome were explored in both schizophrenia and 
bipolar disorder patients. It was shown that in schizophrenia patients, performance 
on most neurocognitive tests was associated with psychosocial functioning, 
whereas in bipolar patients this was true for reaction time components of selective 
attention only. In schizophrenia, symptoms were associated with psychosocial 
functioning to a similar degree as neurocognition was, whereas in the bipolar sam-
ple depressive symptoms were more strongly associated with psychosocial func-
tioning. The study showed that although the presence of multiple cognitive deficits 
is shared between the two groups, the severity of cognitive deficits and its conse-
quences appear to partly differ between schizophrenia and bipolar disorder. 
 
Chapter 4 describes a study investigating the association between psychotic symp-
toms and neurocognitive functioning in bipolar disorder. The study aimed at ex-
amining whether the distinction that is made in schizophrenia, between psychosis 
with developmental impairment and cognitive impairment on the one hand and 
psychosis without developmental impairment and positive symptoms on the other, 
can be extended to bipolar disorder. Neurocognitive functioning and psychopa-
thology were assessed in patients with bipolar disorder, their first-degree relatives 
and healthy controls. Bipolar patients showed impaired cognitive performance on 
multiple cognitive domains, whereas performance of their first-degree relatives was 
comparable to that of controls on all but one domain, suggesting that the evidence 
for cognitive alterations as intermediary phenotype associated with genetic risk for 
bipolar disorder is not strong. The data did show, however, that a history of psy-
chotic symptoms in bipolar patients was suggestive of less likelihood of cognitive 
alterations in their relatives, and that subclinical psychotic symptoms in relatives 
predicted a better cognitive performance. This finding of similar psychosis-
cognition associations as implied by the two pathways to schizophrenia suggests 
Thesis_Jabben_v3.pdf   159 30-6-2009   8:56:35
SUMMARY 
 
Page | 160 
 
that this aetiological model can be extended to the continuum spanning affective 
and non-affective psychosis. This is in line with the idea of a partially overlapping 
vulnerability to bipolar disorder and schizophrenia. 
 
Chapter 5 evaluates several single SNPs and haplotypes along the COMT gene for 
an association with bipolar disorder and cognitive functioning. Previous studies 
have reported associations between cognitive endophenotypes of non-affective 
psychoses and the catechol-O-methyltransferase (COMT) gene, but studies in 
bipolar disorder are scarce. Cognitive functioning was assessed in patients with 
bipolar disorder and healthy controls and from both groups DNA samples were 
obtained. Single marker rs165599 was associated with bipolar liability, whereas 
variation in rs165599 and rs737865 was associated with cognitive performance, 
independent of bipolar diagnosis. Haplotypes were not associated with bipolar risk, 
and rs165599 was a stronger predictor of bipolar disorder status than haplotypes. 
These findings suggests that variation in marker rs165599 at the down stream posi-
tion of the COMT gene might lead to increased bipolar disorder susceptibility and 
cognitive impairments associated with this disorder.  
 
Chapter 6 describes whether cognitive alterations associated with liability to psy-
chosis are associated with expression of psychopathology and functional outcome 
in groups at different levels of risk for psychotic illness. Cognitive functioning, 
psychopathology and functional outcome were investigated in patients with non-
affective psychotic disorders, a group of non-psychotic first-degree relatives and 
subjects at psychometrically defined risk for psychosis. Results showed that there 
was a dose-response relationship between level of cognitive impairment and in-
creasing risk for psychosis, suggesting that cognition can be construed as a vulner-
ability marker across a continuum of risk. In both at risk groups, cognitive speed 
was associated with functional outcome, indicating that the association with social 
disability exists in the context of a vulnerability to psychosis and that cognitive 
endophenotypes are not just neutral indicators of risk. Thus, the study suggests 
that some cognitive alterations associated with transmission of psychosis may have 
a direct impact on the pathway from risk to psychopathology and alterations in 
functioning. 
 
Chapter 7 evaluates the predictive value of cognitive processing speed over and 
above the contribution of symptoms in the prediction of social outcome in a com-
bined group of patients with affective and non-affective psychosis. It explores 
whether cognition has true long-term prognostic value in relation to changes of 
outcome. Cross-sectionally, processing speed was weakly associated with outcome 
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but the effects differed depending on the outcome measures that were used. Lon-
gitudinal prognostic associations were weak or even absent after adjustment for the 
baseline level of outcome. Both cross-sectionally and longitudinally, the associa-
tions between speed and outcome were not substantially stronger than associations 
with psychopathology. The finding of weak cross-sectional associations in the 
absence of specific and unconfounded longitudinal associations suggests that proc-
essing speed is an independent dimension of disease severity rather than a causal 
factor impacting on social outcome in psychotic disorder. 
 
Chapter 8 summarizes the results of the studies presented in this thesis. It at-
tempts to explain the similarities and differences in aetiological and predictive 
value of cognitive functioning in schizophrenia and in bipolar disorder within a 
continuum view of severe mental illness. It is argued that the cognitive dysfunc-
tions in schizophrenia and bipolar disorder stem from partly different origins. Fi-
nally, clinical implications and directions for further research are given.
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SAMENVATTING 
 
In de psychiatrisch diagnostische handboeken wordt een duidelijk categorisch on-
derscheid gemaakt tussen schizofrenie en de bipolaire stoornis. De twee stoornis-
sen vertonen echter veel overeenkomsten in symptomatologie en in de praktijk 
blijken patiënten vaak niet eenvoudig in een van beide categorieën onder te bren-
gen. Behalve in fenomenologie vertonen de bipolaire stoornis en schizofrenie dui-
delijke overeenkomsten in epidemiologische kenmerken, behandeling, en erfelijk-
heid. Ook cognitieve stoornissen lijken een belangrijke rol te spelen bij beide ziek-
tebeelden.  
 
Cognitieve stoornissen vormen een kernsymptoom van schizofrenie en er is steeds 
meer bewijs dat ook euthyme bipolaire patiënten cognitieve disfuncties vertonen. 
Cognitief functioneren wordt beschouwd als indicator van de genetische kwets-
baarheid voor schizofrenie en het blijkt het een goede voorspeller te zijn van het 
dagelijks functioneren van patiënten met deze stoornis. In dit proefschrift, Explo-
ring neurocognition across the psychosis continuum, wordt in verschillende studies de rol 
van cognitie als endofenotype en voorspeller van functioneren bij schizofrenie en 
de bipolaire stoornis onderzocht en de bevindingen worden besproken binnen de 
continuüm opvatting van ‘severe mental illness’.  
 
In hoofdstuk 1 van dit proefschrift worden de fenomenologie en etiologie van de 
bipolaire stoornis en schizofrenie beschreven. Er wordt een overzicht gegeven van 
overeenkomsten tussen de twee ziektebeelden en besproken hoe deze bevindingen 
de dichotomie van twee strikt gescheiden ziektebeelden in twijfel trekken. Neuro-
cognitieve stoornissen worden geïntroduceerd als symptoom van zowel schizofre-
nie als de bipolaire stoornis, en het bewijs dat neurocognitie kan worden be-
schouwd als indicator van de genetische kwetsbaarheid voor zowel schizofrenie als 
voor de bipolaire stoornis wordt besproken. Er wordt geopperd dat een directe 
vergelijking tussen de twee patiëntgroepen en hun familieleden nodig is om meer 
informatie te krijgen over de rol van neurocognitie als endofenotype bij beide 
stoornissen. Ook komt aan bod dat cognitieve stoornissen een belangrijke voor-
speller zijn van het dagelijks functioneren van patiënten met schizofrenie, en er 
wordt beargumenteerd dat longitudinale studies nodig zijn om de voorspellende 
waarde van cognitie op de lange termijn te onderzoeken. Tevens wordt gesugge-
reerd dat het bestuderen van vergelijkbare cognitie-outcome associaties bij de bipo-
laire stoornis ons meer duidelijkheid kan geven over de mogelijke overlap tussen 
de bipolaire stoornis en schizofrenie. 
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In hoofdstuk 2 wordt het bewijs voor neurocognitie als endofenotypische marker 
voor de bipolaire stoornis onderzocht. Een meta-analyse van studies naar cognitief 
functioneren bij euthyme bipolaire patiënten en hun eerstegraads familieleden 
toont dat patiënten met een bipolaire stoornis cognitieve disfuncties vertonen in 
executief functioneren, verbaal geheugen en informatieverwerkingssnelheid. Eer-
stegraads familieleden presteerden slechter dan controle proefpersonen op sommi-
ge cognitieve domeinen, maar de effectgrootten waren klein en bovendien alleen 
significant voor een maat van executieve controle. Deze meta-analyse laat zien dat 
patiënten met een bipolaire stoornis cognitieve afwijkingen vertonen in executief 
functioneren en dat eerstegraads familieleden van patiënten kleine maar tussenlig-
gende afwijkingen vertonen in ditzelfde domein. Dit suggereert dat sommige ma-
ten van executief functioneren een indicator kunnen zijn van de genetische kwets-
baarheid voor de bipolaire stoornis. 
 
Hoofdstuk 3 onderzoekt de rol van neurocognitie als indicator van de genetische 
kwetsbaarheid voor zowel schizofrenie als de bipolaire stoornis. In een directe 
vergelijking tussen de twee patiëntgroepen en hun eerstegraads familieleden wer-
den de gedeelde en unieke cognitieve kenmerken van de twee stoornissen onder-
zocht. Tevens werd in beide patiëntgroepen de samenhang tussen symptomatolo-
gie, cognitief functioneren en psychosociaal functioneren bekeken. De resultaten 
toonden aan dat patiënten met een bipolaire stoornis en patiënten met schizofrenie 
cognitieve stoornissen vertonen in overeenkomstige cognitieve domeinen, maar 
dat deze stoornissen ernstiger zijn bij patiënten met schizofrenie. Tevens werd 
aangetoond dat familieleden van patiënten met schizofrenie duidelijkere cognitieve 
afwijkingen vertonen dan de familieleden van bipolaire patiënten, en dat ze signifi-
cant slechter presteerden op taken naar verbaal geheugen en snelheid van selectie-
ve aandacht.  
Bij patiënten met schizofrenie bestond er een duidelijke samenhang tussen betere 
cognitieve testprestaties en een beter psychosociaal functioneren, terwijl bij bipo-
laire patiënten alleen een maat van selectieve aandacht geassocieerd was met func-
tioneren. Bij patiënten met schizofrenie was symptomatologie even sterk geassoci-
eerd met psychosociaal functioneren als cognitie, terwijl bij de bipolaire patiënten 
depressieve symptomatologie het sterkst met functioneren samenhing. Samenvat-
tend, hoewel cognitieve stoornissen bij zowel schizofrenie als de bipolaire stoornis 
voorkomen, lijken de ernst en de gevolgen ervan gedeeltelijk te verschillen tussen 
de twee ziektebeelden.  
 
In eerder onderzoek werden associaties gevonden tussen cognitieve endofenoty-
pen van schizofrenie en het COMT gen. COMT is echter nog nauwelijks onder-
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zocht in relatie tot cognitief functioneren bij de bipolaire stoornis. Gegeven de 
mogelijke overlap tussen schizofrenie en de bipolaire stoornis werden in hoofd-
stuk 4 verschillende functionele polymorfismen en haplotypes van het catechol-O-
methyltransferase (COMT) gen onderzocht in relatie tot de bipolaire stoornis en 
cognitief functioneren. Neurocognitie werd gemeten bij patiënten met een bipolai-
re stoornis en gezonde controleproefpersonen. Genetisch materiaal werd verza-
meld met behulp van speekselstalen. De resultaten van het onderzoek toonden dat 
het risico allel van COMT polymorfisme rs165599 geassocieerd was met een dia-
gnose bipolaire stoornis en dat variatie in markers rs165599 en rs737865 samen-
hing met cognitief functioneren, onafhankelijk van diagnose. Haplotypes waren 
niet geassocieerd met een kwetsbaarheid voor de bipolaire stoornis en marker 
rs165599 was een sterkere voorspeller van bipolaire status dan de verschillende 
haplotypes. Dit suggereert dat variatie in COMT polymorfisme rs165599 kan lei-
den tot een toename in kwetsbaarheid voor de bipolaire stoornis en een grotere 
kans op cognitieve afwijkigen. 
 
In Hoofdstuk 5 wordt de samenhang tussen psychotische symptomen en neuro-
cognitief functioneren bij de bipolaire stoornis onderzocht. Een consistente bevin-
ding bij schizofrenie is dat er geen associaties bestaan tussen neurocognitieve 
stoornissen en de positieve symptomen van psychose. In dit hoofdstuk werd on-
derzocht of dit onderscheid in twee onafhankelijke symptoom dimensies ook bij 
de bipolaire stoornis kunnen worden gevonden. Hiertoe werden neurocognitie en 
psychopathologie gemeten bij patiënten met een bipolaire stoornis, hun eerste-
graads familieleden en gezonde controleproefpersonen. De resultaten van het on-
derzoek toonden aan dat bipolaire patiënten cognitieve stoornissen vertoonden op 
verschillende cognitieve domeinen, terwijl de prestatie van hun familieleden verge-
lijkbaar was met die van de controlegroep. Dit suggereert dat het bewijs voor neu-
rocognitie als endofenotype, geassocieerd met genetisch risico voor de bipolaire 
stoornis, niet sterk is. Wel werd gevonden dat familieleden van bipolaire patiënten 
met een psychose in de voorgeschiedenis een betere cognitieve prestatie hadden en 
dat er in de groep familieleden een associatie bestond tussen de aanwezigheid van 
subklinische psychotische symptomen en een beter cognitief functioneren. Bij de 
bipolaire stoornis werden dus vergelijkbare psychose - cognitie associaties gevon-
den als bij schizofrenie. Dit ondersteunt het idee van een overlappende kwetsbaar-
heid voor deze twee stoornissen.  
 
Hoofdstuk 6 beschrijft een studie waarin werd onderzocht of cognitieve afwijkin-
gen in groepen met een toenemend risico op psychose geassocieerd zijn met de 
expressie van psychopathologie en met dagelijks functioneren. Neurocognitie, 
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psychopathologie en functional outcome werden gemeten in patiënten met non-
affectieve psychotische stoornissen, een groep niet-psychotische eerstegraads fami-
lieleden en proefpersonen met een psychometrische psychose kwetsbaarheid. Er 
werd een dosisrespons relatie gevonden tussen toenemend risico op psychose en 
het niveau van cognitief functioneren, wat suggereert dat cognitie beschouwd kan 
worden als een indicator van psychose kwetsbaarheid langs het gehele psychose 
continuüm. Bovendien werd er in de twee hoogrisico groepen een significante 
associatie gevonden tussen cognitief functioneren en functional outcome. Dit duidt er 
op dat cognitieve endofenotypen niet slechts neutrale indicatoren van genetisch 
risico zijn, maar een directe invloed lijken te hebben op het ontstaan van psycho-
pathologie en een veranderd functioneren.  
 
Hoofdstuk 7 beschrijft een longitudinaal onderzoek waarbij in een groep patiën-
ten met affectieve en non-affectieve psychose de voorspellende waarde van cogni-
tie werd vergeleken met die van symptomen in relatie tot ‘functional outcome’. Ook 
werd onderzocht of cognitie voorspellende waarde heeft op de lange termijn door 
de samenhang met veranderingen in ‘functional outcome’ te bekijken. Cross-sectioneel 
werd er een zwakke associatie gevonden tussen cognitieve informatieverwerkings-
snelheid en ‘functional outcome’, maar de longitudinaal voorspellende associaties wa-
ren zwak en zelfs helemaal afwezig nadat gecontroleerd was voor het basisniveau 
van functioneren. Zowel cross-sectioneel als longitudinaal was de samenhang tus-
sen cognitie en ‘functional outcome’ niet sterker dan de associaties met psychopatho-
logie. De zwakke cross-sectionele associaties gecombineerd met de afwezigheid 
van specifieke longitudinale associaties suggereren dat cognitieve informatiever-
werkingssnelheid een onafhankelijke dimensie is van ziekte-ernst in plaats van een 
causale invloed op de ‘functional outcome’ van patiënten met psychotische stoornis-
sen. 
 
In hoofdstuk 8 worden de resultaten van de studies in dit proefschrift samengevat. 
Er wordt getracht de overeenkomsten en verschillen in etiologische en voorspel-
lende waarde van cognitief functioneren bij schizofrenie en de bipolaire stoornis te 
verklaren binnen het continuüm idee van ‘severe mental illness’. Er wordt beargumen-
teerd dat de cognitieve stoornissen bij schizofrenie en de bipolaire stoornis een 
gedeeltelijk andere oorzaak lijken te hebben. Tenslotte worden klinische implicaties 
en aanbevelingen voor verder onderzoek besproken.  
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me soms stressvolle momenten achter de computer opgeleverd maar bovenal erg 
gemotiveerd om onderzoek te willen doen. Lydia Krabbendam, mijn copromotor, 
Lydia, dankjewel voor je kundigheid maar vooral voor je vertrouwen en eerlijkheid 
wanneer dat voor mij belangrijk was. Ik vind het super leuk dat ik in Amsterdam 
bij je om de hoek kom werken. Baer Arts, mijn onderzoekspartner van de 
BIPOLCOG studie. Dankjewel voor de fijne samenwerking. Je nuchtere kijk op de 
wetenschap heeft onderzoek doen luchtigheid gegeven. Dank voor de mogelijkhe-
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veel van geleerd. Paul, Nanda en de VMDB wil ik graag bedanken voor de inzet bij 
de werving van deelnemers voor de studie en de mogelijkheid ons werk te presen-
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aan Zorggroep, Riagg Maastricht en het azM, in het bijzonder Frenk Peeters, Da-
nielle Ummels en Caroline van den Bossche, wil ik bedanken voor hun bijdrage 
aan de deelnemerswerving. Dames van de poli Psychiatrie in het azM; Sje, Marion, 
Marie Louise en Leni, zonder jullie zou er organisatorisch veel zijn misgelopen. 
Mijn dank voor de vriendelijke ontvangst van de onderzoeksdeelnemers op de poli.  
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inzet bij het testen van deelnemers voor de studie. Truda, Philippe, Inge en Frida, 
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bedankt dat je zo snel kwam rennen door de gang als mijn laptop niet deed wat ik 
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dacht dat hij zou moeten doen. Trees, Ine, Jolanda, Leni en Wendy, fijn dat ik altijd 
binnen kon lopen met praktische vragen. Misschien maar goed dat ik dat snoep-
potje pas het laatste half jaar heb ontdekt.  
 
Mijn fijne collega’s bij SP, dankzij jullie heeft mijn AiO-tijd de juiste verhouding 
tussen hard werken en ontspanning gekend: dank jullie wel voor de fantastische 
tijd! Patrick, mijn kamergenoot, dankzij jou kon ik af en toe Dagdromen onder 
werktijd. Ik ga je prettige gezelschap missen. Tineke, ik ben blij dat ik je heb leren 
kennen en dat je mijn paranimf wilt zijn. Ik hoop dat je ook op afstand mijn uit-
laatklep wilt blijven. Cécile, door jou ben ik bij SP terecht gekomen. Bedankt voor 
je vertrouwen in me en voor de fijne persoon die je bent. Dank jullie wel, oud-
roomies Janneke en Josien, die me na een stroef begin (‘zo’n Hollandse verdient 
ook geen naambordje aan jullie kamerdeur!’) zo liefdevol hebben opgenomen op 
hun kamer. 
 
De teamleden van Psycope team 3 bedankt, jullie boden me de mogelijkheid om 
wetenschap door een klinische bril te bekijken. Ik heb er veel van geleerd. Doro-
thé, Jorg en het Verfilmde Waan team, het was ontzettend leuk om ‘ons Filmfesti-
val’ met jullie te organiseren! 
 
Dankjewel lieve vrienden. Dankzij eetdeets, festivals, goede gesprekken en andere 
(ont)spannende momenten werden de juiste omstandigheden gecreëerd om ‘we-
tenschap te kunnen bedrijven’. Inge, dankjewel voor je ontwerp van de voorkant 
van dit boekje, ook al kostte het misschien wat Ups en Downs. Pauline, mijn 
schatbewaarster, ik ken sinds de allereerste onderwijsgroep van onze studie. Het 
kan niet anders dan dat jij mijn paranimf bent. Mijn lieve ouders, bedankt voor 
jullie onvoorwaardelijke steun in alles wat ik doe en laat. Tenslotte, dankjewel Sara. 
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